siddharthlohani commited on
Commit
0d9dc73
·
verified ·
1 Parent(s): 7768cb5

Add files using upload-large-folder tool

Browse files
This view is limited to 50 files because it contains too many changes.   See raw diff
Files changed (50) hide show
  1. parsed_sections/legal_matters/2021/AAWH_ascend_legal_matters.txt +1 -0
  2. parsed_sections/legal_matters/2021/ABCL_abcellera_legal_matters.txt +1 -0
  3. parsed_sections/legal_matters/2021/ABOS_acumen_legal_matters.txt +1 -0
  4. parsed_sections/legal_matters/2021/ABSI_absci-corp_legal_matters.txt +1 -0
  5. parsed_sections/legal_matters/2021/ACHR-WT_archer_legal_matters.txt +1 -0
  6. parsed_sections/legal_matters/2021/ACT_enact_legal_matters.txt +1 -0
  7. parsed_sections/legal_matters/2021/ACVA_acv_legal_matters.txt +1 -0
  8. parsed_sections/legal_matters/2021/ADV_advantage_legal_matters.txt +1 -0
  9. parsed_sections/legal_matters/2021/AEI_alset-inc_legal_matters.txt +427 -0
  10. parsed_sections/legal_matters/2021/AFRM_affirm_legal_matters.txt +1 -0
  11. parsed_sections/legal_matters/2021/AKA_a-k-a_legal_matters.txt +1 -0
  12. parsed_sections/legal_matters/2021/ALGS_aligos_legal_matters.txt +1 -0
  13. parsed_sections/legal_matters/2021/ALHC_alignment_legal_matters.txt +1 -0
  14. parsed_sections/legal_matters/2021/ALIT_alight_legal_matters.txt +1 -0
  15. parsed_sections/legal_matters/2021/ALPWF_globalink_legal_matters.txt +1161 -0
  16. parsed_sections/legal_matters/2021/AMBP-WT_ardagh_legal_matters.txt +1 -0
  17. parsed_sections/legal_matters/2021/AMPGW_amplitech_legal_matters.txt +0 -0
  18. parsed_sections/legal_matters/2021/AMWL_american_legal_matters.txt +1 -0
  19. parsed_sections/legal_matters/2021/ANY_sphere-3d_legal_matters.txt +1 -0
  20. parsed_sections/legal_matters/2021/APP_applovin_legal_matters.txt +1 -0
  21. parsed_sections/legal_matters/2021/APXIF_apx_legal_matters.txt +1715 -0
  22. parsed_sections/legal_matters/2021/ARBKL_argo_legal_matters.txt +1 -0
  23. parsed_sections/legal_matters/2021/ARHS_arhaus-inc_legal_matters.txt +1 -0
  24. parsed_sections/legal_matters/2021/ARIS_aris_legal_matters.txt +1 -0
  25. parsed_sections/legal_matters/2021/ARKOW_arko-corp_legal_matters.txt +1 -0
  26. parsed_sections/legal_matters/2021/ARQQW_arqit_legal_matters.txt +1 -0
  27. parsed_sections/legal_matters/2021/ASLE_aersale_legal_matters.txt +1 -0
  28. parsed_sections/legal_matters/2021/ASTLW_algoma_legal_matters.txt +1 -0
  29. parsed_sections/legal_matters/2021/ATEKW_athena_legal_matters.txt +1720 -0
  30. parsed_sections/legal_matters/2021/ATHA_leonabio_legal_matters.txt +1 -0
  31. parsed_sections/legal_matters/2021/AURA_aura_legal_matters.txt +1 -0
  32. parsed_sections/legal_matters/2021/AUROW_aurora_legal_matters.txt +1 -0
  33. parsed_sections/legal_matters/2021/AVAH_aveanna_legal_matters.txt +1 -0
  34. parsed_sections/legal_matters/2021/AVPT_avepoint_legal_matters.txt +1 -0
  35. parsed_sections/legal_matters/2021/BAOS_baosheng_legal_matters.txt +0 -0
  36. parsed_sections/legal_matters/2021/BASA_basanite_legal_matters.txt +2959 -0
  37. parsed_sections/legal_matters/2021/BCAB_bioatla_legal_matters.txt +1 -0
  38. parsed_sections/legal_matters/2021/BCRD_blueone_legal_matters.txt +210 -0
  39. parsed_sections/legal_matters/2021/BEEP_mobile_legal_matters.txt +1 -0
  40. parsed_sections/legal_matters/2021/BEPJ_brookfield_legal_matters.txt +1 -0
  41. parsed_sections/legal_matters/2021/BFLY-WT_butterfly_legal_matters.txt +1 -0
  42. parsed_sections/legal_matters/2021/BKKT-WT_bakkt_legal_matters.txt +1 -0
  43. parsed_sections/legal_matters/2021/BKSY-WT_blacksky_legal_matters.txt +1 -0
  44. parsed_sections/legal_matters/2021/BLBX_blackboxst_legal_matters.txt +0 -0
  45. parsed_sections/legal_matters/2021/BLZE_backblaze_legal_matters.txt +1 -0
  46. parsed_sections/legal_matters/2021/BMBL_bumble-inc_legal_matters.txt +1 -0
  47. parsed_sections/legal_matters/2021/BMEA_biomea_legal_matters.txt +1 -0
  48. parsed_sections/legal_matters/2021/BOLT_bolt_legal_matters.txt +1 -0
  49. parsed_sections/legal_matters/2021/BRCFF_brookfield_legal_matters.txt +1 -0
  50. parsed_sections/legal_matters/2021/BRLSW_borealis_legal_matters.txt +3022 -0
parsed_sections/legal_matters/2021/AAWH_ascend_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the securities being offered by this prospectus and certain legal matters in connection with this offering relating to U.S. law will be passed upon for us by Dorsey Whitney LLP. Saul Ewing Arnstein Lehr LLP is representing the underwriters.
parsed_sections/legal_matters/2021/ABCL_abcellera_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of our common shares offered by this prospectus will be passed upon for us by Blake, Cassels & Graydon LLP, Vancouver, British Columbia.
parsed_sections/legal_matters/2021/ABOS_acumen_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the shares of common stock offered hereby will be passed upon for us by Cooley LLP, Reston, Virginia. Certain legal matters will be passed upon for the underwriters by Ropes & Gray LLP, Boston, Massachusetts.
parsed_sections/legal_matters/2021/ABSI_absci-corp_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ Legal Matters The validity of the common stock offered hereby will be passed upon for us by Goodwin Procter LLP, San Francisco, California. Legal matters in connection with the offering will be passed upon for the underwriters by Latham Watkins LLP, Menlo Park, California.
parsed_sections/legal_matters/2021/ACHR-WT_archer_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the securities offered hereby will be passed upon for us by Cooley LLP.
parsed_sections/legal_matters/2021/ACT_enact_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the common stock offered hereby will be passed upon for us by Sidley Austin LLP. Certain legal matters will be passed upon for us by Evan Stolove, our Executive Vice President and General Counsel. Certain legal matters will be passed upon for the underwriters by Cleary Gottlieb Steen Hamilton LLP. Skadden, Arps, Slate, Meagher Flom LLP is acting as legal counsel to Genworth Financial, Inc.
parsed_sections/legal_matters/2021/ACVA_acv_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the shares of Class A common stock being offered by this prospectus will be passed upon for us by Cooley LLP, New York, New York. Certain legal matters in connection with this offering will be passed upon for the underwriters by Davis Polk & Wardwell LLP, New York, New York.
parsed_sections/legal_matters/2021/ADV_advantage_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of any securities offered by this prospectus will be passed upon for us by Shearman & Sterling LLP.
parsed_sections/legal_matters/2021/AEI_alset-inc_legal_matters.txt ADDED
@@ -0,0 +1,427 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ legal matters by their counsel and other conditions specified in the underwriting agreement. The underwriters
2
+ reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part.
3
+
4
+
5
+
6
+ The
7
+ underwriters propose to offer the common stock and the Pre-funded Warrants offered by us to the public at the public offering price set
8
+ forth on the cover of this prospectus. In addition, the underwriters may offer some of the common stock and/or the Pre-funded Warrants
9
+ to other securities dealers at such price less a concession of $[ ] per share or Pre-funded Warrant. After the initial offering, the
10
+ public offering price and concession to dealers may be changed.
11
+
12
+
13
+
14
+ Discount
15
+
16
+
17
+
18
+ The following table shows
19
+ the public offering price, underwriting discount, non-accountable underwriters expense allowance and proceeds, before expenses,
20
+ to us. The information assumes either no exercise or full exercise by the underwriters of their over-allotment option.
21
+
22
+
23
+
24
+
25
+
26
+
27
+
28
+ Total
29
+
30
+
31
+
32
+ Per Share
33
+ Per Pre-funded Warrant
34
+ Without Over-
35
+ Allotment
36
+
37
+ With Over-
38
+ Allotment
39
+
40
+
41
+
42
+ Public offering price
43
+ $
44
+ $
45
+ $36,000,000
46
+ $41,400,000
47
+
48
+
49
+ Underwriting discount (7.0%)
50
+ $
51
+ $
52
+ $2,520,000
53
+ $2,898,000
54
+
55
+
56
+ Non-accountable expense allowance (1%)
57
+ $
58
+ $
59
+ 360,000
60
+ 414,000
61
+
62
+
63
+ Proceeds, before expenses, to us
64
+ $
65
+ $
66
+ $33,120,000
67
+ $ 38,088,00
68
+
69
+
70
+
71
+
72
+
73
+ Expenses
74
+
75
+
76
+
77
+ We have agreed to pay the underwriter
78
+ a non-accountable expense allowance equal to 1% of the gross proceeds of the Offering. We have also agreed to pay all expenses relating
79
+ to the offering, including, without limitation(a) all filing fees and expenses relating to the registration of the shares to be sold in
80
+ the offering (including shares sold upon exercise of the underwriters over-allotment option) with the Commission; (b) all FINRA
81
+ Public Offering filing fees; (c) all fees and expenses relating to the listing of the Company s equity or equity-linked securities
82
+ on an Exchange; (d) all fees, expenses and disbursements relating to the registration or qualification of the Securities under the "blue
83
+ sky" securities laws of such states and other jurisdictions as underwriters may reasonably designate (including, without limitation,
84
+ all filing and registration fees, and the reasonable fees and disbursements of the Company s "blue sky" counsel, which
85
+ will be underwriter s counsel); (e) all fees, expenses and disbursements relating to the registration, qualification or exemption
86
+ of the shares under the securities laws of such foreign jurisdictions as underwriters may reasonably designate; (f) the costs of all mailing
87
+ and printing of the offering documents; (g) transfer and/or stamp taxes, if any, payable upon the transfer of shares from the Company
88
+ to underwriters; and (h) the fees and expenses of the Company s accountants; and (i) $100,000 for fees and expenses including "road
89
+ show", diligence, and reasonable legal fees and disbursements for Aegis s counsel.
90
+
91
+
92
+
93
+ We estimate that the total expenses
94
+ of the offering, excluding underwriting discount and non-accountable expense allowance, will be approximately $315,548.
95
+
96
+
97
+
98
+ 19
99
+
100
+
101
+
102
+
103
+
104
+ Over-Allotment
105
+ Option
106
+
107
+
108
+
109
+ We
110
+ have granted the underwriters an over-allotment option. This option, which is exercisable for up to 45 days after the closing of this
111
+ Offering, permits the underwriters to purchase additional shares of common stock and/or Pre-funded Warrants, representing 15% of the
112
+ common stock and Pre-funded Warrant sold in the Offering, solely for the purpose of covering over-allotments. If the underwriters exercise
113
+ all or part of this option, they will purchase shares of common stock covered by the option at the public offering price that appears
114
+ on the cover page of this prospectus, less the underwriting discount. The purchase price to be paid per Pre-funded Warrant shall be equal
115
+ to the public offering price of the shares of common stock minus $0.001.
116
+
117
+
118
+
119
+ Company
120
+ Standstill
121
+
122
+
123
+
124
+ We
125
+ have agreed, for a period of two hundred and seventy (270) days after the closing date of this offering, that we will not, without the
126
+ prior written consent of Aegis (a) offer, sell, issue, or otherwise transfer or dispose of, directly or indirectly, any equity of the
127
+ Company or any securities convertible into exercisable or exchangeable for equity of the company; (b) file or cause to be filed any registration
128
+ statement with the SEC relating to the offering of any equity of the Company or any securities convertible into or exercisable or exchangeable
129
+ for equity of the Company, or (c) enter into any agreement or announce the intention to effect any of the actions described in subsections
130
+ (a) or (b) hereof (all of such matters, the "Standstill"). So long as no securities shall be saleable in the public market,
131
+ the foregoing restrictions will not apply with respect to (i) the adoption of an equity incentive plan and the grant of awards or equity
132
+ pursuant to any equity incentive plan and the filing of a registration statement on Form S-8; (ii) the issuance of equity securities
133
+ in connection with an acquisition or strategic relationship, which may include the sale of equity securities, (iii) the issuance of securities
134
+ upon the exercise or exchange of or conversion of any securities issued hereunder and/or securities exercisable or exchangeable for or
135
+ convertible into shares of common stock issued and outstanding on the date of the Underwriting Agreement; and (iv) the issuance of securities
136
+ to affiliates and subsidiaries of the Company.
137
+
138
+
139
+
140
+ Tail
141
+ Financing
142
+
143
+
144
+
145
+ Aegis
146
+ will be entitled to fees in the amounts specified above with respect to any public or private offering or other financing or capital
147
+ raising transaction of any kind ("Tail Financing") to the extent that such financing or capital is provided to the Company
148
+ by funds whom Aegis had contacted during the period beginning on November 8, 2021, and ending two months thereafter or upon the completion
149
+ of or termination of the Offering, whichever is sooner (the "Engagement Period"), or introduced to the Company during the
150
+ Engagement Period, if such Tail Financing is consummated at any time within the six month period following the Engagement Period.
151
+
152
+
153
+
154
+ Stabilization
155
+
156
+
157
+
158
+ In
159
+ accordance with Regulation M under the Exchange Act, the underwriters may engage in activities that stabilize, maintain or otherwise
160
+ affect the price of our common stock, including short sales and purchases to cover positions created by short positions, stabilizing
161
+ transactions, syndicate covering transactions, penalty bids and passive market making.
162
+
163
+
164
+
165
+
166
+
167
+
168
+ Short
169
+ positions involve sales by the underwriters of shares in excess of the number of shares the underwriters are obligated to purchase,
170
+ which creates a syndicate short position. The short position may be either a covered short position or a naked short position. In
171
+ a covered short position, the number of shares involved in the sales made by the underwriters in excess of the number of shares they
172
+ are obligated to purchase is not greater than the number of shares that they may purchase by exercising their option to purchase
173
+ additional shares. In a naked short position, the number of shares involved is greater than the number of shares in their option
174
+ to purchase additional shares. The underwriters may close out any short position by either exercising their option to purchase additional
175
+ shares or purchasing shares in the open market.
176
+
177
+
178
+
179
+
180
+ 20
181
+
182
+
183
+
184
+
185
+
186
+
187
+
188
+
189
+
190
+
191
+ Stabilizing
192
+ transactions permit bids to purchase the underlying security as long as the stabilizing bids do not exceed a specific maximum price.
193
+
194
+
195
+
196
+
197
+
198
+
199
+
200
+
201
+
202
+ Syndicate
203
+ covering transactions involve purchases of our common stock in the open market after the distribution has been completed to cover
204
+ syndicate short positions. In determining the source of shares to close out the short position, the underwriters will consider, among
205
+ other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares
206
+ through the underwriters option to purchase additional shares. If the underwriters sell more shares than could be covered
207
+ by the underwriters option to purchase additional shares, thereby creating a naked short position, the position can only be
208
+ closed out by buying shares in the open market. A naked short position is more likely to be created if the underwriters are concerned
209
+ that there could be downward pressure on the price of the shares in the open market after pricing that could adversely affect investors
210
+ who purchase in the offering.
211
+
212
+
213
+
214
+
215
+
216
+
217
+
218
+
219
+
220
+ Penalty
221
+ bids permit the representative to reclaim a selling concession from a syndicate member when the common stock originally sold by the
222
+ syndicate member is purchased in a stabilizing or syndicate covering transaction to cover syndicate short positions.
223
+
224
+
225
+
226
+
227
+
228
+
229
+
230
+
231
+
232
+ In
233
+ passive market making, market makers in our common stock who are underwriters or prospective underwriters may, subject to limitations,
234
+ make bids for or purchase shares of our common stock until the time, if any, at which a stabilizing bid is made.
235
+
236
+
237
+
238
+
239
+ These
240
+ activities may have the effect of raising or maintaining the market price of our common stock or preventing or retarding a decline in
241
+ the market price of our common stock. As a result of these activities, the price of our common stock may be higher than the price that
242
+ might otherwise exist in the open market. These transactions may be effected on Nasdaq or otherwise and, if commenced, may be discontinued
243
+ at any time.
244
+
245
+
246
+
247
+ Neither
248
+ we nor any of the underwriters make any representation or prediction as to the direction or magnitude of any effect that the transactions
249
+ described above may have on the price of our common stock. In addition, neither we nor any of the underwriters make any representation
250
+ that the Representative will engage in these stabilizing transactions or that any transaction, once commenced, will not be discontinued
251
+ without notice.
252
+
253
+
254
+
255
+ Offering
256
+ Price Determination
257
+
258
+
259
+
260
+ The
261
+ public offering price was negotiated between the representative and us. In determining the public offering price of our common stock,
262
+ the representative considered:
263
+
264
+
265
+
266
+
267
+
268
+ the
269
+ history and prospects for the industry in which we compete;
270
+
271
+
272
+
273
+
274
+
275
+
276
+
277
+ our
278
+ financial information;
279
+
280
+
281
+
282
+
283
+
284
+
285
+
286
+ the
287
+ ability of our management and our business potential and earning prospects;
288
+
289
+
290
+
291
+
292
+
293
+
294
+
295
+ the
296
+ prevailing securities markets at the time of this offering; and
297
+
298
+
299
+
300
+
301
+
302
+
303
+
304
+ the
305
+ recent market prices of, and the demand for, publicly traded shares of generally comparable companies, as well as the recent market
306
+ price of our Company s common stock.
307
+
308
+
309
+
310
+
311
+ 21
312
+
313
+
314
+
315
+
316
+
317
+
318
+
319
+ Indemnification
320
+
321
+
322
+
323
+ We
324
+ have agreed to indemnify Aegis, its affiliates and each person controlling Aegis against any losses, claims, damages, judgments, assessments,
325
+ costs, and other liabilities, as the same are incurred (including the reasonable fees and expenses of counsel), relating to or arising
326
+ out of the offering, undertaken in good faith.
327
+
328
+
329
+
330
+ Discretionary
331
+ Accounts
332
+
333
+
334
+
335
+ The
336
+ underwriters have informed us that they do not expect to make sales to accounts over which they exercise discretionary authority in excess
337
+ of 5% of the shares of our common stock being offered in this offering.
338
+
339
+
340
+
341
+ Other
342
+ Relationships
343
+
344
+
345
+
346
+ Aegis
347
+ may in the future provide us and our affiliates with investment banking and financial advisory services for which Aegis may in the future
348
+ receive customary fees. Aegis may release, or authorize us to release, as the case may be, the common stock and other securities subject
349
+ to the lock-up agreements described above in whole or in part at any time with or without notice.
350
+
351
+
352
+
353
+ In
354
+ connection with our initial public offering, on November 23, 2020, we entered into an underwriting agreement with Aegis pursuant to which
355
+ Aegis received an aggregate of $1,360,800 in underwriting discounts and non-accountable expenses. In addition, we issued Aegis warrants
356
+ to purchase 108,000 shares of our common stock at an exercise price of $9.80 per share.
357
+
358
+
359
+
360
+ On
361
+ May 10, 2021, we entered into an underwriting agreement with Aegis pursuant to which Aegis received an aggregate of $2,480,000 in underwriting
362
+ discounts and non-accountable expenses. On June 17, 2021, Aegis received approximately $317,626 in underwriting discounts and non-accountable
363
+ expenses in connection with exercise of the overallotment option.
364
+
365
+
366
+
367
+ On July 27, 2021, we entered into
368
+ an underwriting agreement with Aegis pursuant to which Aegis received an aggregate of $2,720,000 in underwriting discounts and non-accountable
369
+ expenses. On September 9, 2021, Aegis received approximately $408,000 in underwriting discounts and non-accountable expenses in connection
370
+ with exercise of the overallotment option.
371
+
372
+
373
+
374
+ Offer
375
+ restrictions outside the United States
376
+
377
+
378
+
379
+ Other
380
+ than in the United States, no action has been taken by us or the underwriter that would permit a public offering of the securities offered
381
+ by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be
382
+ offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with
383
+ the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result
384
+ in compliance with the applicable rules and regulations of that jurisdiction. Persons who come into possession of this prospectus are
385
+ advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus.
386
+ This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in
387
+ any jurisdiction in which such an offer or a solicitation is unlawful.
388
+
389
+
390
+
391
+ 22
392
+
393
+
394
+
395
+
396
+
397
+
398
+
399
+ Electronic
400
+ Distribution
401
+
402
+
403
+
404
+ A
405
+ prospectus in electronic format may be made available on the websites maintained by one or more of the underwriters or selling group
406
+ members, if any, participating in the offering. The Representative may allocate a number of shares to the underwriters and selling group
407
+ members, if any, for sale to their online brokerage account holders. Any such allocations for online distributions will be made by the
408
+ representative on the same basis as other allocations.
409
+
410
+
411
+
412
+ Listing
413
+
414
+
415
+
416
+ Our
417
+ common stock listed on the Nasdaq Capital Market under the symbol "AEI."
418
+
419
+
420
+
421
+ Transfer
422
+ Agent and Registrar
423
+
424
+
425
+
426
+ The
427
+ transfer agent and registrar for our common stock is Direct Transfer, LLC, Raleigh, North Carolina.
parsed_sections/legal_matters/2021/AFRM_affirm_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the shares of Class A common stock offered by this prospectus will be passed upon for us by Skadden, Arps, Slate, Meagher & Flom LLP. Certain legal matters relating to this offering will be passed upon for the underwriters by Davis Polk & Wardwell LLP.
parsed_sections/legal_matters/2021/AKA_a-k-a_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS Kirkland & Ellis LLP, Chicago, Illinois will pass upon the validity of the common stock offered hereby on our behalf. Kirkland & Ellis LLP has from time to time represented Summit Partners and some of their respective affiliates in connection with various legal matters. The underwriters are represented by Davis Polk & Wardwell LLP.
parsed_sections/legal_matters/2021/ALGS_aligos_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ Legal matters The validity of the issuance of our common stock offered in this prospectus will be passed upon for us by Latham & Watkins LLP, Menlo Park, California. Davis Polk & Wardwell LLP, Menlo Park, California is acting as counsel for the underwriters in connection with this offering. Latham & Watkins LLP and certain attorneys and investment funds affiliated with the firm own an aggregate of 14,294 shares of common stock of the Company.
parsed_sections/legal_matters/2021/ALHC_alignment_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the issuance of our common stock offered in this prospectus will be passed upon for us by Paul, Weiss, Rifkind, Wharton & Garrison LLP, New York, New York. Certain legal matters will be passed upon for the underwriters by Davis Polk & Wardwell LLP, New York, New York. Table of Contents
parsed_sections/legal_matters/2021/ALIT_alight_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the securities offered hereby will be passed upon for us by Kirkland & Ellis LLP. Any underwriters or agents will be advised about other issues relating to the offering by counsel to be named in the applicable prospectus supplement.
parsed_sections/legal_matters/2021/ALPWF_globalink_legal_matters.txt ADDED
@@ -0,0 +1,1161 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ LEGAL
2
+ MATTERS
3
+
4
+
5
+
6
+ Hunter
7
+ Taubman Fischer & Li LLC is acting as counsel in connection with the registration of our securities under the Securities Act, and
8
+ as such, will pass upon the validity of the securities offered in this prospectus. Certain legal matters will be passed upon on behalf
9
+ of the underwriters by Troutman Pepper Hamilton Sanders LLP.
10
+
11
+
12
+
13
+ EXPERTS
14
+
15
+
16
+
17
+ The
18
+ balance sheet of Globalink Investment Inc. as of September 8, 2021 and the related statements of operations, changes in stockholder s
19
+ equity and cash flows for the period from March 24, 2021 (inception) through September 8, 2021 appearing in this prospectus have been
20
+ audited by Friedman LLP, independent registered public accounting firm, as set forth in their report thereon (which contains an explanatory
21
+ paragraph relating to substantial doubt about the ability of Globalink Investment Inc. to continue as a going concern as described in
22
+ Note 1 to the financial statements), appearing elsewhere in this prospectus, and are included in reliance upon such report given on the
23
+ authority of such firm as experts in accounting and auditing.
24
+
25
+
26
+
27
+ WHERE
28
+ YOU CAN FIND ADDITIONAL INFORMATION
29
+
30
+
31
+
32
+ We
33
+ have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the securities we are offering
34
+ by this prospectus. This prospectus does not contain all of the information included in the registration statement. For further information
35
+ about us and our securities, you should refer to the registration statement and the exhibits and schedules filed with the registration
36
+ statement. Whenever we make reference in this prospectus to any of our contracts, agreements or other documents, the references are materially
37
+ complete but may not include a description of all aspects of such contracts, agreements or other documents, and you should refer to the
38
+ exhibits attached to the registration statement for copies of the actual contract, agreement or other document.
39
+
40
+
41
+
42
+ Upon
43
+ completion of this offering, we will be subject to the information requirements of the Exchange Act and will file annual, quarterly and
44
+ current event reports, proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy
45
+ and information statements and other information regarding registrants that file electronically with the SEC. The SEC s website
46
+ address is www.sec.gov.
47
+
48
+
49
+
50
+ 111
51
+
52
+
53
+
54
+
55
+
56
+
57
+
58
+ GLOBALINK
59
+ INVESTMENT INC.
60
+
61
+ Index to Financial Statements
62
+
63
+
64
+
65
+
66
+
67
+ Page
68
+
69
+
70
+ Report
71
+ of Independent Registered Public Accounting Firm
72
+ F-2
73
+
74
+
75
+ Balance
76
+ Sheet as of September 8, 2021
77
+ F-3
78
+
79
+
80
+ Statement
81
+ of Operations for the period from March 24, 2021 (inception) through September 8, 2021
82
+ F-4
83
+
84
+
85
+ Statement
86
+ of Changes in Stockholder s Equity for the period from March 24, 2021 (inception) through September 8, 2021
87
+ F-5
88
+
89
+
90
+ Statement
91
+ of Cash Flows for the period from March 24, 2021 (inception) through September 8, 2021
92
+ F-6
93
+
94
+
95
+ Notes
96
+ to Financial Statements
97
+ F-7
98
+
99
+
100
+
101
+
102
+ F-1
103
+
104
+
105
+
106
+
107
+
108
+
109
+
110
+
111
+
112
+ REPORT OF INDEPENDENT REGISTERED
113
+ PUBLIC ACCOUNTING FIRM
114
+
115
+
116
+
117
+ To the Board of Directors and Stockholders of
118
+
119
+ Globalink Investment Inc.
120
+
121
+
122
+
123
+ Opinion on the Financial Statements
124
+
125
+
126
+
127
+ We have audited the accompanying balance sheet of
128
+ Globalink Investment Inc. (the "Company") as of September 8, 2021 and the related statements of operations, changes in stockholders
129
+ equity and cash flows for the period from March 24, 2021 (inception) through September 8, 2021 and the related notes (collectively referred
130
+ to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the
131
+ financial position of the Company as of September 8, 2021 and the results of its operations and its cash flows for the period from March
132
+ 24, 2021 (inception) through September 8, 2021, in conformity with accounting principles generally accepted in the United States of America.
133
+
134
+
135
+
136
+ Explanatory Paragraph — Going Concern
137
+
138
+
139
+
140
+ The accompanying financial statements have been prepared
141
+ assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, its business plan is
142
+ dependent on the completion of a financing and the Company s cash and working capital as of September 8, 2021 are not sufficient
143
+ to complete its planned activities. These conditions raise substantial doubt about the Company s ability to continue as a going
144
+ concern. Management s plans in regard to these matters are also described in Notes 1 and 3. The financial statements do not include
145
+ any adjustments that might result from the outcome of this uncertainty.
146
+
147
+
148
+
149
+ Basis for Opinion
150
+
151
+
152
+
153
+ These financial statements are the responsibility
154
+ of the Company s management. Our responsibility is to express an opinion on the Company s financial statements based on our
155
+ audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB")
156
+ and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
157
+ rules and regulations of the Securities and Exchange Commission and the PCAOB.
158
+
159
+
160
+
161
+ We conducted our audit in accordance with the standards
162
+ of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
163
+ are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform,
164
+ an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal
165
+ control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company s internal
166
+ control over financial reporting. Accordingly, we express no such opinion.
167
+
168
+
169
+
170
+ Our audit included performing procedures to assess
171
+ the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
172
+ to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial
173
+ statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as
174
+ evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
175
+
176
+
177
+
178
+ /s/Friedman LLP
179
+
180
+
181
+
182
+ Friedman LLP
183
+
184
+
185
+
186
+ We have served as the Company s auditor since
187
+ 2021.
188
+
189
+
190
+
191
+ New York, NY
192
+
193
+ October 19, 2021, except for Notes 1 and 5 which
194
+ are dated November 19, 2021
195
+
196
+
197
+
198
+ F-2
199
+
200
+
201
+
202
+
203
+
204
+
205
+
206
+ Globalink
207
+ Investment Inc.
208
+
209
+ BALANCE
210
+ SHEET
211
+
212
+ As
213
+ of September 8, 2021
214
+
215
+
216
+
217
+
218
+
219
+
220
+
221
+
222
+ ASSETS
223
+
224
+
225
+
226
+
227
+
228
+
229
+
230
+ CURRENT
231
+ ASSETS
232
+
233
+
234
+
235
+ Prepaid
236
+ expenses
237
+ $50,000
238
+
239
+
240
+ Total
241
+ current assets
242
+ 50,000
243
+
244
+
245
+
246
+
247
+
248
+
249
+ OTHER
250
+ ASSETS
251
+
252
+
253
+
254
+ Deferred
255
+ offering costs
256
+ 61,331
257
+
258
+
259
+ Total
260
+ other assets
261
+ 61,331
262
+
263
+
264
+
265
+
266
+
267
+
268
+ TOTAL
269
+ ASSETS
270
+ $111,331
271
+
272
+
273
+
274
+
275
+
276
+
277
+ LIABILITIES
278
+ AND STOCKHOLDERS , ' ': EQUITY
279
+
280
+
281
+
282
+
283
+
284
+
285
+
286
+ CURRENT
287
+ LIABILITIES
288
+
289
+
290
+
291
+ Accounts
292
+ payable and accrued expenses
293
+ $1,000
294
+
295
+
296
+ Accrued
297
+ offering costs
298
+ 16,331
299
+
300
+
301
+ Note
302
+ payable – related party
303
+ 70,000
304
+
305
+
306
+ Total
307
+ liabilities
308
+ 87,331
309
+
310
+
311
+
312
+
313
+
314
+
315
+ COMMITMENTS
316
+ AND CONTINGENCIES
317
+
318
+
319
+
320
+
321
+
322
+
323
+
324
+ STOCKHOLDER S
325
+ EQUITY
326
+
327
+
328
+
329
+ Common
330
+ stock; $0.001 par value; 50,000,000 shares authorized; 2,875,000 issued and outstanding (1)
331
+ 2,875
332
+
333
+
334
+ Additional
335
+ paid-in capital
336
+ 22,125
337
+
338
+
339
+ Accumulated
340
+ deficit
341
+ (1,000)
342
+
343
+
344
+ Total
345
+ stockholders equity
346
+ 24,000
347
+
348
+
349
+ TOTAL
350
+ LIABILITIES AND STOCKHOLDERS EQUITY
351
+ $111,331
352
+
353
+
354
+
355
+
356
+
357
+ (1)This
358
+ number includes an aggregate of up to 375,000 shares of common stock subject to forfeiture
359
+ if the underwriters over-allotment option is not exercised in full or in part by the
360
+ underwriter (see Note 4).
361
+
362
+
363
+
364
+ The
365
+ accompanying notes are an integral part of these financial statements
366
+
367
+
368
+
369
+ F-3
370
+
371
+
372
+
373
+
374
+
375
+
376
+
377
+ Globalink
378
+ Investment Inc.
379
+
380
+ STATEMENT
381
+ OF OPERATIONS
382
+
383
+ For
384
+ the period March 24, 2021 (inception) through September 8, 2021
385
+
386
+
387
+
388
+
389
+
390
+
391
+
392
+
393
+
394
+ For
395
+ the period March 24, 2021 (inception) through September 8, 2021
396
+
397
+
398
+ OPERATING
399
+ EXPENSES
400
+
401
+
402
+
403
+ General
404
+ and administrative
405
+ $1,000
406
+
407
+
408
+ Total
409
+ expenses
410
+ 1,000
411
+
412
+
413
+ NET
414
+ LOSS
415
+ $(1,000)
416
+
417
+
418
+
419
+
420
+
421
+
422
+ Weighted
423
+ average shares outstanding, basic and diluted (1)
424
+ 2,500,000
425
+
426
+
427
+ Basic
428
+ and diluted net loss per share
429
+ $(0.00)
430
+
431
+
432
+
433
+
434
+
435
+ (1)This
436
+ number excludes an aggregate of up to 375,000 shares of common stock subject to forfeiture
437
+ if the underwriters over-allotment option is not exercised in full or in part by the
438
+ underwriter (see Note 4).
439
+
440
+
441
+
442
+ The
443
+ accompanying notes are an integral part of these financial statements
444
+
445
+
446
+
447
+ F-4
448
+
449
+
450
+
451
+
452
+
453
+
454
+
455
+ Globalink
456
+ Investment Inc.
457
+
458
+ STATEMENT
459
+ OF CHANGES IN STOCKHOLDERS EQUITY
460
+
461
+ For
462
+ the period March 24, 2021 (inception) through September 8, 2021
463
+
464
+
465
+
466
+
467
+
468
+
469
+
470
+
471
+
472
+ Common
473
+ Stock
474
+
475
+
476
+
477
+
478
+
479
+
480
+
481
+ Shares
482
+
483
+
484
+ Amount
485
+
486
+ Additional
487
+ paid-in capital
488
+ Accumulated
489
+ deficit
490
+ Total
491
+
492
+ stockholders
493
+ equity
494
+
495
+
496
+
497
+ Balance,
498
+ March 24, 2021
499
+ —
500
+ $—
501
+ $—
502
+ $—
503
+ $—
504
+
505
+
506
+
507
+
508
+
509
+
510
+
511
+
512
+
513
+
514
+ Issuance
515
+ of common stock to sponsor (1)
516
+ 2,875,000
517
+ 2,875
518
+ 22,125
519
+ —
520
+ 25,000
521
+
522
+
523
+
524
+
525
+
526
+
527
+
528
+
529
+
530
+
531
+ Net
532
+ loss
533
+ —
534
+ —
535
+ —
536
+ (1,000)
537
+ (1,000)
538
+
539
+
540
+
541
+
542
+
543
+
544
+
545
+
546
+
547
+
548
+ Balance,
549
+ September 8, 2021
550
+ 2,875,000
551
+ $2,875
552
+ $22,125
553
+ $(1,000)
554
+ $24,000
555
+
556
+
557
+
558
+
559
+
560
+ (1)This
561
+ number includes an aggregate of up to 375,000 shares of common stock subject to forfeiture
562
+ if the underwriters over-allotment option is not exercised in full or in part by the
563
+ underwriter (see Note 4).
564
+
565
+
566
+
567
+ The
568
+ accompanying notes are an integral part of these financial statements
569
+
570
+
571
+
572
+ F-5
573
+
574
+
575
+
576
+
577
+
578
+
579
+
580
+ Globalink
581
+ Investment Inc.
582
+
583
+ STATEMENT
584
+ OF CASH FLOWS
585
+
586
+ For
587
+ the period March 24, 2021 (inception) through September 8, 2021
588
+
589
+
590
+
591
+
592
+
593
+
594
+
595
+
596
+
597
+ For
598
+ the period March 24, 2021 (inception) through September 8, 2021
599
+
600
+
601
+ CASH
602
+ FLOWS FROM OPERATING ACTIVITIES
603
+
604
+
605
+
606
+ Net
607
+ loss
608
+ $(1,000)
609
+
610
+
611
+ Adjustments
612
+ to reconcile net income to net cash used in operating activities
613
+
614
+
615
+
616
+ Accounts
617
+ payable and accrued expenses
618
+ 1,000
619
+
620
+
621
+
622
+
623
+
624
+
625
+ Net
626
+ cash used in operating activities
627
+ —
628
+
629
+
630
+
631
+
632
+
633
+
634
+ NET
635
+ INCREASE (DECREASE) IN CASH
636
+ —
637
+
638
+
639
+
640
+
641
+
642
+
643
+ CASH,
644
+ BEGINNING OF PERIOD
645
+ —
646
+
647
+
648
+
649
+
650
+
651
+
652
+ CASH,
653
+ END OF PERIOD
654
+ $—
655
+
656
+
657
+
658
+
659
+
660
+
661
+ Supplemental
662
+ disclosure of noncash activities:
663
+
664
+
665
+
666
+ Payment
667
+ of prepaid expenses by the Sponsor in exchange for the issuance of common stock
668
+ $25,000
669
+
670
+
671
+ Payment
672
+ of deferred offering costs by note payable – related party
673
+ $45,000
674
+
675
+
676
+ Prepaid
677
+ expenses paid by note payable – related party
678
+ $25,000
679
+
680
+
681
+ Deferred
682
+ offering costs included in accrued offering costs
683
+ $16,331
684
+
685
+
686
+
687
+
688
+
689
+ The
690
+ accompanying notes are an integral part of these financial statements
691
+
692
+
693
+
694
+ F-6
695
+
696
+
697
+
698
+
699
+
700
+
701
+
702
+ Globalink
703
+ Investment Inc.
704
+
705
+
706
+
707
+ NOTES
708
+ TO FINANCIAL STATEMENTS
709
+
710
+
711
+
712
+ September
713
+ 8, 2021
714
+
715
+
716
+
717
+ Note
718
+ 1 – Description of Organization, Business Operations and Going Concern
719
+
720
+
721
+
722
+ Globalink
723
+ Investment Inc. (the "Company") was incorporated in Delaware on March 24, 2021. The Company was formed for the purpose of
724
+ effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one
725
+ or more businesses (the "Business Combination"). Although the Company is not limited to a particular industry or sector for
726
+ purposes of consummating a Business Combination, the Company intends to focus its search on technology industry, specifically within
727
+ the e-commerce and payments sectors. The Company is an emerging growth company and, as such, the Company is subject to all of the risks
728
+ associated with emerging growth companies.
729
+
730
+
731
+
732
+ As
733
+ of September 8, 2021, the Company had not commenced any operations. All activity for the period from March 24, 2021 (inception) through
734
+ September 8, 2021, relates to the Company s formation and the proposed initial public offering described below. The Company will
735
+ not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will
736
+ generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Proposed
737
+ Public Offering (as defined below). The Company has selected December 31 as its fiscal year end.
738
+
739
+
740
+
741
+ The
742
+ Company s ability to commence operations is contingent upon obtaining adequate financial resources through a proposed public offering
743
+ (the "Proposed Public Offering") of 10,000,000 units (each, a "Unit" and collectively, the "Units")
744
+ at $10.00 per Unit (or 11,500,000 units if the underwriters over-allotment option is exercised in full), which is discussed in
745
+ Note 3, and the sale of 517,500 units for an aggregate of $5,175,000 (or 570,000 units if the underwriters
746
+ over-allotment option is exercised in full, for an aggregate of $5,700,000 (the "Private Units") at a price of $10.00
747
+ per Private Placement Unit in a private placement to Public Gold Marketing Sdn. Bhd, a Malaysian private limited company, an entity not
748
+ affiliated with the company, the sponsor or the underwriters, that will close simultaneously with the Proposed Public Offering.
749
+
750
+
751
+
752
+ The
753
+ Company s management has broad discretion with respect to the specific application of the net proceeds of the Proposed Public Offering
754
+ and the sale of Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating
755
+ a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.
756
+
757
+
758
+
759
+ The
760
+ Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held
761
+ in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust
762
+ Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business
763
+ Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise
764
+ acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment
765
+ Company Act of 1940, as amended (the "Investment Company Act"). Upon the closing of the Proposed Public Offering, management
766
+ has agreed that an amount equal to at least $10.15 per Unit sold in the Proposed Public Offering will be held in a trust account
767
+ ("Trust Account") and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the
768
+ Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money
769
+ market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company
770
+ Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the
771
+ Trust Account as described below.
772
+
773
+
774
+
775
+ F-7
776
+
777
+
778
+
779
+
780
+
781
+
782
+
783
+ The
784
+ Company will provide its holders of the outstanding its common stock, par value $0.001 ("common stock"), sold in the Proposed
785
+ Public Offering (the "public stockholders") with the opportunity to redeem all or a portion of their Public Share upon the
786
+ completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or
787
+ (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct
788
+ a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public
789
+ Shares (as defined below in Note 3) for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.15
790
+ per Public Share). The per-share amount to be distributed to public stockholders who redeem their Public Shares will not be reduced
791
+ by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares will
792
+ be recorded at a redemption value and classified as temporary equity upon the completion of the Proposed Public Offering in accordance
793
+ with the Financial Accounting Standards Board s ("FASB") Accounting Standards Codification ("ASC") Topic
794
+ 480 "Distinguishing Liabilities from Equity." In such case, the Company will proceed with a Business Combination if the Company
795
+ has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are
796
+ voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder
797
+ vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the "Amended
798
+ and Restated Certificate of Incorporation"), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities
799
+ and Exchange Commission ("SEC") and file tender offer documents with the SEC prior to completing a Business Combination.
800
+ If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business
801
+ or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not
802
+ pursuant to the tender offer rules. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether
803
+ they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination,
804
+ the initial stockholders (as defined below) have agreed to vote its Founder Shares (as defined below in Note 4) and any Public Shares
805
+ purchased during or after the Proposed Public Offering in favor of a Business Combination.
806
+
807
+
808
+
809
+ Subsequent
810
+ to the consummation of the Proposed Public Offering, the Company will adopt an insider trading policy which will require insiders to:
811
+ (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material non-public information
812
+ and (ii) to clear all trades with the Company s legal counsel prior to execution. In addition, our insiders have entered into letter
813
+ agreements with us, pursuant to which they have agreed to waive their redemption rights with respect to their insider shares if we fail
814
+ to complete our initial business combination within 15 months (or up to 21 months if our time to complete a business combination
815
+ is extended as described herein) from the closing of this offering (although they will be entitled to redemption rights with respect
816
+ to any public shares they hold if we fail to complete our business combination within the prescribed time frame).
817
+
818
+
819
+
820
+ Notwithstanding
821
+ the foregoing, the Amended and Restated Certificate of Incorporation will provide that a public shareholder, together with any affiliate
822
+ of such shareholder or any other person with whom such shareholder is acting in concert or as a "group" (as defined under
823
+ Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), will be restricted from redeeming its
824
+ shares with respect to more than an aggregate of 15% or more of the common stock sold in the Proposed Public Offering, without the prior
825
+ consent of the Company.
826
+
827
+
828
+
829
+ The
830
+ Company s sponsor, officers and directors (the "initial stockholders") have agreed not to propose an amendment to the
831
+ Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company s obligation to redeem
832
+ 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders
833
+ with the opportunity to redeem their common stock in conjunction with any such amendment.
834
+
835
+
836
+
837
+ If
838
+ the Company is unable to complete a Business Combination within 15 months (or up to 21 months if it s time to complete
839
+ a business combination is extended) from the closing of the Proposed Public Offering (the "Combination Period"), the Company
840
+ will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business
841
+ days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the
842
+ Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay the Company s
843
+ franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public
844
+ Shares, which redemption will completely extinguish public stockholders rights as stockholders (including the right to receive
845
+ further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption,
846
+ subject to the approval of the Company s remaining stockholders and the Company s board of directors, dissolve and liquidate,
847
+ subject in each case to the Company s obligations under Delaware law to provide for claims of creditors and the requirements of
848
+ other applicable law.
849
+
850
+
851
+
852
+ F-8
853
+
854
+
855
+
856
+
857
+
858
+
859
+
860
+ The
861
+ initial stockholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete
862
+ a Business Combination within the Combination Period. However, if the initial stockholders should acquire Public Shares in or after the
863
+ Proposed Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares
864
+ if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights
865
+ to its deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business
866
+ Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust
867
+ Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the
868
+ per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.15
869
+ per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the sponsor has agreed to be
870
+ liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective
871
+ target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account.
872
+ This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim
873
+ of any kind in or to any monies held in the Trust Account or to any claims under the Company s indemnity of the underwriters of
874
+ the Proposed Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the "Securities
875
+ Act"). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the sponsor will not
876
+ be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the sponsor
877
+ will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective
878
+ target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title,
879
+ interest or claim of any kind in or to monies held in the Trust Account.
880
+
881
+
882
+
883
+ Going
884
+ Concern Consideration
885
+
886
+
887
+
888
+ As
889
+ of September 8, 2021, the Company had no cash and working capital of approximately $(37,331). Further, the Company has incurred and expects
890
+ to continue to incur significant costs in pursuit of its financing and acquisition plans. The Company lacks the financial resources it
891
+ needs to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial
892
+ statements. Management s plans to address this need for capital through the Proposed Public Offering. The Company cannot assure
893
+ that its plans to raise capital or to consummate an initial Business Combination will be successful. In addition, management is currently
894
+ evaluating the impact of the COVID-19 pandemic on the industry and its effect on the Company s financial position, results of its
895
+ operations and/or closing the initial public offering or search for a target company.
896
+
897
+
898
+
899
+ These
900
+ factors, among others, raise substantial doubt about the Company s ability to continue as going concern one year from the date
901
+ these financial statements are issued. The financial statements do not include any adjustments that might result from its inability to
902
+ consummate the Proposed Public Offering or its inability to continue as a going concern.
903
+
904
+
905
+
906
+ Note
907
+ 2 – Summary of Significant Accounting Policies
908
+
909
+
910
+
911
+ Basis
912
+ of Presentation
913
+
914
+
915
+
916
+ The
917
+ accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United
918
+ States of America ("U.S. GAAP") and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission
919
+ (the "SEC").
920
+
921
+
922
+
923
+ F-9
924
+
925
+
926
+
927
+
928
+
929
+
930
+
931
+ Emerging
932
+ Growth Company
933
+
934
+
935
+
936
+ The
937
+ Company is an "emerging growth company" as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012
938
+ (the "JOBS Act") exempts emerging growth companies from being required to comply with new or revised financial accounting
939
+ standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
940
+ not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
941
+ standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with
942
+ the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected
943
+ not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application
944
+ dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time
945
+ private companies adopt the new or revised standard.
946
+
947
+
948
+
949
+ This
950
+ may make comparison of the Company s financial statement with another public company that is neither an emerging growth company
951
+ nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential
952
+ differences in accounting standards used.
953
+
954
+
955
+
956
+ Net
957
+ Loss Per Share
958
+
959
+
960
+
961
+ The
962
+ Company complies with accounting and disclosure requirements of FASB ASC Topic 260, "Earnings Per Share." Net loss per share
963
+ is computed by dividing net loss by the weighted average number of common stock outstanding during the period. Weighted average shares
964
+ were reduced for the effect of an aggregate of 375,000 common stock that are subject to forfeiture if the underwriters over-allotment
965
+ option is not exercised by the underwriters (Note 4). At September 8, 2021, the Company did not have any dilutive securities and other
966
+ contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result,
967
+ diluted loss per share is the same as basic loss per share for the period presented.
968
+
969
+
970
+
971
+ Cash
972
+ and cash equivalents
973
+
974
+
975
+
976
+ The
977
+ Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
978
+ The Company did not have any cash or cash equivalents as of September 8, 2021.
979
+
980
+
981
+
982
+ Concentration
983
+ of Credit Risk
984
+
985
+
986
+
987
+ Financial
988
+ instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
989
+ which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At September 8, 2021, the Company has not experienced
990
+ losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
991
+
992
+
993
+
994
+ Fair
995
+ Value of Financial Instruments
996
+
997
+
998
+
999
+ The
1000
+ fair value of the Company s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, "Fair
1001
+ Value Measurements and Disclosures," approximates the carrying amounts represented in the balance sheet, primarily due to their
1002
+ short-term nature.
1003
+
1004
+
1005
+
1006
+ Use
1007
+ of Estimates
1008
+
1009
+
1010
+
1011
+ The
1012
+ preparation of financial statements in conformity with U.S. GAAP requires the Company s management to make estimates and assumptions
1013
+ that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
1014
+ statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
1015
+
1016
+
1017
+
1018
+ Income
1019
+ Taxes
1020
+
1021
+
1022
+
1023
+ The
1024
+ Company complies with the accounting and reporting requirements of ASC Topic 740, "Income Taxes," which requires an asset
1025
+ and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed
1026
+ for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible
1027
+ amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.
1028
+ Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
1029
+
1030
+
1031
+
1032
+ F-10
1033
+
1034
+
1035
+
1036
+
1037
+
1038
+
1039
+
1040
+ FASB
1041
+ ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
1042
+ positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than
1043
+ not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 8, 2021. The Company
1044
+ recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the
1045
+ payment of interest and penalties for the period from March 24, 2021 (date of inception) to September 8, 2021. The Company is currently
1046
+ not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The
1047
+ Company is subject to income tax examinations by major taxing authorities since inception.
1048
+
1049
+
1050
+
1051
+ The
1052
+ provision for income taxes was deemed to be de minimis for the period March 24, 2021 (inception) through September 8, 2021.
1053
+
1054
+
1055
+
1056
+ Deferred
1057
+ Offering Costs Associated with the Proposed Public Offering
1058
+
1059
+
1060
+
1061
+ Deferred
1062
+ offering costs will consist of direct costs incurred through the balance sheet date that are directly related to the Proposed Public
1063
+ Offering and that will be charged to shareholder s equity upon the completion of the Proposed Public Offering. Should the Proposed
1064
+ Public Offering prove to be unsuccessful, these deferred costs, as well as additional expenses to be incurred, will be charged to operations.
1065
+ At September 8, 2021, the Company has incurred approximately $61,331 of deferred offering costs.
1066
+
1067
+
1068
+
1069
+ Warrants
1070
+
1071
+
1072
+
1073
+ The
1074
+ Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant s
1075
+ specific terms and applicable authoritative guidance in Financial Accounting Standards Board ("FASB") Accounting Standards
1076
+ Codification ("ASC") 480, Distinguishing Liabilities from Equity ("ASC 480") and ASC 815, Derivatives and Hedging
1077
+ ("ASC 815"). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet
1078
+ the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under
1079
+ ASC 815, including whether the warrants are indexed to the Company s common stock and whether the warrant holders could potentially
1080
+ require "net cash settlement" in a circumstance outside of the Company s control, among other conditions for equity
1081
+ classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as
1082
+ of each subsequent quarterly period end date while the warrants are outstanding.
1083
+
1084
+
1085
+
1086
+ For
1087
+ issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component
1088
+ of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification,
1089
+ the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter.
1090
+ Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.
1091
+
1092
+
1093
+
1094
+ Recent
1095
+ Accounting Pronouncements
1096
+
1097
+
1098
+
1099
+ In
1100
+ August 2020, the FASB issued Accounting Standards Update ("ASU") No. 2020-06, Debt – debt with Conversion and Other
1101
+ Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity s Own Equity (Subtopic 815-40): Accounting for
1102
+ Convertible Instruments and Contracts in an Entity s Own Equity ("ASU 2020-06"), which simplifies accounting for convertible
1103
+ instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that
1104
+ are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share
1105
+ calculation in certain areas. The Company adopted ASU 2020-06 on March 24, 2021, (inception). Adoption of the ASU did not impact the
1106
+ Company s financial position, results of operations or cash flows.
1107
+
1108
+
1109
+
1110
+ F-11
1111
+
1112
+
1113
+
1114
+
1115
+
1116
+
1117
+
1118
+ Note
1119
+ 3 – Proposed Public Offering
1120
+
1121
+
1122
+
1123
+ Pursuant
1124
+ to the Proposed Public Offering, the Company intends to offer for sale 10,000,000 units at a price of $10.00 per Unit for aggregate proceeds
1125
+ of $100,000,000 (or 11,500,000 Units if the underwriter s over-allotment option is exercised in full for aggregate proceeds of
1126
+ $115,000,000). Each Unit consists of one share of common stock (such common stock included in the Units being offered, the "Public
1127
+ Shares"), one warrant to purchase one-half (1/2) of one share of common stock, and one right to receive one-tenth (1/10) of one
1128
+ share of common stock at the closing of a Business Combination (see Note 6).
1129
+
1130
+
1131
+
1132
+ Note
1133
+ 4 – Related Party Transactions
1134
+
1135
+
1136
+
1137
+ Founder
1138
+ Shares
1139
+
1140
+
1141
+
1142
+ On
1143
+ August 19, 2021, our Sponsor purchased 2,875,000 shares (the "Founder Shares") of the Company s common stock, par value
1144
+ $0.001 for an aggregate price of $25,000. The Founder Shares will automatically convert into common stock at the time of the Company s
1145
+ initial Business Combination and are subject to certain transfer restrictions, as described in Note 7. Holders of Founder Shares may
1146
+ also elect to convert their common stock into an equal number of common stock, subject to adjustment, at any time. The initial stockholders
1147
+ have agreed to forfeit up to 375,000 Founder Shares to the extent that the underwriters over-allotment option is not exercised
1148
+ in full by the underwriters. The forfeiture will be adjusted to the extent that the underwriters over-allotment option is not
1149
+ exercised in full by the underwriters so that the Founder Shares will represent 20.0% of the Company s issued and outstanding shares
1150
+ after the Proposed Public Offering. If the Company increases or decreases the size of the offering, the Company will effect a stock dividend
1151
+ or share contribution back to capital, as applicable, immediately prior to the consummation of the Proposed Public Offering in such amount
1152
+ as to maintain the Founder Share ownership of the Company s stockholders prior to the Proposed Public Offering at 20.0% of the
1153
+ Company s issued and outstanding common stock upon the consummation of the Proposed Public Offering.
1154
+
1155
+
1156
+
1157
+ The
1158
+ initial stockholders will agree, subject to limited exceptions, 50% of these shares will not be transferred, assigned, sold or released
1159
+ from escrow until the earlier of six months after the date of the consummation of our initial business combination and the date on which
1160
+ the closing price of our common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations
1161
+ and re
parsed_sections/legal_matters/2021/AMBP-WT_ardagh_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the Shares and certain matters related to the assumption of Warrants has been passed upon by Elvinger Hoss Prussen, soci t anonyme, 2, place Winston Churchill L-1340 Luxembourg, Grand Duchy of Luxembourg, Luxembourg counsel to the Company. The validity of the Warrants has been passed upon by Shearman & Sterling LLP, New York, NY. We have been advised on U.S. securities matters by Shearman & Sterling LLP, New York, NY. TABLE OF CONTENTS
parsed_sections/legal_matters/2021/AMPGW_amplitech_legal_matters.txt ADDED
The diff for this file is too large to render. See raw diff
 
parsed_sections/legal_matters/2021/AMWL_american_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the shares being sold in this offering will be passed upon for us by Davis Polk & Wardwell LLP, New York, New York. Certain legal matters will be passed upon on behalf of the underwriters by Latham & Watkins LLP, New York, New York.
parsed_sections/legal_matters/2021/ANY_sphere-3d_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The legality of the issuance of the shares offered in this prospectus will be passed upon for us by Pryor Cashman LLP, New York, New York. Certain legal matters in connection with this offering have been passed upon for the underwriter by Ellenoff Grossman & Schole LLP, New York, New York.
parsed_sections/legal_matters/2021/APP_applovin_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS Wilson Sonsini Goodrich & Rosati, P.C., Palo Alto, California, which has acted as our counsel in connection with this offering, will pass upon the validity of the shares of our Class A common stock being offered by this prospectus. The underwriters have been represented by Fenwick & West LLP, Mountain View, California. An investment fund associated with Fenwick & West LLP owns less than 1% of our outstanding capital stock as of September 30, 2021.
parsed_sections/legal_matters/2021/APXIF_apx_legal_matters.txt ADDED
@@ -0,0 +1,1715 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ legal matters by counsel and to other conditions.
2
+ The underwriting agreement provides that the underwriters are obligated to purchase all the units in this offering if any are purchased,
3
+ other than those units covered by the over-allotment option described below.
4
+
5
+
6
+
7
+ We have granted to the underwriters an option,
8
+ exercisable for 45 days from the date of this prospectus, to purchase on a pro rata basis up to 2,250,000 additional units at the initial
9
+ public offering price, less the underwriting discounts and commissions. The option may be exercised only to cover any over-allotments
10
+ of units. Any units issued or sold under the option will be issued and sold on the same terms and conditions as the other units that are
11
+ the subject of this offering.
12
+
13
+
14
+
15
+ 181
16
+
17
+ Table of Contents
18
+
19
+
20
+
21
+ The underwriters propose to offer the units initially
22
+ at the public offering price on the cover page of this prospectus and to selling group members at that price less a selling concession
23
+ of $ per unit. If all of the units are not sold at the public offering price, the underwriters
24
+ may change the offering price and the other selling terms.
25
+
26
+
27
+
28
+ The following table summarizes the compensation
29
+ and estimated expenses we will pay:
30
+
31
+
32
+
33
+
34
+
35
+
36
+ Per Unit(1)
37
+
38
+ Total
39
+
40
+
41
+
42
+
43
+ Without
44
+
45
+ Over-allotment
46
+
47
+ With
48
+
49
+ Over-allotment
50
+
51
+ Without
52
+
53
+ Over-allotment
54
+
55
+ With
56
+
57
+ Over-allotment
58
+
59
+
60
+ Underwriting Discounts and Commissions paid by us
61
+
62
+ $
63
+ 0.55
64
+
65
+
66
+ $
67
+ 0.55
68
+
69
+
70
+ $
71
+ 8,250,000
72
+
73
+
74
+ $
75
+ 9,487,500
76
+
77
+
78
+
79
+
80
+
81
+
82
+
83
+
84
+
85
+
86
+
87
+
88
+
89
+
90
+
91
+
92
+
93
+
94
+
95
+
96
+
97
+
98
+
99
+
100
+
101
+ (1)Includes $0.35
102
+ per unit, or $5,250,000 (or $6,037,500 if the over-allotment option is exercised in full) in the aggregate,
103
+ which is payable to the underwriters for deferred underwriting commissions to be placed in a trust account located in the United States
104
+ as described herein. The deferred commissions will be released to the underwriters only on completion of an initial business combination,
105
+ in an amount equal to $0.35 multiplied by the number of Class A ordinary shares sold as part of the
106
+ units in this offering, as described in this prospectus.
107
+
108
+
109
+
110
+ We estimate that our non-reimbursed out-of-pocket
111
+ expenses for this offering will be approximately $1,400,000. We have agreed to pay for the FINRA-related fees and expenses of the underwriters
112
+ legal counsel, not to exceed $25,000.
113
+
114
+
115
+
116
+ The representative has informed us that the
117
+ underwriters do not intend to make sales to discretionary accounts.
118
+
119
+
120
+
121
+ We, our sponsor and our officers and directors
122
+ have agreed that we will not offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, without the prior
123
+ written consent of BofA Securities, Inc. for a period of 180 days after the date of this prospectus, any units, warrants, Class A ordinary
124
+ shares or any other securities convertible into, or exercisable, or exchangeable for, Class A ordinary shares; provided, however, that
125
+ we may (1) issue and sell the private placement warrants; (2) issue and sell the additional units to cover our underwriters over-allotment
126
+ option (if any); (3) register with the SEC pursuant to an agreement to be entered into concurrently with the issuance and sale of the
127
+ securities in this offering, the resale of the private placement warrants and the Class A ordinary shares issuable upon exercise of the
128
+ warrants and the founder shares; and (4) issue securities in connection with our initial business combination. However, the foregoing
129
+ shall not apply to the forfeiture of any founder shares pursuant to their terms or any transfer of founder shares to any current or future
130
+ independent director of the company (as long as such current or future independent director is subject to the terms of the letter agreement,
131
+ filed herewith, at the time of such transfer; and as long as, to the extent any Section 16 reporting obligation is triggered as a result
132
+ of such transfer, any related Section 16 filing includes a practical explanation as to the nature of the transfer). The representative
133
+ in its sole discretion may release any of the securities subject to these lock-up agreements at any time without notice.
134
+
135
+
136
+
137
+ Our sponsor, initial shareholders, officers, and
138
+ directors have agreed not to transfer, assign or sell any of their founder shares and any Class A ordinary shares issued upon conversion
139
+ thereof until the earlier to occur of (A) one year after the completion of our initial business combination; or (B) subsequent to our
140
+ initial business combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as
141
+ adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within
142
+ any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date following the completion
143
+ of our initial business combination on which we complete a liquidation, merger, amalgamation, stock exchange, reorganization or other
144
+ similar transaction that results in all of our public shareholders having the right to exchange their Class
145
+ A ordinary shares for cash, securities or other property (except with respect to permitted transferees as described herein under "Principal
146
+ Shareholders—Transfers of Founder Shares and
147
+
148
+
149
+
150
+ 182
151
+
152
+ Table of Contents
153
+
154
+
155
+
156
+ Private Placement Warrants"). Any permitted transferees
157
+ would be subject to the same restrictions and other agreements of our initial shareholders with respect to any founder shares.
158
+
159
+
160
+
161
+ The private placement warrants (including the
162
+ Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until
163
+ 30 days after the completion of our initial business combination (except with respect to permitted transferees as described herein under
164
+ "Principal Shareholders—Transfers of Founder Shares and Private Placement Warrants").
165
+
166
+
167
+
168
+ We have agreed to indemnify the underwriters against
169
+ certain liabilities under the Securities Act, or contribute to payments that the underwriters may be required to make in that respect.
170
+
171
+
172
+
173
+ We expect our units to be listed on Nasdaq, under
174
+ the symbol "APXIU" and, once the Class A ordinary shares and warrants begin separate trading, to have our Class A ordinary
175
+ shares and warrants listed on Nasdaq under the symbols "APXI" and "APXIW," respectively. We cannot guarantee that
176
+ our securities will be approved for listing on Nasdaq.
177
+
178
+
179
+
180
+ Prior to this offering, there has been no public
181
+ market for our securities. Consequently, the initial public offering price for the units was determined by negotiations between us and
182
+ the representative.
183
+
184
+
185
+
186
+ The determination of our per unit offering price
187
+ was more arbitrary than would typically be the case if we were an operating company. Among the factors considered in determining the initial
188
+ public offering price were the history and prospects of companies whose principal business is the acquisition of other companies, prior
189
+ offerings of those companies, our management, our capital structure, and currently prevailing general conditions in equity securities
190
+ markets, including current market valuations of publicly traded companies considered comparable to our company. We cannot assure you,
191
+ however, that the price at which the units, Class A ordinary shares or warrants will sell in the public market after this offering will
192
+ not be lower than the initial public offering price or that an active trading market in our units, Class A ordinary shares or warrants
193
+ will develop and continue after this offering.
194
+
195
+
196
+
197
+ If we do not complete our initial business combination
198
+ within 15 months from the closing of this offering (or within 21 months if we extend the period of time to consummate our initial business
199
+ combination in accordance with the terms described in this prospectus), the trustee and the underwriters have agreed that: (1) they will
200
+ forfeit any rights or claims to their deferred underwriting discounts and commissions, including any accrued interest thereon, then in
201
+ the trust account; and (2) the deferred underwriters discounts and commissions will be distributed on a pro rata basis, together
202
+ with any accrued interest thereon (which interest shall be net of taxes payable) to the public shareholders.
203
+
204
+
205
+
206
+ In connection with this offering, the underwriters
207
+ may purchase and sell units in the open market. Purchases and sales in the open market may include short sales, purchases to cover short
208
+ positions, which may include purchases pursuant to the over-allotment option and stabilizing purchases, in accordance with Regulation
209
+ M under the Exchange Act.
210
+
211
+
212
+
213
+ Short sales involve secondary
214
+ market sales by the underwriters of a greater number of units than they are required to purchase in the offering.
215
+
216
+
217
+
218
+ "Covered" short sales
219
+ are sales of units in an amount up to the number of units represented by the underwriters over-allotment option.
220
+
221
+
222
+
223
+ "Naked" short sales
224
+ are sales of units in an amount in excess of the number of units represented by the underwriters over-allotment option.
225
+
226
+
227
+
228
+ Covering transactions involve
229
+ purchases of units either pursuant to the over-allotment option or in the open market after the distribution has been completed
230
+ in order to cover short positions.
231
+
232
+
233
+
234
+ To close a naked short position,
235
+ the underwriters must purchase units in the open market after the distribution has been completed. A naked short position is more
236
+ likely to be created if the underwriters
237
+
238
+ 183
239
+
240
+ Table of Contents
241
+
242
+
243
+
244
+ are
245
+ concerned that there may be downward pressure on the price of the units in the open market after pricing that could adversely affect
246
+ investors who purchase in the offering.
247
+
248
+
249
+
250
+ To close a covered short position,
251
+ the underwriters must purchase units in the open market after the distribution has been completed or must exercise the over-allotment option.
252
+ In determining the source of units to close the covered short position, the underwriters will consider, among other things, the
253
+ price of units available for purchase in the open market as compared to the price at which they may purchase units through
254
+ the over-allotment option.
255
+
256
+
257
+
258
+ Stabilizing transactions involve
259
+ bids to purchase units so long as the stabilizing bids do not exceed a specified maximum.
260
+
261
+
262
+
263
+ Purchases to cover short positions and stabilizing
264
+ purchases, as well as other purchases by the underwriters for their own accounts, may have the effect of preventing or retarding a decline
265
+ in the market price of the units. They may also cause the price of the units to be higher than the price that would otherwise
266
+ exist in the open market in the absence of these transactions. The underwriters may conduct these transactions in the over-the-counter market
267
+ or otherwise. If the underwriters commence any of these transactions, they may discontinue them at any time.
268
+
269
+
270
+
271
+ We are not under any contractual obligation to
272
+ engage any of the underwriters to provide any services for us after this offering and have no present intent to do so. However, any of
273
+ the underwriters may introduce us to potential target businesses or assist us in raising additional capital in the future. If any of the
274
+ underwriters provide services to us after this offering, we may pay such underwriter fair and reasonable fees that would be determined
275
+ at that time in an arm s length negotiation; and we may pay the underwriters of this offering or any entity with which they are
276
+ affiliated, a finder s fee or other compensation for services rendered to us in connection with the completion of a business combination.
277
+
278
+
279
+
280
+ Some of the underwriters and their affiliates
281
+ have engaged in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business
282
+ with us or our affiliates. They have received, or may in the future receive, customary fees and commissions for these transactions.
283
+
284
+
285
+
286
+ In addition, in the ordinary course of their business
287
+ activities, the underwriters and their affiliates may make or hold a broad array of investments and actively trade debt and equity securities
288
+ (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their
289
+ customers.
290
+
291
+
292
+
293
+ Such investments and securities activities may
294
+ involve securities and/or instruments of ours or our affiliates. The underwriters and their affiliates may also make investment recommendations
295
+ and/or publish or express independent research views in respect of such securities or financial instruments and may hold, or recommend
296
+ to clients that they acquire, long and/or short positions in such securities and instruments.
297
+
298
+
299
+
300
+ A prospectus in electronic format may be made
301
+ available on the websites maintained by one or more of the underwriters, or selling group members, if any, participating in this offering
302
+ and one or more of the underwriters participating in this offering may distribute prospectuses electronically. The representative may
303
+ agree to allocate a number of units to underwriters and selling group members for sale to their online brokerage account holders. Internet
304
+ distributions will be allocated by the underwriters and selling group members that will make internet distributions on the same basis
305
+ as other allocations.
306
+
307
+
308
+
309
+ The units are offered for sale in the United States,
310
+ Europe, Asia and other jurisdictions where it is lawful to make such offers.
311
+
312
+
313
+
314
+ Each of the underwriters has represented and agreed
315
+ that it has not offered, sold or delivered and will not offer, sell or deliver any of the units directly or indirectly, or distribute
316
+ this prospectus or any other offering material relating to the units, in or from any jurisdiction except under circumstances that will
317
+ result
318
+
319
+
320
+
321
+ 184
322
+
323
+ Table of Contents
324
+
325
+
326
+
327
+ in compliance with the applicable laws and regulations thereof and
328
+ that will not impose any obligations on us except as set forth in the underwriting agreement.
329
+
330
+
331
+
332
+ European Economic Area
333
+
334
+
335
+
336
+ In relation to each Member State of the European
337
+ Economic Area (each a "Relevant State"), no units have been offered or will be offered pursuant to this offering to the public
338
+ in that Relevant State prior to the publication of a prospectus in relation to the units which has been approved by the competent authority
339
+ in that Relevant State or, where appropriate, approved in another Relevant State and notified to the competent authority in that Relevant
340
+ State, all in accordance with the Prospectus Regulation, except that offers of units may be made to the public in that Relevant State
341
+ at any time under the following exemptions under the Prospectus Regulation:
342
+
343
+
344
+
345
+
346
+
347
+ (a)
348
+ to any legal entity which is a qualified investor as defined under the Prospectus Regulation;
349
+
350
+
351
+
352
+
353
+
354
+
355
+ (b)
356
+ to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus Regulation), subject to obtaining the prior consent of the Representative for any such offer; or
357
+
358
+
359
+
360
+
361
+
362
+
363
+ (c)
364
+ in any other circumstances falling within Article 1(4) of the Prospectus Regulation,
365
+
366
+
367
+
368
+
369
+ provided that no such offer of units shall require
370
+ the issuer or any underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant
371
+ to Article 23 of the Prospectus Regulation.
372
+
373
+
374
+
375
+ Each person in a Relevant State who initially
376
+ acquires any units or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with the company and
377
+ the underwriters that it is a qualified investor within the meaning of the Prospectus Regulation.
378
+
379
+
380
+
381
+ In the case of any units being offered to a financial
382
+ intermediary as that term is used in Article 5(1) of the Prospectus Regulation, each such financial intermediary will be deemed to have
383
+ represented, acknowledged and agreed that the units acquired by it in the offer have not been acquired on a non-discretionary basis on
384
+ behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer
385
+ to the public other than their offer or resale in a Relevant State to qualified investors, in circumstances in which the prior consent
386
+ of the underwriters has been obtained to each such proposed offer or resale.
387
+
388
+
389
+
390
+ The company, the underwriters and their affiliates
391
+ will rely upon the truth and accuracy of the foregoing representations, acknowledgements and agreements.
392
+
393
+
394
+
395
+ For the purposes of this provision, the expression
396
+ an "offer to the public" in relation to any units in any Relevant State means the communication in any form and by any means
397
+ of sufficient information on the terms of the offer and any units to be offered so as to enable an investor to decide to purchase or subscribe
398
+ for any units, and the expression "Prospectus Regulation" means Regulation (EU) 2017/1129.
399
+
400
+
401
+
402
+ The above selling restrictions is in addition
403
+ to any other selling restrictions set out below.
404
+
405
+
406
+
407
+ In connection with the offering, the underwriters
408
+ are not acting for anyone other than the issuer and will not be responsible to anyone other than the issuer for providing the protections
409
+ afforded to their clients nor for providing advice in relation to the offering.
410
+
411
+
412
+
413
+ Notice to Prospective Investors in the United
414
+ Kingdom
415
+
416
+
417
+
418
+ In relation to the United Kingdom ("UK"),
419
+ no units have been offered or will be offered pursuant to this offering to the public in the UK prior to the publication of a prospectus
420
+ in relation to the units which has been approved by the Financial Conduct Authority in the UK in accordance with the UK Prospectus
421
+
422
+
423
+
424
+ 185
425
+
426
+ Table of Contents
427
+
428
+
429
+
430
+ Regulation and the FSMA, except that offers of units may be made to
431
+ the public in the UK at any time under the following exemptions under the UK Prospectus Regulation and the FSMA:
432
+
433
+
434
+
435
+
436
+
437
+ (a)
438
+ to any legal entity which is a qualified investor as defined under the UK Prospectus Regulation;
439
+
440
+
441
+
442
+
443
+
444
+
445
+ (b)
446
+ to fewer than 150 natural or legal persons (other than qualified investors as defined under the UK Prospectus Regulation), subject to obtaining the prior consent of the Representative for any such offer; or
447
+
448
+
449
+
450
+
451
+
452
+
453
+ (c)
454
+ at any time in other circumstances falling within section 86 of the FSMA,
455
+
456
+
457
+
458
+
459
+ provided that no such offer of units shall require
460
+ the issuer or any underwriter to publish a prospectus pursuant to Section 85 of the FSMA or Article 3 of the UK Prospectus Regulation
461
+ or supplement a prospectus pursuant to Article 23 of the UK Prospectus Regulation.
462
+
463
+
464
+
465
+ Each person in the UK who initially acquires any
466
+ units or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with the company and the underwriters
467
+ that it is a qualified investor within the meaning of the UK Prospectus Regulation.
468
+
469
+
470
+
471
+ In the case of any units being offered to a financial
472
+ intermediary as that term is used in Article 5(1) of the UK Prospectus Regulation, each such financial intermediary will be deemed to
473
+ have represented, acknowledged and agreed that the units acquired by it in the offer have not been acquired on a non-discretionary basis
474
+ on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an
475
+ offer to the public other than their offer or resale in the UK to qualified investors, in circumstances in which the prior consent of
476
+ the underwriters has been obtained to each such proposed offer or resale.
477
+
478
+
479
+
480
+ The company, the underwriters and their affiliates
481
+ will rely upon the truth and accuracy of the foregoing representations, acknowledgements and agreements.
482
+
483
+
484
+
485
+ For the purposes of this provision, the expression
486
+ an "offer to the public" in relation to any units in the UK means the communication in any form and by any means of sufficient
487
+ information on the terms of the offer and any units to be offered so as to enable an investor to decide to purchase or subscribe for any
488
+ units, the expression "UK Prospectus Regulation" means Regulation (EU) 2017/1129 as it forms part of domestic law by virtue
489
+ of the European Union (Withdrawal) Act 2018, and the expression "FSMA" means the Financial Services and Markets Act 2000.
490
+
491
+
492
+
493
+ In connection with the offering, the underwriters
494
+ are not acting for anyone other than the issuer and will not be responsible to anyone other than the issuer for providing the protections
495
+ afforded to their clients nor for providing advice in relation to the offering.
496
+
497
+
498
+
499
+ This document is for distribution only to persons
500
+ who (i) have professional experience in matters relating to investments and who qualify as investment professionals within the meaning
501
+ of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the "Financial Promotion
502
+ Order"), (ii) are persons falling within Article 49(2)(a) to (d) ("high net worth companies, unincorporated associations etc.")
503
+ of the Financial Promotion Order, (iii) are outside the United Kingdom, or (iv) are persons to whom an invitation or inducement to engage
504
+ in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000, as amended ("FSMA"))
505
+ in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons
506
+ together being referred to as "relevant persons"). This document is directed only at relevant persons and must not be acted
507
+ on or relied on by persons who are not relevant persons. Any investment or investment activity to which this document relates is available
508
+ only to relevant persons and will be engaged in only with relevant persons.
509
+
510
+
511
+
512
+ 186
513
+
514
+ Table of Contents
515
+
516
+
517
+
518
+ Notice to Residents of Japan
519
+
520
+
521
+
522
+ The units have not been and will not be registered
523
+ under the Financial Instruments and Exchange Law of Japan (Law No. 25 of 1948, as amended) and, accordingly, will not be offered
524
+ or sold, directly or indirectly, in Japan, or for the benefit of any Japanese Person or to others for re-offering or resale, directly
525
+ or indirectly, in Japan or to any Japanese Person, except in compliance with all applicable laws, regulations and ministerial guidelines
526
+ promulgated by relevant Japanese governmental or regulatory authorities in effect at the relevant time. For the purposes of this paragraph,
527
+ "Japanese Person" shall mean any person resident in Japan, including any corporation or other entity organized under
528
+ the laws of Japan.
529
+
530
+
531
+
532
+ Notice to Residents of Hong Kong
533
+
534
+
535
+
536
+ The units may not be offered or sold in Hong Kong
537
+ by means of any document other than (i) in circumstances which do not constitute an offer to the public within the meaning of the
538
+ Companies Ordinance (Cap. 32, Laws of Hong Kong), or (ii) to "professional investors" within the meaning of
539
+ the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder, or (iii) in other circumstances
540
+ which do not result in the document being a "prospectus" within the meaning of the Companies Ordinance (Cap. 32, Laws
541
+ of Hong Kong) and no advertisement, invitation or document relating to the units may be issued or may be in the possession of
542
+ any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which
543
+ are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the laws of Hong Kong) other
544
+ than with respect to units which are or are intended to be disposed of only to persons outside Hong Kong or only to "professional
545
+ investors" within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder.
546
+
547
+
548
+
549
+ Notice to Residents of Singapore
550
+
551
+
552
+
553
+ This prospectus has not been
554
+ registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other document or material in
555
+ connection with the offer or sale, or invitation for subscription or purchase, of the units may not be circulated or distributed,
556
+ nor may the units be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly,
557
+ to persons in Singapore other than (i) to an institutional investor under Section 274 of the Securities and Futures Act, Chapter
558
+ 289 of Singapore (the "SFA"), (ii) to a relevant person pursuant to Section 275(1), or any person pursuant to Section 275(1A),
559
+ and in accordance with the conditions specified in Section 275 of the SFA or (iii) otherwise pursuant to, and in accordance
560
+ with the conditions of, any other applicable provision of the SFA, in each case subject to compliance with conditions set forth in the
561
+ SFA.
562
+
563
+
564
+
565
+ Where the units are subscribed or purchased
566
+ under Section 275 of the SFA by a relevant person which is
567
+
568
+
569
+
570
+ a corporation (which is not an
571
+ accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share
572
+ capital of which is owned by one or more individuals, each of whom is an accredited investor; or
573
+
574
+
575
+
576
+ a trust (where the trustee is
577
+ not an accredited investor) whose sole purpose is to hold investments and each beneficiary is an accredited investor, shares, debentures
578
+ and units of shares and debentures of that corporation or the beneficiaries rights and interest (howsoever described) in
579
+ that trust shall not be transferred within six months after that corporation or that trust has acquired the shares pursuant to an
580
+ offer made under Section 275 of the SFA except:
581
+
582
+
583
+
584
+ oto an institutional investor
585
+ (for corporations, under Section 274 of the SFA) or to a relevant person defined in Section 275(2) of the SFA, or to any person
586
+ pursuant to an offer that is made on terms that such shares, debentures and units of shares and debentures of that corporation or
587
+ such rights and interest in that trust are acquired at a consideration of not less than $150,000 (or its equivalent in a foreign currency)
588
+ for each transaction, whether such amount is to be paid for in cash or by exchange of securities or other assets, and further for corporations,
589
+ in accordance with the conditions specified in Section 275 of the SFA;
590
+
591
+ 187
592
+
593
+ Table of Contents
594
+
595
+
596
+
597
+ owhere no consideration is or
598
+ will be given for the transfer; or
599
+
600
+
601
+
602
+ owhere the transfer is by operation
603
+ of law.
604
+
605
+
606
+
607
+ Solely for the purposes of our obligations pursuant
608
+ to Section 309B of the SFA, the company has determined, and hereby notifies all relevant persons (as defined in the CMP Regulations 2018),
609
+ that the units are "prescribed capital markets products" (as defined in the CMP Regulations 2018) and Excluded Investment
610
+ Products (as defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16: Notice on the Recommendations
611
+ on Investment Products).
612
+
613
+
614
+
615
+ Notice to Residents of Germany
616
+
617
+
618
+
619
+ Each person who is in possession of this prospectus
620
+ is aware that no German sales prospectus (Verkaufsprospekt) within the meaning of the Securities Sales Prospectus Act (Wertpapier- Verkaufsprospektgesetz,
621
+ the "Act") of the Federal Republic of Germany has been or will be published with respect to our units. In particular, each
622
+ underwriter has represented that it has not engaged and has agreed that it will not engage in a public offering (offentliches Angebot)
623
+ within the meaning of the Act with respect to any of our units otherwise then in accordance with the Act and all other applicable legal
624
+ and regulatory requirements.
625
+
626
+
627
+
628
+ Notice to Residents of France
629
+
630
+
631
+
632
+ Neither this prospectus nor any other offering
633
+ material relating to the units described in this prospectus has been submitted to the clearance procedures of the Autorit des
634
+ March s Financiers or of the competent authority of another member state of the European Economic Area and notified to the Autorit
635
+ des March s Financiers. The units have not been offered or sold and will not be offered or sold, directly or indirectly, to the
636
+ public in France. Neither this prospectus nor any other offering material relating to the units has been or will be:
637
+
638
+
639
+
640
+ released, issued, distributed or caused
641
+ to be released, issued or distributed to the public in France; or
642
+
643
+
644
+
645
+ used in connection with any offer for
646
+ subscription or sale of the units to the public in France.
647
+
648
+
649
+
650
+ Such offers, sales and distributions will be made
651
+ in France only:
652
+
653
+
654
+
655
+ to qualified investors (investisseurs
656
+ qualifi s) and/or to a restricted circle of investors (cercle restreint d investisseurs), in each case investing for their
657
+ own account, all as defined in, and in accordance with, articles L.411-2, D.411-1, D.411-2, D.734-1, D.744-1, D.754-1 and D.764-1 of the
658
+ French Code mon taire et financier;
659
+
660
+
661
+
662
+ to investment services providers authorized
663
+ to engage in portfolio management on behalf of third parties; or
664
+
665
+
666
+
667
+ in a transaction that, in accordance
668
+ with article L.411-2-II-1 -or-2 -or 3 of the French Code mon taire et financier and article 211-2 of the General
669
+ Regulations (R glement G n ral) of the Autorit des March s Financiers, does not constitute a public
670
+ offer (appel public l pargne).
671
+
672
+
673
+
674
+ The units may be resold directly or indirectly,
675
+ only in compliance with articles L.411-1, L.411-2, L.412-1 and L.621-8 through L.621-8-3 of the French Code mon taire et financier.
676
+
677
+
678
+
679
+ Notice to Residents of the Netherlands
680
+
681
+
682
+
683
+ Our units may not be offered, sold, transferred
684
+ or delivered in or from the Netherlands as part of their initial distribution or at any time thereafter, directly or indirectly, other
685
+ than to, individuals or legal entities situated in The Netherlands who or which trade or invest in securities in the conduct of a business
686
+ or
687
+
688
+
689
+
690
+ 188
691
+
692
+ Table of Contents
693
+
694
+
695
+
696
+ profession (which includes banks, securities intermediaries (including
697
+ dealers and brokers), insurance companies, pension funds, collective investment institution, central governments, large international
698
+ and supranational organizations, other institutional investors and other parties, including treasury departments of commercial enterprises,
699
+ which as an ancillary activity regularly invest in securities; hereinafter, "Professional Investors"); provided that in the
700
+ offer, prospectus and in any other documents or advertisements in which a forthcoming offering of our units is publicly announced (whether
701
+ electronically or otherwise) in The Netherlands it is stated that such offer is and will be exclusively made to such Professional Investors.
702
+ Individual or legal entities who are not Professional Investors may not participate in the offering of our units, and this prospectus
703
+ or any other offering material relating to our units may not be considered an offer or the prospect of an offer to sell or exchange our
704
+ units.
705
+
706
+
707
+
708
+ Notice to Prospective
709
+ Investors in the Cayman Islands
710
+
711
+
712
+
713
+ No invitation, whether
714
+ directly or indirectly, may be made to the public in the Cayman Islands to subscribe for our units.
715
+
716
+
717
+
718
+ Notice to Canadian Residents
719
+
720
+
721
+
722
+ The units may be sold
723
+ in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National
724
+ Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are
725
+ permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations.
726
+ Any resale of the units must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements
727
+ of applicable securities laws.
728
+
729
+
730
+
731
+ Securities legislation in
732
+ certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including
733
+ any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser
734
+ within the time limit prescribed by the securities legislation of the purchaser s province or territory. The purchaser should refer
735
+ to any applicable provisions of the securities legislation of the purchaser s province or territory for particulars of these rights
736
+ or consult with a legal advisor.
737
+
738
+
739
+
740
+ Pursuant to section 3A.3
741
+ of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required to comply with the
742
+ disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.
743
+
744
+
745
+
746
+ Notice to Prospective Investors in the Dubai
747
+ International Financial Centre
748
+
749
+
750
+
751
+ This prospectus relates to an Exempt Offer in
752
+ accordance with the Offered Securities Rules of the Dubai Financial Services Authority ("DFSA"). This prospectus is intended
753
+ for distribution only to persons of a type specified in the Offered Securities Rules of the DFSA. It must not be delivered to, or relied
754
+ on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The
755
+ DFSA has not approved this prospectus nor taken steps to verify the information set forth herein and has no responsibility for the prospectus.
756
+ The securities to which this prospectus relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers
757
+ of the securities offered should conduct their own due diligence on the securities. If you do not understand the contents of this prospectus
758
+ you should consult an authorized financial advisor.
759
+
760
+
761
+
762
+ Notice to Prospective Investors in Australia
763
+
764
+
765
+
766
+ No placement document, prospectus, product disclosure
767
+ statement or other disclosure document has been lodged with the Australian Securities and Investments Commission, in relation to the offering.
768
+ This prospectus does not constitute a prospectus, product disclosure statement or other disclosure document under the Corporations Act
769
+ 2001 (the "Corporations Act"), and does not purport to include the information required for a prospectus, product disclosure
770
+ statement or other disclosure document under the Corporations Act.
771
+
772
+
773
+
774
+ 189
775
+
776
+ Table of Contents
777
+
778
+
779
+
780
+ Any offer in Australia of the securities may only
781
+ be made to persons (the "Exempt Investors") who are "sophisticated investors" (within the meaning of section 708(8)
782
+ of the Corporations Act), "professional investors" (within the meaning of section 708(11) of the Corporations Act) or otherwise
783
+ pursuant to one or more exemptions contained in section 708 of the Corporations Act so that it is lawful to offer the securities without
784
+ disclosure to investors under Chapter 6D of the Corporations Act.
785
+
786
+
787
+
788
+ The securities applied for by Exempt Investors
789
+ in Australia must not be offered for sale in Australia in the period of 12 months after the date of allotment under the offering,
790
+ except in circumstances where disclosure to investors under Chapter 6D of the Corporations Act would not be required pursuant to an exemption
791
+ under section 708 of the Corporations Act or otherwise or where the offer is pursuant to a disclosure document which complies with Chapter
792
+ 6D of the Corporations Act. Any person acquiring securities must observe such Australian on-sale restrictions. This prospectus contains
793
+ general information only and does not take account of the investment objectives, financial situation or particular needs of any particular
794
+ person. It does not contain any securities recommendations or financial product advice. Before making an investment decision, investors
795
+ need to consider whether the information in this prospectus is appropriate to their needs, objectives and circumstances, and, if necessary,
796
+ seek expert advice on those matters.
797
+
798
+
799
+
800
+ Notice to Prospective Investors in Switzerland
801
+
802
+
803
+
804
+ The securities may not be publicly offered in
805
+ Switzerland and will not be listed on the SIX Swiss Exchange ("SIX") or on any other stock exchange or regulated trading facility
806
+ in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or
807
+ art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules
808
+ or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering
809
+ or marketing material relating to the securities or the offering may be publicly distributed or otherwise made publicly available in Switzerland.
810
+
811
+
812
+
813
+ Neither this document nor any other offering or
814
+ marketing material relating to the offering, the company, the shares have been or will be filed with or approved by any Swiss regulatory
815
+ authority. In particular, this document will not be filed with, and the offer of securities will not be supervised by, the Swiss Financial
816
+ Market Supervisory Authority FINMA (FINMA), and the offer of securities has not been and will not be authorized under the Swiss Federal
817
+ Act on Collective Investment Schemes ("CISA"). The investor protection afforded to acquirers of interests in collective investment
818
+ schemes under the CISA does not extend to acquirers of securities.
819
+
820
+
821
+
822
+ Legal
823
+ Matters
824
+
825
+
826
+
827
+ Davis Polk & Wardwell LLP is acting as counsel
828
+ in connection with the registration of our securities under the Securities Act, and as such, will pass upon the validity of the securities
829
+ offered in this prospectus with respect to units and warrants. Maples and Calder (Cayman) LLP will pass upon the validity of the securities
830
+ offered in this prospectus with respect to the ordinary shares and matters of Cayman Islands law. In connection with this offering, Shearman
831
+ & Sterling LLP is acting as counsel to the underwriters.
832
+
833
+
834
+
835
+ Experts
836
+
837
+
838
+
839
+ The financial statements of APx Acquisition Corp.
840
+ I as of September 30, 2021 and for the period from May 13, 2021 (inception) through September 30, 2021 appearing in this prospectus have been audited by Marcum LLP, independent registered
841
+ public accounting firm, as set forth in their report thereon (which contains an explanatory paragraph relating to substantial doubt about
842
+ the ability of APx Acquisition Corp. I to continue as a going concern as described in Note 1 to the financial statements), appearing elsewhere
843
+ in this prospectus, and are included in reliance upon the report of such firm given upon their authority as experts in accounting and
844
+ auditing.
845
+
846
+
847
+
848
+ 190
849
+
850
+ Table of Contents
851
+
852
+
853
+
854
+ Where
855
+ You Can Find Additional Information
856
+
857
+
858
+
859
+ We have filed with the SEC a registration statement
860
+ on Form S-1 under the Securities Act with respect to the securities we are offering by this prospectus. This prospectus does not contain
861
+ all of the information included in the registration statement. For further information about us and our securities, you should refer to
862
+ the registration statement and the exhibits and schedules filed with the registration statement. Whenever we make reference in this prospectus
863
+ to any of our contracts, agreements or other documents, the references are materially complete but may not include a description of all
864
+ aspects of such contracts, agreements or other documents, and you should refer to the exhibits attached to the registration statement
865
+ for copies of the actual contract, agreement or other document.
866
+
867
+
868
+
869
+ Upon completion of this offering, we will be subject
870
+ to the information requirements of the Exchange Act and will file annual, quarterly and current event reports, proxy statements and other
871
+ information with the SEC. You can read our SEC filings, including the registration statement, over the Internet at the SEC s website
872
+ at www.sec.gov.
873
+
874
+
875
+
876
+ 191
877
+
878
+ Table of Contents
879
+
880
+
881
+
882
+ APx ACQUISITION CORP. I
883
+
884
+ INDEX
885
+ TO FINANCIAL STATEMENTS
886
+
887
+
888
+
889
+
890
+
891
+
892
+ PAGE
893
+
894
+
895
+ Report of Independent Registered Public Accounting Firm
896
+
897
+ F-2
898
+
899
+
900
+ Balance Sheet as of September 30, 2021
901
+
902
+ F-3
903
+
904
+
905
+ Statement of Operations for the period from May 13, 2021 (inception) through September 30, 2021
906
+
907
+ F-4
908
+
909
+
910
+ Statement of Changes in Shareholder s Equity for the period from May 13, 2021 (inception) through September 30, 2021
911
+
912
+ F-5
913
+
914
+
915
+ Statement of Cash Flows for the period from May 13, 2021 (inception) through September 30, 2021
916
+
917
+ F-6
918
+
919
+
920
+ Notes to Financial Statements
921
+
922
+ F-7
923
+
924
+
925
+
926
+ F-1
927
+
928
+ Table of Contents
929
+
930
+
931
+
932
+ REPORT OF INDEPENDENT REGISTERED
933
+ PUBLIC ACCOUNTING FIRM
934
+
935
+
936
+
937
+ To the Shareholder and Board of Directors of
938
+
939
+ APx Acquisition Corp. I
940
+
941
+
942
+
943
+ Opinion on the Financial Statements
944
+
945
+
946
+
947
+ We have audited the accompanying balance sheet
948
+ of APx Acquisition Corp. I (the "Company") as of September 30, 2021, the related statements of operations, changes in shareholder s
949
+ equity and cash flows for the period from May 13, 2021 (inception) through September 30, 2021, and the related notes (collectively referred
950
+ to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the
951
+ financial position of the Company as of September 30, 2021, and the results of its operations and its cash flows for the period from May 13,
952
+ 2021 (inception) through September 30, 2021, in conformity with accounting principles generally accepted in the United States of America.
953
+
954
+
955
+
956
+ Explanatory Paragraph – Going Concern
957
+
958
+
959
+
960
+ The accompanying financial statements have been
961
+ prepared assuming that the Company will continue as a going concern. As more fully described in Note 1 to the financial statements, the
962
+ Company has a working capital deficiency, has incurred losses and needs to raise additional funds to meet its obligations and sustain
963
+ its operations. These conditions raise substantial doubt about the Company's ability to continue as a going concern. Management s plans
964
+ in regard to these matters are also described in Notes 1 and 3. The financial statements do not include any adjustments that might result
965
+ from the outcome of this uncertainty.
966
+
967
+
968
+
969
+ Basis for Opinion
970
+
971
+
972
+
973
+ These financial statements are the responsibility
974
+ of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We
975
+ are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are
976
+ required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
977
+ regulations of the Securities and Exchange Commission and the PCAOB.
978
+
979
+
980
+
981
+ We conducted our audit in accordance with the
982
+ standards of the PCAOB. Those standards require
983
+ that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement,
984
+ whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over
985
+ financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but
986
+ not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly,
987
+ we express no such opinion.
988
+
989
+
990
+
991
+ Our audit included performing procedures to assess
992
+ the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
993
+ to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
994
+ Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
995
+ the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
996
+
997
+
998
+
999
+ /s/ Marcum llp
1000
+
1001
+
1002
+
1003
+ Marcum llp
1004
+
1005
+
1006
+
1007
+ We have served as the Company s auditor since 2021.
1008
+
1009
+
1010
+
1011
+ Houston, Texas
1012
+
1013
+ November 19, 2021
1014
+
1015
+
1016
+
1017
+ F-2
1018
+
1019
+ Table of Contents
1020
+
1021
+
1022
+
1023
+
1024
+
1025
+ APx ACQUISITION CORP. I
1026
+
1027
+ BALANCE SHEET
1028
+
1029
+
1030
+
1031
+
1032
+
1033
+ September 30, 2021
1034
+
1035
+
1036
+
1037
+
1038
+
1039
+
1040
+ ASSETS
1041
+
1042
+
1043
+
1044
+ Deferred offering costs
1045
+ $536,440
1046
+
1047
+
1048
+ TOTAL ASSETS
1049
+ $536,440
1050
+
1051
+
1052
+
1053
+
1054
+
1055
+
1056
+ LIABILITIES AND SHAREHOLDER S EQUITY
1057
+
1058
+
1059
+
1060
+
1061
+
1062
+
1063
+
1064
+ Current Liabilities
1065
+
1066
+
1067
+
1068
+ Accrued expenses
1069
+ $518,318
1070
+
1071
+
1072
+ Total Current Liabilities
1073
+ 518,318
1074
+
1075
+
1076
+
1077
+
1078
+
1079
+
1080
+ Commitments and contingencies (Note 6)
1081
+
1082
+
1083
+
1084
+
1085
+
1086
+
1087
+
1088
+ Shareholder s Equity
1089
+
1090
+
1091
+
1092
+ Preference shares, $0.0001 par value; 1,000,000 shares authorized; none outstanding
1093
+
1094
+
1095
+
1096
+ Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; none outstanding
1097
+
1098
+
1099
+
1100
+ Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 4,312,500 shares issued and outstanding (1)
1101
+ 431
1102
+
1103
+
1104
+ Additional paid in capital
1105
+ 24,569
1106
+
1107
+
1108
+ Accumulated deficit
1109
+ (6,878)
1110
+
1111
+
1112
+ Total Shareholder s Equity
1113
+ 18,122
1114
+
1115
+
1116
+ TOTAL LIABILITIES AND SHAREHOLDER S EQUITY
1117
+ $536,440
1118
+
1119
+
1120
+
1121
+
1122
+
1123
+ (1)Includes an aggregate of up to
1124
+ 562,500 Class B ordinary shares that are subject to forfeiture if the over-allotment option is not exercised in full by the underwriters
1125
+ (see Note 8).
1126
+
1127
+
1128
+
1129
+ The accompanying notes are an integral part of
1130
+ these financial statements.
1131
+
1132
+
1133
+
1134
+ F-3
1135
+
1136
+ Table of Contents
1137
+
1138
+
1139
+
1140
+ APx ACQUISITION CORP. I
1141
+
1142
+ STATEMENT OF OPERATIONS
1143
+
1144
+
1145
+
1146
+
1147
+
1148
+
1149
+ For the period from May 13, 2021 (inception) through September 30, 2021
1150
+
1151
+
1152
+
1153
+
1154
+
1155
+
1156
+
1157
+
1158
+
1159
+
1160
+
1161
+ Formation costs and other operating expenses
1162
+
1163
+ $
1164
+ 6,878
1165
+
1166
+
1167
+
1168
+
1169
+ Net loss
1170
+
1171
+ $
1172
+ (6,878
1173
+ )
1174
+
1175
+
1176
+
1177
+ Weighted average ordinary shares outstanding, basic and diluted (1)
1178
+
1179
+
1180
+ 3,750,000
1181
+
1182
+
1183
+
1184
+
1185
+ Basic and diluted net loss per ordinary share
1186
+
1187
+ $
1188
+
1189
+
1190
+
1191
+
1192
+
1193
+
1194
+
1195
+ (1)Excludes an aggregate of up to
1196
+ 562,500 Class B ordinary shares that are subject to forfeiture if the over-allotment option is not exercised in full by the underwriters
1197
+ (see Note 8).
1198
+
1199
+
1200
+
1201
+ The accompanying notes are an integral part of
1202
+ these financial statements.
1203
+
1204
+
1205
+
1206
+ F-4
1207
+
1208
+ Table of Contents
1209
+
1210
+
1211
+
1212
+ APx ACQUISITION CORP. I
1213
+
1214
+ STATEMENT OF CHANGES IN SHAREHOLDER S EQUITY
1215
+
1216
+ For the period from May 13, 2021 (inception)
1217
+ through September 30, 2021
1218
+
1219
+
1220
+
1221
+
1222
+
1223
+
1224
+ Class B
1225
+
1226
+
1227
+ Additional
1228
+
1229
+
1230
+
1231
+
1232
+
1233
+ Total
1234
+
1235
+
1236
+
1237
+
1238
+
1239
+ Ordinary Shares
1240
+
1241
+
1242
+ Paid in
1243
+
1244
+
1245
+ Accumulated
1246
+
1247
+
1248
+ Shareholder s
1249
+
1250
+
1251
+
1252
+
1253
+
1254
+ Shares
1255
+
1256
+
1257
+ Amount
1258
+
1259
+
1260
+ Capital
1261
+
1262
+
1263
+ Deficit
1264
+
1265
+
1266
+ Equity
1267
+
1268
+
1269
+
1270
+ Balance – May 13, 2021 (inception)
1271
+
1272
+
1273
+
1274
+
1275
+
1276
+ $
1277
+
1278
+
1279
+
1280
+ $
1281
+ -
1282
+
1283
+
1284
+ $
1285
+ -
1286
+
1287
+
1288
+ $
1289
+ -
1290
+
1291
+
1292
+
1293
+ Issuance of Class B ordinary shares to sponsors (1)
1294
+
1295
+
1296
+ 4,312,500
1297
+
1298
+
1299
+
1300
+ 431
1301
+
1302
+
1303
+
1304
+ 24,569
1305
+
1306
+
1307
+
1308
+ -
1309
+
1310
+
1311
+
1312
+ 25,000
1313
+
1314
+
1315
+
1316
+ Net loss
1317
+
1318
+
1319
+
1320
+
1321
+
1322
+
1323
+
1324
+
1325
+
1326
+
1327
+ -
1328
+
1329
+
1330
+
1331
+ (6,878
1332
+ )
1333
+
1334
+
1335
+ (6,878
1336
+ )
1337
+
1338
+
1339
+ Balance – September 30, 2021
1340
+
1341
+
1342
+ 4,312,500
1343
+
1344
+
1345
+ $
1346
+ 431
1347
+
1348
+
1349
+ $
1350
+ 24,569
1351
+
1352
+
1353
+ $
1354
+ (6,878
1355
+ )
1356
+
1357
+ $
1358
+ 18,122
1359
+
1360
+
1361
+
1362
+
1363
+
1364
+ (1)Includes an aggregate of up to
1365
+ 562,500 Class B ordinary shares that are subject to forfeiture if the over-allotment option is not exercised in full by the underwriters
1366
+ (see Note 8).
1367
+
1368
+
1369
+
1370
+ The accompanying notes are an integral part of
1371
+ these financial statements.
1372
+
1373
+
1374
+
1375
+ F-5
1376
+
1377
+ Table of Contents
1378
+
1379
+
1380
+
1381
+ APx ACQUISITION CORP. I
1382
+
1383
+ STATEMENT OF CASH FLOWS
1384
+
1385
+
1386
+
1387
+
1388
+
1389
+
1390
+ For the period from May 13, 2021 (inception) through September 30, 2021
1391
+
1392
+
1393
+
1394
+
1395
+
1396
+
1397
+
1398
+
1399
+
1400
+
1401
+
1402
+ Cash flow from operating activities:
1403
+
1404
+
1405
+
1406
+
1407
+
1408
+
1409
+
1410
+ Net loss
1411
+
1412
+ $
1413
+ (6,878
1414
+ )
1415
+
1416
+
1417
+
1418
+ Adjustments to reconcile net loss to net cash used in operating activities:
1419
+
1420
+
1421
+
1422
+
1423
+
1424
+
1425
+
1426
+ Changes in operating assets and liabilities:
1427
+
1428
+
1429
+
1430
+
1431
+
1432
+
1433
+
1434
+ Accrued offering expenses
1435
+
1436
+
1437
+ 6,878
1438
+
1439
+
1440
+
1441
+
1442
+ Net cash used in operating activities
1443
+
1444
+
1445
+
1446
+
1447
+
1448
+
1449
+
1450
+ Net change in cash
1451
+
1452
+
1453
+
1454
+
1455
+
1456
+
1457
+
1458
+ Cash at the beginning of the period
1459
+
1460
+
1461
+
1462
+
1463
+
1464
+
1465
+
1466
+ Cash at the end of the period
1467
+
1468
+ $
1469
+
1470
+
1471
+
1472
+
1473
+
1474
+ Non-cash investing and financing activities:
1475
+
1476
+
1477
+
1478
+
1479
+
1480
+
1481
+
1482
+ Deferred offering costs included in accrued offering costs
1483
+
1484
+ $
1485
+ 511,440
1486
+
1487
+
1488
+
1489
+
1490
+ Deferred offering costs paid by sponsor in exchange for issuance of Class B ordinary shares
1491
+
1492
+ $
1493
+ 25,000
1494
+
1495
+
1496
+
1497
+
1498
+
1499
+
1500
+ The accompanying notes are an integral part of
1501
+ these financial statements.
1502
+
1503
+
1504
+
1505
+ F-6
1506
+
1507
+ Table of Contents
1508
+
1509
+
1510
+
1511
+ APx ACQUISITION CORP. I
1512
+ NOTES TO FINANCIAL STATEMENTS
1513
+
1514
+
1515
+ NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
1516
+
1517
+
1518
+
1519
+ APx
1520
+ Acquisition Corp. I (the "Company") is a blank check company incorporated in the Cayman Islands on May 13, 2021. The Company
1521
+ was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other
1522
+ similar business combination with one or more businesses (the "Business Combination").The Company is an early stage and emerging
1523
+ growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
1524
+
1525
+
1526
+
1527
+ As
1528
+ of September 30, 2021, the Company had not yet commenced any operations. All activity for the period May 13, 2021 (inception) through
1529
+ September 30, 2021 relates to the Company s formation and the proposed initial public offering (the "Proposed Offering")
1530
+ which is described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination,
1531
+ at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Proposed
1532
+ Offering. The Company has selected December 31 as its fiscal year end.
1533
+
1534
+
1535
+
1536
+ The
1537
+ Company s ability to commence operations is contingent upon obtaining adequate financial resources through a proposed initial public
1538
+ offering of 15,000,000 units at $10.00 per unit (or 17,250,000 units if the underwriter s over-allotment option is exercised in
1539
+ full) (the "Units" and, with respect to the shares of Class A ordinary shares included in the Units being offered, the "Public
1540
+ Shares") which is discussed in Note 3 and the sale of 8,050,000 warrants (or 8,950,000 warrants if the underwriter s over-allotment
1541
+ option is exercised in full) (the "Private Placement Warrants") at a price of $1.00 per Private Placement Warrant that will
1542
+ close in a private placement to APx Cap Sponsor Group I, LLC (the "Sponsor") simultaneously with the closing of the Proposed
1543
+ Offering (see Note 4).
1544
+
1545
+
1546
+
1547
+ The
1548
+ Company s management has broad discretion with respect to the specific application of the net proceeds of the Proposed Offering
1549
+ and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward
1550
+ consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that
1551
+ together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (less any deferred underwriting
1552
+ commissions and taxes payable on interest earned on the Trust Account) at the time of the signing a definitive agreement to enter a Business
1553
+ Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more
1554
+ of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to
1555
+ be required to register as an investment company under the Investment Company Act of 1940, as amended (the "Investment Company
1556
+ Act"). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the
1557
+ Proposed Offering, management has agreed that $10.00 per Unit sold in the Proposed Offering, including the proceeds from the sale of
1558
+ the Private Placement Warrants, will be held in a trust account (the "Trust Account") and invested in U.S. government securities,
1559
+ within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended
1560
+ investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as
1561
+ determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds
1562
+ in the Trust Account to the Company s shareholders, as described below.
1563
+
1564
+
1565
+
1566
+ The
1567
+ Company will provide its holders of the outstanding Public Shares (the "public shareholders") with the opportunity to redeem
1568
+ all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting
1569
+ called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the
1570
+ Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to
1571
+ redeem their shares, regardless of whether they vote for or against a
1572
+
1573
+
1574
+
1575
+ F-7
1576
+
1577
+ Table of Contents
1578
+
1579
+
1580
+ APx ACQUISITION CORP. I
1581
+ NOTES TO FINANCIAL STATEMENTS
1582
+
1583
+
1584
+ Business Combination. The Company will proceed
1585
+ with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such
1586
+ consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are
1587
+ voted in favor of the Business Combination.
1588
+
1589
+
1590
+
1591
+ If
1592
+ the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules,
1593
+ the Company s Certificate of Incorporation provides that, a public shareholder, together with any affiliate of such shareholder
1594
+ or any other person with whom such shareholder is acting in concert or as a "group" (as defined under Section 13 of the Securities
1595
+ Exchange Act of 1934, as amended (the "Exchange Act")), will be restricted from seeking redemption rights with respect to
1596
+ 15% or more of the Public Shares without the Company s prior written consent.
1597
+
1598
+
1599
+
1600
+ The
1601
+ public shareholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially
1602
+ $10.20 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company
1603
+ to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their shares will not be reduced by the
1604
+ deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 6). There will be no redemption rights
1605
+ upon the completion of a Business Combination with respect to the Company s warrants. These shares of Class A ordinary shares will
1606
+ be recorded at a redemption value and classified as temporary equity upon the completion of the Proposed Offering, in accordance with
1607
+ Accounting Standards Codification ("ASC") Topic 480 "Distinguishing Liabilities from Equity."
1608
+
1609
+
1610
+
1611
+ If
1612
+ a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the
1613
+ Company will, pursuant to its Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the Securities
1614
+ and Exchange Commission (the "SEC"), and file tender offer documents containing substantially the same information as would
1615
+ be included in a proxy statement with the SEC prior to completing a Business Combination.
1616
+
1617
+
1618
+
1619
+ The
1620
+ Company s Sponsor has agreed (a) to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after
1621
+ the Proposed Offering in favor of a Business Combination, (b) not to propose an amendment to the Company s Certificate of Incorporation
1622
+ with respect to the Company s pre-Business Combination activities prior to the consummation of a Business Combination unless the
1623
+ Company provides dissenting public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment;
1624
+ (c) not to redeem any shares (including the Founder Shares) into the right to receive cash from the Trust Account in connection with
1625
+ a shareholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination
1626
+ if the Company does not seek shareholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated
1627
+ Certificate of Incorporation relating to shareholders rights of pre-Business Combination activity and (d) that the Founder Shares
1628
+ shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor
1629
+ will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the
1630
+ Proposed Offering if the Company fails to complete its Business Combination.
1631
+
1632
+
1633
+
1634
+ If
1635
+ the Company is unable to complete a Business Combination within 15 months from the closing of the Proposed Offering (or within 21 months
1636
+ if we extend the period of time to consummate our initial business combination in accordance with the terms described in this prospectus)
1637
+ (the "Combination Period"), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly
1638
+ as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash,
1639
+ equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account
1640
+ and not previously released to us to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of
1641
+ then outstanding public shares, which redemption will completely extinguish public shareholder s rights as shareholders (including
1642
+ the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible
1643
+ following such redemption, subject to the approval of the remaining shareholders and the Company s board of directors, proceed
1644
+ to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware
1645
+ law to provide for
1646
+
1647
+
1648
+
1649
+ F-8
1650
+
1651
+ Table of Contents
1652
+
1653
+
1654
+ APx ACQUISITION CORP. I
1655
+ NOTES TO FINANCIAL STATEMENTS
1656
+
1657
+
1658
+ claims of creditors and the requirements of applicable
1659
+ law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the
1660
+ Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with
1661
+ the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution,
1662
+ it is possible that the per share value of the assets remaining available for distribution will be less than the Proposed Offering price
1663
+ per Unit $10.00.
1664
+
1665
+
1666
+
1667
+ The
1668
+ Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products
1669
+ sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality
1670
+ or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.20
1671
+ per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account,
1672
+ if less than $10.20 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will
1673
+ not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in
1674
+ the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company s indemnity of
1675
+ the underwriter of Proposed Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended
1676
+ (the "Securities Act"). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor
1677
+ has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that
1678
+ the Sponsor s only assets are securities of the Company. Therefore, the Company cannot assure its shareholders that the Sponsor
1679
+ would be able to satisfy those obligations. None of the Company s officers or directors will indemnify the Company for claims by
1680
+ third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the
1681
+ possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors,
1682
+ service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the
1683
+ Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
1684
+
1685
+
1686
+
1687
+ Risks and Uncertainties
1688
+
1689
+
1690
+
1691
+ Management
1692
+ continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that
1693
+ the virus could have a negative effect on the Company s financial position, results of its operations and/or search for a target
1694
+ company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not
1695
+ include any adjustments that might result from the outcome of this uncertainty.
1696
+
1697
+
1698
+
1699
+ Going Concern Consideration
1700
+
1701
+
1702
+
1703
+ At
1704
+ September 30, 2021, the Company had no cash and a working capital deficiency of $518,318. The Company has incurred and expects to continue
1705
+ to incur significant costs in pursuit of its financing and acquisition plans. These conditions raise substantial doubt about the Company s
1706
+ ability to continue as a going concern within one year after the date that the financial statements are issued. Management plans to address
1707
+ this uncertainty through a Proposed Offering as discussed in Note 3. There is no assurance that the Company s plans to raise capital
1708
+ or to consummate a Business Combination will be successful or successful within the Combination Period. The Sponsor has agreed to loan
1709
+ the Company up to an aggregate amount of $300,000 to be used, in part, for transaction costs incurred in connection with the Proposed
1710
+ Offering (the "Promissory Note"). The financial statements do not include any adjustments that might result from the outcome
1711
+ of this uncertainty.
1712
+
1713
+
1714
+
1715
+ NOTE 2.
parsed_sections/legal_matters/2021/ARBKL_argo_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS Sidley Austin LLP will pass upon certain legal matters for us in connection with the offering of the Notes. The underwriters are being represented in connection with the offering by Duane Morris LLP. TABLE OF CONTENTS
parsed_sections/legal_matters/2021/ARHS_arhaus-inc_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of common stock offered hereby is being passed upon for us by Baker & Hostetler LLP. Certain legal matters concerning this offering will be passed upon for the underwriters by Latham & Watkins LLP.
parsed_sections/legal_matters/2021/ARIS_aris_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the shares of Class A common stock offered by this prospectus will be passed upon for us by Gibson, Dunn & Crutcher LLP, Houston, Texas. Certain legal matters in connection with this offering will be passed upon for the underwriters by Latham & Watkins LLP, Austin, Texas.
parsed_sections/legal_matters/2021/ARKOW_arko-corp_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the securities offered by this prospectus will be passed upon for us by Greenberg Traurig, LLP.
parsed_sections/legal_matters/2021/ARQQW_arqit_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the Ordinary Shares offered by this prospectus has been passed upon by Maples and Calder (Cayman) LLP. The validity of the Warrants offered by this prospectus has been passed upon by White & Case LLP. TABLE OF CONTENTS
parsed_sections/legal_matters/2021/ASLE_aersale_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of any securities offered by this prospectus will be passed upon for us by Latham & Watkins LLP.
parsed_sections/legal_matters/2021/ASTLW_algoma_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS Certain legal matters relating to U.S. law will be passed upon for us by Paul, Weiss, Rifkind, Wharton & Garrison LLP, New York, New York. Certain Canadian legal matters will be passed upon for us by Goodmans LLP, Toronto, Ontario, Canada. The legality of the Common Shares will be passed upon by Lawson Lundell LLP.
parsed_sections/legal_matters/2021/ATEKW_athena_legal_matters.txt ADDED
@@ -0,0 +1,1720 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ legal matters by counsel and to other conditions. The underwriters are obligated to purchase all of the units (other than those covered by the over-allotment option described below) if they purchase any of the units.
2
+
3
+ Units sold by the underwriters to the public will initially be offered at the initial public offering price set forth on the cover of this prospectus. If all of the units are not sold at the initial offering price, the underwriters may change the offering price and the other selling terms. The representative has advised us that the underwriters do not intend to make sales to discretionary accounts. Sales of any units made outside of the United States may be made by affiliates of the underwriters. The offering of the units by the underwriters is subject to receipt and acceptance and subject to the underwriters right to reject any order in whole or in part.
4
+
5
+ If the underwriters sell more units than the total number set forth in the table above, we have granted to the underwriters an option, exercisable for 45 days from the date of this prospectus, to purchase up to 3,750,000 additional units at the public offering price less the underwriting discount. The underwriters may exercise this option solely for the purpose of covering over-allotments, if any, in connection with this offering. To the extent the option is exercised, each underwriter must purchase a number of additional units approximately proportionate to that underwriter s initial purchase commitment. Any units issued or sold under the option will be issued and sold on the same terms and conditions as the other units that are the subject of this offering.
6
+
7
+ We, our sponsor and our officers and directors have agreed that, for a period of 180 days from the date of this prospectus, we and they will not, without the prior written consent of the representative, offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, any units, warrants, shares of common stock or any other securities convertible into, or exercisable, or exchangeable for, shares of common stock, subject to certain exceptions. The representative in its sole discretion may release any of the securities subject to these lock-up agreements at any time without notice. Our sponsor, officers and directors are also subject to separate transfer restrictions on their founder shares and private placement units pursuant to the insider letters as described herein.
8
+
9
+ Our sponsor, founder, officers and directors have agreed not to transfer, assign or sell any founder shares held by them until the earlier to occur of: (1) one year after the completion of our initial business combination; or (2) the date on which we complete a liquidation, merger, stock exchange, reorganization or other similar transaction after our initial business combination that results in all of our public stockholders having the right to exchange their shares of common stock for cash, securities or other property (except as described herein under Principal Stockholders Transfers of Founder Shares and Private Placement Units ). Any permitted transferees would be subject to the same restrictions and other agreements of our sponsor with respect to any founder shares. We refer to such transfer restrictions throughout this prospectus as the lock-up. Notwithstanding the foregoing, if the closing price of our common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, the founder shares will be released from the lock-up. The private placement units (including the Class A common stock issuable upon exercise of the private placement warrants) will not be transferable, assignable or saleable until 30 days after the completion of our initial business combination (except with respect to permitted transferees as described herein under the section of this prospectus entitled Principal Stockholders Transfers of Founder Shares and Private Placement Units ).
10
+
11
+
12
+
13
+ 168
14
+
15
+ Table of Contents
16
+
17
+
18
+ Prior to this offering, there has been no public market for our securities. Consequently, the initial public offering price for the units was determined by negotiations between us and the representative.
19
+
20
+ Among the factors considered in determining the initial public offering price were the history and prospects of companies whose principal business is the acquisition of other companies, prior offerings of those companies, our management, our capital structure, and currently prevailing general conditions in the equity securities markets, including current market valuations of publicly traded companies considered comparable to our company. We cannot assure you, however, that the price at which the units, Class A common stock or warrants will sell in the public market after this offering will not be lower than the initial public offering price or that an active trading market in our units, Class A common stock or warrants will develop and continue after this offering.
21
+
22
+ We intend to apply to have our units listed on the NYSE under the symbol ATEK.U commencing on or promptly after the date of this prospectus. We cannot guarantee that our securities will be approved for listing on the NYSE. Once the securities comprising the units begin separate trading, we expect that the Class A common stock and warrants will be listed on the NYSE under the symbols ATEK and ATEK WS, respectively.
23
+
24
+ The following table shows the underwriting discounts and commissions that we are to pay to the underwriters in connection with this offering. These amounts are shown assuming both no exercise and full exercise of the underwriters over-allotment option.
25
+
26
+
27
+
28
+
29
+
30
+
31
+
32
+
33
+
34
+ Paid by the Company
35
+
36
+
37
+
38
+
39
+
40
+
41
+
42
+
43
+ No Exercise
44
+
45
+
46
+
47
+
48
+ Full Exercise
49
+
50
+
51
+
52
+
53
+
54
+
55
+ Per Unit(1)
56
+
57
+
58
+
59
+
60
+ $
61
+
62
+
63
+
64
+ 0.55
65
+
66
+
67
+
68
+
69
+ $
70
+
71
+
72
+
73
+ 0.55
74
+
75
+
76
+
77
+
78
+
79
+
80
+ Total(1)
81
+
82
+
83
+
84
+
85
+ $
86
+
87
+
88
+
89
+ 13,750,000
90
+
91
+
92
+
93
+
94
+ $
95
+
96
+
97
+
98
+ 15,812,500
99
+
100
+
101
+
102
+
103
+
104
+ ____________
105
+ (1) $0.20 per unit sold in the base offering, or $5,000,000 in the aggregate is payable upon the closing of this offering. Include $0.35 per unit sold in the base offering, or $8,750,000 in the aggregate, payable to the underwriters for deferred underwriting commissions to be placed in the trust account and to the underwriters only upon the completion of an initial business combination. If the underwriters over-allotment option is exercised, $0.55 per over-allotment unit, or up to an additional $2,062,500 or $10,812,500 in the aggregate if the underwriters over-allotment option is exercised in full, will be deposited in the trust account. The deferred commissions will be released to the underwriters only on completion of an initial business combination.
106
+
107
+ If we do not complete our initial business combination and subsequently liquidate, the trustee and the underwriters have agreed that they will forfeit any rights or claims to their deferred underwriting discounts and commissions, including any accrued interest thereon, then in the trust account upon liquidation.
108
+
109
+ In connection with the offering, the underwriters may purchase and sell units in the open market. Purchases and sales in the open market may include short sales, purchases to cover short positions, which may include purchases pursuant to the over-allotment option and stabilizing purchases, in accordance with Regulation M under the Exchange Act.
110
+
111
+ Short sales involve secondary market sales by the underwriters of a greater number of units than they are required to purchase in the offering.
112
+
113
+ Covered short sales are sales of units in an amount up to the number of units represented by the underwriters over-allotment option.
114
+
115
+ Naked short sales are sales of units in an amount in excess of the number of units represented by the underwriters over-allotment option.
116
+
117
+ Covering transactions involve purchases of units either pursuant to the over-allotment option or in the open market after the distribution has been completed in order to cover short positions.
118
+
119
+ To close a naked short position, the underwriters must purchase units in the open market after the distribution has been completed. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the units in the open market after pricing that could adversely affect investors who purchase in the offering.
120
+
121
+
122
+
123
+ 169
124
+
125
+ Table of Contents
126
+
127
+
128
+ To close a covered short position, the underwriters must purchase units in the open market after the distribution has been completed or must exercise the over-allotment option. In determining the source of units to close the covered short position, the underwriters will consider, among other things, the price of units available for purchase in the open market as compared to the price at which they may purchase units through the over-allotment option.
129
+
130
+ Stabilizing transactions involve bids to purchase units so long as the stabilizing bids do not exceed a specified maximum.
131
+
132
+ Purchases to cover short positions and stabilizing purchases, as well as other purchases by the underwriters for their own accounts, may have the effect of preventing or retarding a decline in the market price of the units. They may also cause the price of the units to be higher than the price that would otherwise exist in the open market in the absence of these transactions. The underwriters may conduct these transactions in the over-the-counter market or otherwise. If the underwriters commence any of these transactions, they may discontinue them at any time.
133
+
134
+ We estimate that our portion of the total expenses of this offering payable by us will be $550,000, excluding underwriting discounts and commissions. We have also agreed to pay the FINRA-related fees and expenses of the underwriters legal counsel, not to exceed $25,000.
135
+
136
+ The underwriters have agreed to reimburse certain of our expenses.
137
+
138
+ We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act, or to contribute to payments the underwriters may be required to make because of any of those liabilities.
139
+
140
+ We are not under any contractual obligation to engage any of the underwriters to provide any services for us after this offering, and have no present intent to do so. However, any of the underwriters may introduce us to potential target businesses or assist us in raising additional capital in the future. If any of the underwriters provide services to us after this offering, we may pay such underwriter fair and reasonable fees that would be determined at that time in an arm s length negotiation; provided that no agreement will be entered into with any of the underwriters and no fees for such services will be paid to any of the underwriters prior to the date that is 60 days from the date of this prospectus, unless FINRA determines that such payment would not be deemed underwriters compensation in connection with this offering and we may pay the underwriters of this offering or any entity with which they are affiliated a finder s fee or other compensation for services rendered to us in connection with the completion of a business combination.
141
+
142
+ Some of the underwriters and their affiliates have engaged in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business with us or our affiliates. They have received, or may in the future receive, customary fees and commissions for these transactions.
143
+
144
+ In addition, in the ordinary course of their business activities, the underwriters and their affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers. Such investments and securities activities may involve securities and/or instruments of ours or our affiliates.
145
+
146
+ The underwriters and their affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.
147
+
148
+ Notice to Prospective Investors in European Economic Area
149
+
150
+ In relation to each Member State of the European Economic Area (each a Member State ), no units have been offered or will be offered pursuant to the offering to the public in that Member State prior to the publication of a prospectus in relation to the units which has been approved by the competent authority in that Member State or,
151
+
152
+
153
+
154
+ 170
155
+
156
+ Table of Contents
157
+
158
+
159
+ where appropriate, approved in another Member State and notified to the competent authority in that Member State, all in accordance with the Prospectus Regulation), except that offers of units may be made to the public in that Member State at any time under the following exemptions under the Prospectus Regulation:
160
+
161
+ (a) to any legal entity which is a qualified investor as defined under the Prospectus Regulation;
162
+
163
+ (b) to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus Regulation), subject to obtaining the prior consent of the Representative for any such offer; or
164
+
165
+ (c) in any other circumstances falling within Article 1(4) of the Prospectus Regulation,
166
+
167
+ provided that no such offer of units shall require the company or any Representative to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation.
168
+
169
+ For the purposes of this provision, the expression an offer to the public in relation to any units in any Member State means the communication in any form and by any means of sufficient information on the terms of the offer and any units to be offered so as to enable an investor to decide to purchase or subscribe for any units, and the expression Prospectus Regulation means Regulation (EU) 2017/1129.
170
+
171
+ Notice to Prospective Investors in United Kingdom
172
+
173
+ The underwriters have represented and agreed that:
174
+
175
+ (a) they have only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000 (FSMA)) received by it in connection with the issue or sale of the units in circumstances in which Section 21(1) of the FSMA does not apply to the company; and
176
+
177
+ (b) they have complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the units in, from or otherwise involving the United Kingdom.
178
+
179
+ Notice to Prospective Investors in France
180
+
181
+ Neither this prospectus nor any other offering material relating to the units described in this prospectus has been submitted to the clearance procedures of the Autorit des March s Financiers or of the competent authority of another member state of the European Economic Area and notified to the Autorit des March s Financiers. The units have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in France. Neither this prospectus nor any other offering material relating to the units has been or will be:
182
+
183
+ released, issued, distributed or caused to be released, issued or distributed to the public in France; or
184
+
185
+ used in connection with any offer for subscription or sale of the units to the public in France. Such offers, sales and distributions will be made in France only:
186
+
187
+ To qualified investors (investisseurs qualifi s) and/or to a restricted circle of investors (cercle restreint d investisseurs), in each case investing for their own account, all as defined in, and in accordance with, articles L.411-2, D.411-1, D.411-2, D.734-1, D.744-1, D.754-1 and D.764-1 of the French Code mon taire et financier;
188
+
189
+ to investment services providers authorized to engage in portfolio management on behalf of third parties; or
190
+
191
+ in a transaction that, in accordance with article L.411-2-II-1 -or-2 -or 3 of the French Code mon taire et financier and article 211-2 of the General Regulations (R glement G n ral) of the Autorit des March s Financiers, does not constitute a public offer (appel public l pargne).
192
+
193
+
194
+
195
+ 171
196
+
197
+ Table of Contents
198
+
199
+
200
+ The units may be resold directly or indirectly, only in compliance with articles L.411-1, L.411-2, L.412-1 and L.621-8 through L.621-8-3 of the French Code mon taire et financier.
201
+
202
+ Notice to Prospective Investors in Hong Kong
203
+
204
+ The units may not be offered or sold in Hong Kong by means of any document other than (i) in circumstances which do not constitute an offer to the public within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong), or (ii) to professional investors within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder, or (iii) in other circumstances which do not result in the document being a prospectus within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong) and no advertisement, invitation or document relating to the units may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the laws of Hong Kong) other than with respect to units which are or are intended to be disposed of only to persons outside Hong Kong or only to professional investors within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder.
205
+
206
+ Notice to Prospective Investors in Japan
207
+
208
+ The units offered in this prospectus have not been and will not be registered under the Financial Instruments and Exchange Law of Japan. The units have not been offered or sold and will not be offered or sold, directly or indirectly, in Japan or to or for the account of any resident of Japan (including any corporation or other entity organized under the laws of Japan), except (i) pursuant to an exemption from the registration requirements of the Financial Instruments and Exchange Law and (ii) in compliance with any other applicable requirements of Japanese law.
209
+
210
+ Notice to Prospective Investors in Singapore
211
+
212
+ This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the units may not be circulated or distributed, nor may the units be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor under Section 274 of the Securities and Futures Act, Chapter 289 of Singapore (the SFA ), (ii) to a relevant person pursuant to Section 275(1), or any person pursuant to Section 275(1A), and in accordance with the conditions specified in Section 275 of the SFA or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA, in each case subject to compliance with conditions set forth in the SFA.
213
+
214
+ Where the units are subscribed or purchased under Section 275 of the SFA by a relevant person which is
215
+
216
+ a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or
217
+
218
+ a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary is an accredited investor, shares, debentures and units of shares and debentures of that corporation or the beneficiaries rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the shares pursuant to an offer made under Section 275 of the SFA except:
219
+
220
+ to an institutional investor (for corporations, under Section 274 of the SFA) or to a relevant person defined in Section 275(2) of the SFA, or to any person pursuant to an offer that is made on terms that such shares, debentures and units of shares and debentures of that corporation or such rights and interest in that trust
221
+
222
+
223
+
224
+ 172
225
+
226
+ Table of Contents
227
+
228
+
229
+ are acquired at a consideration of not less than $200,000 (or its equivalent in a foreign currency) for each transaction, whether such amount is to be paid for in cash or by exchange of securities or other assets, and further for corporations, in accordance with the conditions specified in Section 275 of the SFA;
230
+
231
+ where no consideration is or will be given for the transfer; or
232
+
233
+ where the transfer is by operation of law.
234
+
235
+ Notice to Prospective Investors in Canada
236
+
237
+ The units may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the units must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.
238
+
239
+ Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser s province or territory for particulars of these rights or consult with a legal advisor.
240
+
241
+ Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.
242
+
243
+ Notice to Prospective Investors in the Dubai International Financial Centre
244
+
245
+ This prospectus relates to an Exempt Offer in accordance with the Offered Securities Rules of the Dubai Financial Services Authority ( DFSA ). This prospectus is intended for distribution only to persons of a type specified in the Offered Securities Rules of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus nor taken steps to verify the information set forth herein and has no responsibility for the prospectus. The securities to which this prospectus relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the securities offered should conduct their own due diligence on the securities. If you do not understand the contents of this prospectus you should consult an authorized financial advisor.
246
+
247
+ Notice to Prospective Investors in Australia
248
+
249
+ No placement document, prospectus, product disclosure statement or other disclosure document has been lodged with the Australian Securities and Investments Commission ( ASIC ), in relation to the offering. This prospectus does not constitute a prospectus, product disclosure statement or other disclosure document under the Corporations Act 2001 (the Corporations Act ), and does not purport to include the information required for a prospectus, product disclosure statement or other disclosure document under the Corporations Act.
250
+
251
+ Any offer in Australia of the securities may only be made to persons (the Exempt Investors ) who are sophisticated investors (within the meaning of section 708(8) of the Corporations Act), professional investors (within the meaning of section 708(11) of the Corporations Act) or otherwise pursuant to one or more exemptions contained in section 708 of the Corporations Act so that it is lawful to offer the securities without disclosure to investors under Chapter 6D of the Corporations Act.
252
+
253
+
254
+
255
+ 173
256
+
257
+ Table of Contents
258
+
259
+
260
+ The securities applied for by Exempt Investors in Australia must not be offered for sale in Australia in the period of 12 months after the date of allotment under the offering, except in circumstances where disclosure to investors under Chapter 6D of the Corporations Act would not be required pursuant to an exemption under section 708 of the Corporations Act or otherwise or where the offer is pursuant to a disclosure document which complies with Chapter 6D of the Corporations Act. Any person acquiring securities must observe such Australian on-sale restrictions. This prospectus contains general information only and does not take account of the investment objectives, financial situation or particular needs of any particular person. It does not contain any securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether the information in this prospectus is appropriate to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters.
261
+
262
+ Notice to Prospective Investors in Switzerland
263
+
264
+ The securities may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange ( SIX ) or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating to the securities or the offering may be publicly distributed or otherwise made publicly available in Switzerland.
265
+
266
+ Neither this document nor any other offering or marketing material relating to the offering, the company, the shares have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of securities will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA (FINMA), and the offer of securities has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes ( CISA ). The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of securities.
267
+
268
+
269
+
270
+ 174
271
+
272
+ Table of Contents
273
+
274
+
275
+ Legal Matters
276
+
277
+ McDermott Will & Emery LLP, New York, New York, is acting as counsel in connection with the registration of our securities under the Securities Act, and as such, will pass upon the validity of the securities offered in this prospectus. Shearman & Sterling LLP, New York, New York, advised the underwriters in connection with the offering of the securities.
278
+
279
+ Experts
280
+
281
+ The financial statements of Athena Technology Acquisition Corp. II as of September 15, 2021, and for the period May 20, 2021 (inception) through September 15, 2021, included in this prospectus have been audited by WithumSmith+Brown, PC, independent registered public accounting firm, as set forth in their report thereon, appearing elsewhere in this prospectus, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing.
282
+
283
+ Where You Can Find Additional Information
284
+
285
+ We have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the securities we are offering by this prospectus. This prospectus does not contain all of the information included in the registration statement. For further information about us and our securities, you should refer to the registration statement and the exhibits and schedules filed with the registration statement. Whenever we make reference in this prospectus to any of our contracts, agreements or other documents, the references are materially complete but may not include a description of all aspects of such contracts, agreements or other documents, and you should refer to the exhibits attached to the registration statement for copies of the actual contract, agreement or other document.
286
+
287
+ Upon completion of this offering, we will be subject to the information requirements of the Exchange Act and will file annual, quarterly and current event reports, proxy statements and other information with the SEC. You can read our SEC filings, including the registration statement, over the Internet at the SEC s website at www.sec.gov.
288
+
289
+
290
+
291
+ 175
292
+
293
+ Table of Contents
294
+
295
+
296
+ ATHENA TECHNOLOGY ACQUISITION CORP. II
297
+ INDEX TO FINANCIAL STATEMENTS
298
+
299
+
300
+
301
+
302
+
303
+
304
+
305
+
306
+
307
+ Page
308
+
309
+
310
+
311
+
312
+
313
+
314
+ Report of Independent Registered Public Accounting Firm
315
+
316
+
317
+
318
+
319
+ F-2
320
+
321
+
322
+
323
+
324
+
325
+
326
+ Financial Statements:
327
+
328
+
329
+
330
+
331
+
332
+
333
+
334
+
335
+ Balance Sheet as of September 15, 2021
336
+
337
+
338
+
339
+
340
+ F-3
341
+
342
+
343
+
344
+
345
+
346
+
347
+ Statement of Operations for the period from May 20, 2021 (inception) through
348
+ September 15, 2021
349
+
350
+
351
+
352
+
353
+ F-4
354
+
355
+
356
+
357
+
358
+
359
+
360
+ Statement of Changes in Stockholder s Equity for the period from May 20, 2021 (inception) through September 15, 2021
361
+
362
+
363
+
364
+
365
+ F-5
366
+
367
+
368
+
369
+
370
+
371
+
372
+ Statement of Cash Flows for the period from May 20, 2021 (inception) through
373
+ September 15, 2021
374
+
375
+
376
+
377
+
378
+ F-6
379
+
380
+
381
+
382
+
383
+
384
+
385
+ Notes to Financial Statements
386
+
387
+
388
+
389
+
390
+ F-7
391
+
392
+
393
+
394
+
395
+
396
+
397
+
398
+ F-1
399
+
400
+ Table of Contents
401
+
402
+
403
+ REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
404
+
405
+ To the Stockholder and the Board of Directors of
406
+ Athena Technology Acquisition Corp. II
407
+
408
+ Opinion on the Financial Statements
409
+
410
+ We have audited the accompanying balance sheet of Athena Technology Acquisition Corp. II (the Company ) as of September 15, 2021, the related statements of operations, changes in stockholder s equity and cash flows for the period from May 20, 2021 (inception) through September 15, 2021, and the related notes (collectively referred to as the financial statements ). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of September 15, 2021, and the results of its operations and its cash flows for the period from May 20, 2021 (inception) through September 15, 2021, in conformity with accounting principles generally accepted in the United States of America.
411
+
412
+ Basis for Opinion
413
+
414
+ These financial statements are the responsibility of the Company s management. Our responsibility is to express an opinion on the Company s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (the PCAOB ) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
415
+
416
+ We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company s internal control over financial reporting. Accordingly, we express no such opinion.
417
+
418
+ Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
419
+
420
+ /s/ WithumSmith+Brown, PC
421
+
422
+ We have served as the Company s auditor since 2021.
423
+
424
+ New York, New York
425
+ November 22, 2021
426
+
427
+
428
+
429
+ F-2
430
+
431
+ Table of Contents
432
+
433
+
434
+ ATHENA TECHNOLOGY ACQUISITION CORP. II
435
+ BALANCE SHEET
436
+ SEPTEMBER 15, 2021
437
+
438
+
439
+
440
+
441
+
442
+
443
+ ASSETS
444
+
445
+
446
+
447
+
448
+
449
+
450
+
451
+
452
+
453
+
454
+
455
+
456
+
457
+
458
+
459
+
460
+ CURRENT ASSETS
461
+
462
+
463
+
464
+
465
+
466
+
467
+
468
+
469
+
470
+
471
+
472
+
473
+
474
+
475
+
476
+
477
+ Prepaid expenses
478
+
479
+
480
+
481
+
482
+ $
483
+
484
+
485
+
486
+ 25,000
487
+
488
+
489
+
490
+
491
+
492
+
493
+
494
+
495
+
496
+
497
+ Total current assets
498
+
499
+
500
+
501
+
502
+
503
+
504
+
505
+
506
+ 25,000
507
+
508
+
509
+
510
+
511
+
512
+
513
+
514
+
515
+
516
+
517
+
518
+
519
+
520
+
521
+
522
+
523
+
524
+
525
+
526
+
527
+
528
+
529
+
530
+
531
+ OTHER ASSETS
532
+
533
+
534
+
535
+
536
+
537
+
538
+
539
+
540
+
541
+
542
+
543
+
544
+
545
+
546
+
547
+
548
+ Deferred offering costs
549
+
550
+
551
+
552
+
553
+
554
+
555
+
556
+
557
+ 10,000
558
+
559
+
560
+
561
+
562
+
563
+
564
+
565
+
566
+
567
+
568
+ Total other assets
569
+
570
+
571
+
572
+
573
+
574
+
575
+
576
+
577
+ 10,000
578
+
579
+
580
+
581
+
582
+
583
+
584
+
585
+
586
+
587
+
588
+
589
+
590
+
591
+
592
+
593
+
594
+
595
+
596
+
597
+
598
+
599
+
600
+
601
+
602
+ TOTAL ASSETS
603
+
604
+
605
+
606
+
607
+ $
608
+
609
+
610
+
611
+ 35,000
612
+
613
+
614
+
615
+
616
+
617
+
618
+
619
+
620
+
621
+
622
+
623
+
624
+
625
+
626
+
627
+
628
+
629
+
630
+
631
+
632
+
633
+
634
+
635
+
636
+ LIABILITIES AND STOCKHOLDER S EQUITY
637
+
638
+
639
+
640
+
641
+
642
+
643
+
644
+
645
+
646
+
647
+
648
+
649
+
650
+
651
+
652
+
653
+ CURRENT LIABILITIES
654
+
655
+
656
+
657
+
658
+
659
+
660
+
661
+
662
+
663
+
664
+
665
+
666
+
667
+
668
+
669
+
670
+ Accounts payable and accrued expenses
671
+
672
+
673
+
674
+
675
+ $
676
+
677
+
678
+
679
+ 1,160
680
+
681
+
682
+
683
+
684
+
685
+
686
+
687
+
688
+
689
+
690
+ Accrued offering costs
691
+
692
+
693
+
694
+
695
+
696
+
697
+
698
+
699
+ 10,000
700
+
701
+
702
+
703
+
704
+
705
+
706
+
707
+
708
+
709
+
710
+ Total liabilities
711
+
712
+
713
+
714
+
715
+
716
+
717
+
718
+
719
+ 11,160
720
+
721
+
722
+
723
+
724
+
725
+
726
+
727
+
728
+
729
+
730
+
731
+
732
+
733
+
734
+
735
+
736
+
737
+
738
+
739
+
740
+
741
+
742
+
743
+
744
+ COMMITMENTS AND CONTINGENCIES
745
+
746
+
747
+
748
+
749
+
750
+
751
+
752
+
753
+
754
+
755
+
756
+
757
+
758
+
759
+
760
+
761
+
762
+
763
+
764
+
765
+
766
+
767
+
768
+
769
+
770
+
771
+
772
+
773
+
774
+
775
+ STOCKHOLDER S EQUITY
776
+
777
+
778
+
779
+
780
+
781
+
782
+
783
+
784
+
785
+
786
+
787
+
788
+
789
+
790
+
791
+
792
+ Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
793
+
794
+
795
+
796
+
797
+
798
+
799
+
800
+
801
+
802
+
803
+
804
+
805
+
806
+
807
+
808
+
809
+
810
+
811
+
812
+ Class A common stock, $0.0001 par value; 300,000,000 shares authorized; none issued or outstanding
813
+
814
+
815
+
816
+
817
+
818
+
819
+
820
+
821
+
822
+
823
+
824
+
825
+
826
+
827
+
828
+
829
+
830
+
831
+
832
+ Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 10,062,500 shares issued and outstanding(1)(2)
833
+
834
+
835
+
836
+
837
+
838
+
839
+
840
+
841
+ 1,006
842
+
843
+
844
+
845
+
846
+
847
+
848
+
849
+
850
+
851
+
852
+ Additional paid-in capital
853
+
854
+
855
+
856
+
857
+
858
+
859
+
860
+
861
+ 23,994
862
+
863
+
864
+
865
+
866
+
867
+
868
+
869
+
870
+
871
+
872
+ Accumulated deficit
873
+
874
+
875
+
876
+
877
+
878
+
879
+
880
+
881
+ (1,160
882
+
883
+
884
+
885
+ )
886
+
887
+
888
+
889
+
890
+
891
+
892
+ Total Stockholder s Equity
893
+
894
+
895
+
896
+
897
+
898
+
899
+
900
+
901
+ 23,840
902
+
903
+
904
+
905
+
906
+
907
+
908
+
909
+
910
+
911
+
912
+ TOTAL LIABILITIES AND STOCKHOLDER S EQUITY
913
+
914
+
915
+
916
+
917
+ $
918
+
919
+
920
+
921
+ 35,000
922
+
923
+
924
+
925
+
926
+
927
+
928
+
929
+
930
+
931
+ ____________
932
+ (1) This number includes up to 1,312,500 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 4).
933
+
934
+ (2) Shares have been retroactively restated to reflect the recapitalization of the Company in the form of a 1.36672326 for 1 stock split (see Note 4)
935
+
936
+ The accompanying notes are an integral part of these financial statements.
937
+
938
+
939
+
940
+ F-3
941
+
942
+ Table of Contents
943
+
944
+
945
+ ATHENA TECHNOLOGY ACQUISITION CORP. II
946
+ STATEMENT OF OPERATIONS
947
+ FOR THE PERIOD FROM MAY 20, 2021 (INCEPTION) THROUGH SEPTEMBER 15, 2021
948
+
949
+
950
+
951
+
952
+
953
+
954
+ OPERATING EXPENSES
955
+
956
+
957
+
958
+
959
+
960
+
961
+
962
+
963
+
964
+
965
+
966
+
967
+
968
+
969
+
970
+
971
+ General and administrative
972
+
973
+
974
+
975
+
976
+ $
977
+
978
+
979
+
980
+ 1,160
981
+
982
+
983
+
984
+
985
+
986
+
987
+
988
+
989
+
990
+
991
+ NET LOSS
992
+
993
+
994
+
995
+
996
+ $
997
+
998
+
999
+
1000
+ (1,160
1001
+
1002
+
1003
+
1004
+ )
1005
+
1006
+
1007
+
1008
+
1009
+
1010
+
1011
+
1012
+
1013
+
1014
+
1015
+
1016
+
1017
+
1018
+
1019
+
1020
+
1021
+
1022
+
1023
+
1024
+
1025
+ Basic and diluted weighted average shares common outstanding(1)(2)
1026
+
1027
+
1028
+
1029
+
1030
+
1031
+
1032
+
1033
+
1034
+ 8,750,000
1035
+
1036
+
1037
+
1038
+
1039
+
1040
+
1041
+
1042
+
1043
+
1044
+
1045
+
1046
+
1047
+
1048
+
1049
+
1050
+
1051
+
1052
+
1053
+
1054
+
1055
+
1056
+
1057
+
1058
+
1059
+ Basic and diluted net loss per common share
1060
+
1061
+
1062
+
1063
+
1064
+ $
1065
+
1066
+
1067
+
1068
+ (0.00
1069
+
1070
+
1071
+
1072
+ )
1073
+
1074
+
1075
+
1076
+
1077
+
1078
+ ____________
1079
+ (1) This number excludes an aggregate of up to 1,312,500 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 4).
1080
+
1081
+ (2) Shares have been retroactively restated to reflect the recapitalization of the Company in the form of a 1.36672326 for 1 stock split (see Note 4)
1082
+
1083
+ The accompanying notes are an integral part of these financial statements.
1084
+
1085
+
1086
+
1087
+ F-4
1088
+
1089
+ Table of Contents
1090
+
1091
+
1092
+ ATHENA TECHNOLOGY ACQUISITION CORP. II
1093
+ STATEMENT OF CHANGES IN STOCKHOLDER S EQUITY
1094
+ FOR THE PERIOD FROM MAY 20, 2021 (INCEPTION) THROUGH SEPTEMBER 15, 2021
1095
+
1096
+
1097
+
1098
+
1099
+
1100
+
1101
+
1102
+
1103
+
1104
+ Class B
1105
+ Common Stock
1106
+
1107
+
1108
+
1109
+
1110
+ Additional
1111
+ Paid-in
1112
+ Capital
1113
+
1114
+
1115
+
1116
+
1117
+ Accumulated
1118
+ Deficit
1119
+
1120
+
1121
+
1122
+
1123
+ Total
1124
+ Stockholder s
1125
+ Equity
1126
+
1127
+
1128
+
1129
+
1130
+
1131
+
1132
+ Shares(1)
1133
+
1134
+
1135
+
1136
+
1137
+ Amount
1138
+
1139
+
1140
+
1141
+
1142
+
1143
+
1144
+
1145
+ Balance as of May 20, 2021 (inception)
1146
+
1147
+
1148
+
1149
+
1150
+
1151
+
1152
+
1153
+
1154
+
1155
+ $
1156
+
1157
+
1158
+
1159
+
1160
+
1161
+
1162
+
1163
+
1164
+ $
1165
+
1166
+
1167
+
1168
+
1169
+
1170
+
1171
+
1172
+
1173
+ $
1174
+
1175
+
1176
+
1177
+
1178
+
1179
+
1180
+
1181
+
1182
+
1183
+
1184
+
1185
+
1186
+ $
1187
+
1188
+
1189
+
1190
+
1191
+
1192
+
1193
+
1194
+
1195
+
1196
+
1197
+
1198
+
1199
+
1200
+
1201
+ Class B common stock issued to Sponsor(1)(2)
1202
+
1203
+
1204
+
1205
+
1206
+ 10,062,500
1207
+
1208
+
1209
+
1210
+
1211
+
1212
+
1213
+
1214
+
1215
+ 1,006
1216
+
1217
+
1218
+
1219
+
1220
+
1221
+
1222
+
1223
+
1224
+ 23,994
1225
+
1226
+
1227
+
1228
+
1229
+
1230
+
1231
+
1232
+
1233
+
1234
+
1235
+
1236
+
1237
+
1238
+
1239
+
1240
+
1241
+
1242
+
1243
+
1244
+
1245
+
1246
+ 25,000
1247
+
1248
+
1249
+
1250
+
1251
+
1252
+
1253
+
1254
+
1255
+
1256
+
1257
+ Net loss
1258
+
1259
+
1260
+
1261
+
1262
+
1263
+
1264
+
1265
+
1266
+
1267
+
1268
+
1269
+
1270
+
1271
+
1272
+
1273
+
1274
+
1275
+
1276
+
1277
+
1278
+
1279
+
1280
+
1281
+
1282
+
1283
+
1284
+
1285
+
1286
+
1287
+
1288
+
1289
+ (1,160
1290
+
1291
+
1292
+
1293
+ )
1294
+
1295
+
1296
+
1297
+
1298
+
1299
+
1300
+
1301
+
1302
+ (1,160
1303
+
1304
+
1305
+
1306
+ )
1307
+
1308
+
1309
+
1310
+
1311
+
1312
+
1313
+ Balance as of September 15, 2021
1314
+
1315
+
1316
+
1317
+
1318
+ 10,062,500
1319
+
1320
+
1321
+
1322
+
1323
+ $
1324
+
1325
+
1326
+
1327
+ 1,006
1328
+
1329
+
1330
+
1331
+
1332
+ $
1333
+
1334
+
1335
+
1336
+ 23,994
1337
+
1338
+
1339
+
1340
+
1341
+ $
1342
+
1343
+
1344
+
1345
+ (1,160
1346
+
1347
+
1348
+
1349
+ )
1350
+
1351
+
1352
+
1353
+
1354
+ $
1355
+
1356
+
1357
+
1358
+ 23,840
1359
+
1360
+
1361
+
1362
+
1363
+
1364
+
1365
+
1366
+
1367
+
1368
+ ____________
1369
+ (1) This number includes up to 1,312,500 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 4).
1370
+
1371
+ (2) Shares have been retroactively restated to reflect the recapitalization of the Company in the form of a 1.36672326 for 1 stock split (see Note 4)
1372
+
1373
+ The accompanying notes are an integral part of these financial statements.
1374
+
1375
+
1376
+
1377
+ F-5
1378
+
1379
+ Table of Contents
1380
+
1381
+
1382
+ ATHENA TECHNOLOGY ACQUISITION CORP. II
1383
+ STATEMENT OF CASH FLOWS
1384
+ FOR THE PERIOD FROM MAY 20, 2021 (INCEPTION) THROUGH SEPTEMBER 15, 2021
1385
+
1386
+
1387
+
1388
+
1389
+
1390
+
1391
+ CASH FLOWS FROM OPERATING ACTIVITIES
1392
+
1393
+
1394
+
1395
+
1396
+
1397
+
1398
+
1399
+
1400
+
1401
+
1402
+
1403
+
1404
+
1405
+
1406
+
1407
+
1408
+ Net loss
1409
+
1410
+
1411
+
1412
+
1413
+ $
1414
+
1415
+
1416
+
1417
+ (1,160
1418
+
1419
+
1420
+
1421
+ )
1422
+
1423
+
1424
+
1425
+
1426
+
1427
+
1428
+ Adjustments to reconcile net loss to net cash used in operating activities:
1429
+
1430
+
1431
+
1432
+
1433
+
1434
+
1435
+
1436
+
1437
+
1438
+
1439
+
1440
+
1441
+
1442
+
1443
+
1444
+
1445
+ Accounts payable and accrued expenses
1446
+
1447
+
1448
+
1449
+
1450
+
1451
+
1452
+
1453
+
1454
+ 1,160
1455
+
1456
+
1457
+
1458
+
1459
+
1460
+
1461
+
1462
+
1463
+
1464
+
1465
+ Net cash used in operating activities
1466
+
1467
+
1468
+
1469
+
1470
+
1471
+
1472
+
1473
+
1474
+
1475
+
1476
+
1477
+
1478
+
1479
+
1480
+
1481
+
1482
+
1483
+
1484
+
1485
+
1486
+
1487
+
1488
+
1489
+
1490
+
1491
+
1492
+
1493
+
1494
+
1495
+
1496
+
1497
+
1498
+
1499
+ NET CHANGE IN CASH
1500
+
1501
+
1502
+
1503
+
1504
+
1505
+
1506
+
1507
+
1508
+
1509
+
1510
+
1511
+
1512
+
1513
+
1514
+
1515
+
1516
+
1517
+
1518
+
1519
+
1520
+
1521
+
1522
+
1523
+
1524
+
1525
+
1526
+
1527
+
1528
+
1529
+
1530
+
1531
+
1532
+
1533
+ CASH, BEGINNING OF THE PERIOD
1534
+
1535
+
1536
+
1537
+
1538
+
1539
+
1540
+
1541
+
1542
+
1543
+
1544
+
1545
+
1546
+
1547
+
1548
+
1549
+
1550
+
1551
+
1552
+
1553
+
1554
+
1555
+
1556
+
1557
+
1558
+
1559
+
1560
+
1561
+
1562
+
1563
+
1564
+
1565
+
1566
+
1567
+ CASH, END OF THE PERIOD
1568
+
1569
+
1570
+
1571
+
1572
+ $
1573
+
1574
+
1575
+
1576
+
1577
+
1578
+
1579
+
1580
+
1581
+
1582
+
1583
+
1584
+
1585
+
1586
+
1587
+
1588
+
1589
+
1590
+
1591
+
1592
+
1593
+
1594
+
1595
+
1596
+
1597
+
1598
+
1599
+
1600
+
1601
+ Supplemental disclosure of cash flow information:
1602
+
1603
+
1604
+
1605
+
1606
+
1607
+
1608
+
1609
+
1610
+
1611
+
1612
+
1613
+
1614
+
1615
+
1616
+
1617
+
1618
+ Prepaid expenses paid by Sponsor in exchange for issuance of Class B common stock
1619
+
1620
+
1621
+
1622
+
1623
+ $
1624
+
1625
+
1626
+
1627
+ 25,000
1628
+
1629
+
1630
+
1631
+
1632
+
1633
+
1634
+
1635
+
1636
+
1637
+
1638
+ Deferred offering costs included in accrued offering costs
1639
+
1640
+
1641
+
1642
+
1643
+ $
1644
+
1645
+
1646
+
1647
+ 10,000
1648
+
1649
+
1650
+
1651
+
1652
+
1653
+
1654
+
1655
+
1656
+
1657
+ The accompanying notes are an integral part of these financial statements.
1658
+
1659
+
1660
+
1661
+ F-6
1662
+
1663
+ Table of Contents
1664
+
1665
+
1666
+ ATHENA TECHNOLOGY ACQUISITION CORP. II
1667
+ NOTES TO FINANCIAL STATEMENTS
1668
+ SEPTEMBER 15, 2021
1669
+
1670
+ Note 1 Description of Organization and Business Operations
1671
+
1672
+ Athena Technology Acquisition Corp. II (the Company ) was incorporated in Delaware on May 20, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the Business Combination ). Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus its search on a target in an industry where the Company believes the expertise of the management team and Advisors will provide the Company with a competitive advantage. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.
1673
+
1674
+ As of September 15, 2021, the Company had not commenced any operations. All activity for the period from May 20, 2021 (inception) through September 15, 2021, relates to the Company s formation and the proposed initial public offering described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Proposed Public Offering, as defined below. The Company has selected December 31 as its fiscal year end.
1675
+
1676
+ The Company s ability to commence operations is contingent upon obtaining adequate financial resources through a proposed public offering (the Proposed Public Offering ) of 25,000,000 units (each, a Unit and collectively, the Units ) at $10.00 per Unit (or 28,750,000 units if the underwriters over-allotment option is exercised in full), which is discussed in Note 3, and the sale of 950,000 units for an aggregate of $9,500,000 (or 987,500 units for an aggregate of $9,875,000 if the underwriters over-allotment option is exercised in full), (the Private Placement Units ) at a price of $10.00 per Private Placement Unit in a private placement to Athena Technology Sponsor II, LLC (the Sponsor ), that will close simultaneously with the Proposed Public Offering.
1677
+
1678
+ The Company s management has broad discretion with respect to the specific application of the net proceeds of the Proposed Public Offering and the sale of Private Placement units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.
1679
+
1680
+ The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the Investment Company Act ). Upon the closing of the Proposed Public Offering, management has agreed that an amount equal to at least $10.10 per Unit sold in the Proposed Public Offering will be held in a trust account ( Trust Account ) and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.
1681
+
1682
+ The Company will provide its holders of the outstanding its Class A common stock, par value $0.0001 ( Class A common stock ), sold in the Proposed Public Offering (the public stockholders ) with the opportunity to redeem all or a portion of their Public Share upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as
1683
+
1684
+
1685
+
1686
+ F-7
1687
+
1688
+ Table of Contents
1689
+
1690
+
1691
+ ATHENA TECHNOLOGY ACQUISITION CORP. II
1692
+ NOTES TO FINANCIAL STATEMENTS
1693
+ SEPTEMBER 15, 2021
1694
+
1695
+ to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares (as defined below in Note 3) for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.10 per Public Share). The per-share amount to be distributed to public stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Proposed Public Offering in accordance with the Financial Accounting Standards Board s ( FASB ) Accounting Standards Codification ( ASC ) Topic 480 Distinguishing Liabilities from Equity. In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the Amended and Restated Certificate of Incorporation ), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission ( SEC ) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transactions is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the initial stockholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Proposed Public Offering in favor of a Business Combination.
1696
+
1697
+ Subsequent to the consummation of the Proposed Public Offering, the Company will adopt an insider trading policy which will require insiders to: (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material non-public information and (ii) to clear all trades with the Company s legal counsel prior to execution. In addition, the initial stockholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.
1698
+
1699
+ Notwithstanding the foregoing, the Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a group (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the Exchange Act )), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A common stock sold in the Proposed Public Offering, without the prior consent of the Company.
1700
+
1701
+ The Company s Sponsor, officers and directors (the initial stockholders ) have agreed not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Class A common stock in conjunction with any such amendment.
1702
+
1703
+ If the Company is unable to complete a Business Combination within 18 months from the closing of the Proposed Public Offering (the Combination Period ), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay the Company s franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders rights as stockholders (including the right to receive further liquidating distributions, if any), subject
1704
+
1705
+
1706
+
1707
+ F-8
1708
+
1709
+ Table of Contents
1710
+
1711
+
1712
+ ATHENA TECHNOLOGY ACQUISITION CORP. II
1713
+ NOTES TO FINANCIAL STATEMENTS
1714
+ SEPTEMBER 15, 2021
1715
+
1716
+ to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company s remaining stockholders and the Company s board of directors, dissolve and liquidate, subject in each case to the Company s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
1717
+
1718
+ The initial stockholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial stockholders should acquire Public Shares in or after the Proposed Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to its deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.10 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company s indemnity of the underwriters of the Proposed Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the Securities Act ). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
1719
+
1720
+ Note 2
parsed_sections/legal_matters/2021/ATHA_leonabio_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the shares of the common stock offered hereby will be passed upon for us by Wilson Sonsini Goodrich & Rosati, Professional Corporation, Seattle, Washington. Cooley, LLP, Seattle Washington, is acting as counsel for the underwriters. Investment funds associated with Wilson Sonsini Goodrich & Rosati, Professional Corporation, hold shares of our common stock and preferred stock convertible into our common stock representing an aggregate of 13,706 shares of our common stock, which is less than 1% of our outstanding shares of common stock.
parsed_sections/legal_matters/2021/AURA_aura_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the shares of common stock offered by this prospectus will be passed upon for us by Goodwin Procter LLP, Boston, Massachusetts. The underwriters are being represented by Cooley LLP, Boston, Massachusetts.
parsed_sections/legal_matters/2021/AUROW_aurora_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the Securities offered hereby has been passed upon for us by Wilson Sonsini Goodrich & Rosati, Professional Corporation, New York, New York, which has acted as our counsel in connection with this offering. Certain members of, and investment partnerships comprised of members of, and persons associated with, Wilson Sonsini Goodrich & Rosati, Professional Corporation, directly or indirectly own less than 1% of the outstanding shares of our common stock.
parsed_sections/legal_matters/2021/AVAH_aveanna_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS Greenberg Traurig, P.A., Kirkland & Ellis LLP and Dechert LLP have acted as counsel for us, and certain legal matters with regard to the validity of the shares of common stock offered hereby will be passed upon for us by Greenberg Traurig, P.A. Davis Polk & Wardwell LLP has acted as counsel for the underwriters in connection with certain legal matters related to this offering.
parsed_sections/legal_matters/2021/AVPT_avepoint_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the securities offered hereby will be passed upon for us by Cooley LLP, Palo Alto, CA.
parsed_sections/legal_matters/2021/BAOS_baosheng_legal_matters.txt ADDED
The diff for this file is too large to render. See raw diff
 
parsed_sections/legal_matters/2021/BASA_basanite_legal_matters.txt ADDED
@@ -0,0 +1,2959 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ LEGAL MATTERS
2
+
3
+
4
+
5
+ Certain
6
+ legal matters with respect to the shares of common stock offered hereby will be passed upon by Saltzman Mugan Dushoff, LLC.
7
+
8
+
9
+
10
+ EXPERTS
11
+
12
+
13
+
14
+ The
15
+ consolidated financial statements of Basanite, Inc. as of December 31, 2020 and 2019, and for each of the years in the two-year period
16
+ ended December 31, 2020, included in our Annual Report on Form 10K, have been incorporated by reference herein in reliance upon the report
17
+ of Cherry Bekaert LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said
18
+ firm as experts in accounting in auditing.
19
+
20
+
21
+
22
+ WHERE YOU CAN
23
+ FIND MORE INFORMATION
24
+
25
+
26
+
27
+ We
28
+ have filed a registration statement on Form S-1 with the SEC with respect to our common stock offered by this prospectus. This prospectus
29
+ does not contain all of the information set forth in the registration statement. You should refer to the registration statement and its
30
+ exhibits for additional information. Whenever we make references in this prospectus to any of our contracts, agreements or other documents,
31
+ the references are not necessarily complete, and you should refer to the exhibits attached to the registration statement for the copies
32
+ of the actual contract, agreement or other document.
33
+
34
+
35
+
36
+ Our
37
+ fiscal year ends on December 31. We are a reporting company and file annual, quarterly, and current reports, and other information
38
+ with the SEC. Our SEC filings are available to the public on the SEC s Internet site at http://www.sec.gov. We maintain a website
39
+ at www.basaniteindustries.com. Information contained in or accessible through our website is not and should not be considered a
40
+ part of this prospectus and you should not rely on that information in deciding whether to invest in our common stock.
41
+
42
+
43
+
44
+
45
+
46
+
47
+
48
+
49
+
50
+
51
+
52
+ 61
53
+
54
+
55
+
56
+
57
+
58
+
59
+
60
+ INDEX TO FINANCIAL
61
+ STATEMENTS
62
+
63
+
64
+
65
+ CONSOLIDATED FINANCIAL STATEMENTS
66
+
67
+
68
+
69
+
70
+
71
+
72
+ Page
73
+
74
+
75
+
76
+
77
+
78
+
79
+
80
+ Report of Independent Registered Public Accounting Firm
81
+
82
+ F-2
83
+
84
+
85
+
86
+
87
+
88
+
89
+
90
+ Consolidated Balance Sheets
91
+
92
+ F-4
93
+
94
+
95
+
96
+
97
+
98
+
99
+
100
+ Consolidated Statements of Operations
101
+
102
+ F-5
103
+
104
+
105
+
106
+
107
+
108
+
109
+
110
+ Consolidated Statements of Stockholders Deficit
111
+
112
+ F-6
113
+
114
+
115
+
116
+
117
+
118
+
119
+
120
+ Consolidated Statements of Cash Flows
121
+
122
+ F-7
123
+
124
+
125
+
126
+
127
+
128
+
129
+
130
+ Notes to Consolidated Financial Statements
131
+
132
+ F-9
133
+
134
+
135
+
136
+ CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
137
+
138
+
139
+
140
+
141
+
142
+
143
+ Page
144
+
145
+
146
+
147
+
148
+
149
+
150
+
151
+ Condensed Consolidated Balance Sheets as of September 30, 2021 (Unaudited) and December
152
+ 31, 2020
153
+
154
+ F-28
155
+
156
+
157
+
158
+
159
+
160
+
161
+
162
+ Condensed Consolidated Statements of Operations (Unaudited) for the Three and Nine Months
163
+ ended September 30, 2021 and 2020
164
+
165
+ F-29
166
+
167
+
168
+
169
+
170
+
171
+
172
+
173
+ Condensed Consolidated Statements of Stockholder s Deficit (Unaudited) for Nine Months
174
+ ended September 30, 2021 and 2020
175
+
176
+ F-30
177
+
178
+
179
+
180
+
181
+
182
+
183
+
184
+ Condensed Consolidated Statements of Cash Flows (Unaudited) for the Nine Months Ended September
185
+ 30, 2021 and 2020
186
+
187
+ F-32
188
+
189
+
190
+
191
+
192
+
193
+
194
+
195
+ Notes to Condensed Consolidated Financial Statements (Unaudited)
196
+
197
+ F-33
198
+
199
+
200
+
201
+
202
+
203
+
204
+
205
+
206
+
207
+
208
+
209
+
210
+
211
+
212
+ F-1
213
+
214
+
215
+
216
+
217
+
218
+ REPORT OF INDEPENDENT
219
+ REGISTERED PUBLIC ACCOUNTING FIRM
220
+
221
+
222
+
223
+
224
+
225
+ To the Board of Directors and Stockholders
226
+
227
+ Basanite, Inc.
228
+
229
+
230
+
231
+
232
+
233
+ Opinion on the Financial Statements
234
+
235
+ We have audited the accompanying consolidated
236
+ balance sheets of Basanite, Inc. (the Company ) as of December 31, 2020 and 2019, and the consolidated statements of operations,
237
+ stockholders deficit, and cash flows for each of the years in the two-year period ended December 31, 2020, and the related notes
238
+ (collectively referred to as the consolidated financial statements ). In our opinion, the consolidated financial statements
239
+ present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its
240
+ operations and its cash flows for each of the years in the two-year period ended December 31, 2020, in conformity with accounting
241
+ principles generally accepted in the United States of America.
242
+
243
+
244
+
245
+ Explanatory Paragraph Going Concern
246
+
247
+ The accompanying consolidated financial statements
248
+ have been prepared assuming the Company will continue as a going concern. As more fully discussed in Note 1 to the consolidated financial
249
+ statements, the Company s significant operating losses and need to raise additional funds to meet its obligations and sustain its
250
+ operations raise substantial doubt about its ability to continue as a going concern. Management s evaluation of the events and conditions
251
+ and management s plans regarding those matters are also described in Note 1. The consolidated financial statements do not include
252
+ any adjustments that might result from the outcome of this uncertainty.
253
+
254
+
255
+
256
+ Basis for Opinion
257
+
258
+ These consolidated financial statements are the
259
+ responsibility of the Company s management. Our responsibility is to express an opinion on the Company s consolidated financial
260
+ statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United
261
+ States) ( PCAOB ) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
262
+ laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
263
+
264
+
265
+
266
+ We conducted our audits in accordance with the
267
+ standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial
268
+ statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged
269
+ to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding
270
+ of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company s
271
+ internal control over financial reporting. Accordingly, we express no such opinion.
272
+
273
+
274
+
275
+ Our audits included performing procedures to assess
276
+ the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures
277
+ that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the
278
+ consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by
279
+ management, as well as evaluating the overall presentation of the consolidated financial statements. We believe our audits provide a reasonable
280
+ basis for our opinion.
281
+
282
+
283
+
284
+ Critical Audit Matters
285
+
286
+ The critical audit matters communicated below
287
+ are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated
288
+ to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements
289
+ and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter
290
+ in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit
291
+ matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
292
+
293
+
294
+
295
+ F-2
296
+
297
+
298
+
299
+
300
+
301
+ Debt and Equity Instruments
302
+
303
+ As disclosed in Notes 5, 6, 7, 8, and 10 to the
304
+ consolidated financial statements, the Company has entered into convertible and nonconvertible note agreements containing attached warrants
305
+ with individuals including related parties. The accounting for the transactions were complex, as it required assessment as to whether
306
+ features, other than the conversion feature, required bifurcation and separate valuation. Additionally, the transactions were complex
307
+ as they required valuation of the conversion feature in the debt instrument, which involved estimation of the fair value of the debt instrument
308
+ absent of any conversion feature, and evaluation of the appropriate classification of the conversion feature in the financial statements.
309
+
310
+
311
+
312
+ Our audit procedures included the following:
313
+
314
+
315
+
316
+ We obtained an understanding of the internal controls and processes in place over management s process
317
+ for recording debt and equity transactions.
318
+
319
+ We obtained and read the underlying convertible notes agreements.
320
+
321
+ We confirmed related party notes payable balances and terms with respective note holders.
322
+
323
+ We verified proper approval of equity transactions by the Board of Directors.
324
+
325
+ We evaluated the Company s selection of the valuation methodology and significant assumptions used
326
+ by the Company, and evaluated the completeness and accuracy of the underlying data supporting the significant assumptions. Specifically,
327
+ when assessing the key assumptions, we evaluated the appropriateness of the Company s estimates of its credit risk, volatility, dividend
328
+ yield, and the market risk free rate.
329
+
330
+ We tested management s application of the relevant accounting guidance.
331
+
332
+
333
+
334
+
335
+
336
+
337
+
338
+
339
+ /s/ Cherry Bekaert LLP
340
+
341
+
342
+
343
+
344
+
345
+
346
+ We have served as the Company s auditor since 2019.
347
+
348
+
349
+
350
+
351
+
352
+
353
+ Fort Lauderdale, Florida
354
+
355
+
356
+ March 31, 2021
357
+
358
+
359
+
360
+
361
+
362
+
363
+
364
+
365
+
366
+
367
+
368
+
369
+
370
+
371
+
372
+
373
+
374
+
375
+
376
+
377
+
378
+ F-3
379
+
380
+
381
+
382
+
383
+
384
+ BASANITE, INC. AND
385
+ SUBSIDIARIES
386
+
387
+ CONSOLIDATED BALANCE SHEETS
388
+
389
+
390
+
391
+
392
+
393
+
394
+
395
+
396
+
397
+
398
+
399
+
400
+
401
+
402
+ December 31, 2020
403
+
404
+
405
+ December 31, 2019
406
+
407
+
408
+
409
+
410
+
411
+
412
+
413
+
414
+
415
+
416
+
417
+
418
+ ASSETS
419
+
420
+
421
+
422
+
423
+
424
+
425
+
426
+
427
+
428
+
429
+
430
+
431
+
432
+
433
+
434
+
435
+
436
+
437
+
438
+
439
+
440
+ CURRENT ASSETS
441
+
442
+
443
+
444
+
445
+
446
+
447
+
448
+
449
+
450
+
451
+ Cash
452
+
453
+ $
454
+ 259,505
455
+
456
+
457
+ $
458
+ 129,152
459
+
460
+
461
+
462
+ Accounts receivable, net
463
+
464
+
465
+ 1,907
466
+
467
+
468
+
469
+
470
+
471
+
472
+
473
+ Inventory
474
+
475
+
476
+ 446,575
477
+
478
+
479
+
480
+ 159,472
481
+
482
+
483
+
484
+ Prepaid expenses
485
+
486
+
487
+ 40,283
488
+
489
+
490
+
491
+ 26,640
492
+
493
+
494
+
495
+ Deposits and other current assets
496
+
497
+
498
+ 75,995
499
+
500
+
501
+
502
+ 145,671
503
+
504
+
505
+
506
+ TOTAL CURRENT ASSETS
507
+
508
+
509
+ 824,265
510
+
511
+
512
+
513
+ 460,935
514
+
515
+
516
+
517
+
518
+
519
+
520
+
521
+
522
+
523
+
524
+
525
+
526
+
527
+
528
+ Lease right-of-use asset
529
+
530
+
531
+ 1,004,167
532
+
533
+
534
+
535
+ 1,222,853
536
+
537
+
538
+
539
+ Fixed assets, net
540
+
541
+
542
+ 1,020,035
543
+
544
+
545
+
546
+ 771,996
547
+
548
+
549
+
550
+ Other assets
551
+
552
+
553
+
554
+
555
+
556
+
557
+ 5,380
558
+
559
+
560
+
561
+ TOTAL LONG TERM ASSETS
562
+
563
+
564
+ 2,024,202
565
+
566
+
567
+
568
+ 2,000,229
569
+
570
+
571
+
572
+
573
+
574
+
575
+
576
+
577
+
578
+
579
+
580
+
581
+
582
+
583
+ TOTAL ASSETS
584
+
585
+ $
586
+ 2,848,467
587
+
588
+
589
+ $
590
+ 2,461,164
591
+
592
+
593
+
594
+
595
+
596
+
597
+
598
+
599
+
600
+
601
+
602
+
603
+
604
+
605
+ LIABILITIES AND STOCKHOLDERS' DEFICIT
606
+
607
+
608
+
609
+
610
+
611
+
612
+
613
+
614
+
615
+
616
+
617
+
618
+
619
+
620
+
621
+
622
+
623
+
624
+
625
+
626
+
627
+ CURRENT LIABILITIES
628
+
629
+
630
+
631
+
632
+
633
+
634
+
635
+
636
+
637
+
638
+ Accounts payable
639
+
640
+ $
641
+ 249,353
642
+
643
+
644
+ $
645
+ 218,082
646
+
647
+
648
+
649
+ Accrued expenses
650
+
651
+
652
+ 197,350
653
+
654
+
655
+
656
+ 489,179
657
+
658
+
659
+
660
+ Accrued legal liabilities
661
+
662
+
663
+ 809,127
664
+
665
+
666
+
667
+ 790,606
668
+
669
+
670
+
671
+ Notes payable
672
+
673
+
674
+ 128,021
675
+
676
+
677
+
678
+ 219,617
679
+
680
+
681
+
682
+ Notes payable - convertible, net
683
+
684
+
685
+ 10,000
686
+
687
+
688
+
689
+ 453,991
690
+
691
+
692
+
693
+ Notes payable - convertible - related party, net
694
+
695
+
696
+ 1,025,000
697
+
698
+
699
+
700
+
701
+
702
+
703
+
704
+ Subscription liability
705
+
706
+
707
+ 40,000
708
+
709
+
710
+
711
+
712
+
713
+
714
+
715
+ Lease liability - current portion
716
+
717
+
718
+ 267,289
719
+
720
+
721
+
722
+ 221,997
723
+
724
+
725
+
726
+ TOTAL CURRENT LIABILITIES
727
+
728
+
729
+ 2,726,140
730
+
731
+
732
+
733
+ 2,393,472
734
+
735
+
736
+
737
+
738
+
739
+
740
+
741
+
742
+
743
+
744
+
745
+
746
+
747
+
748
+ Lease liability - net of current portion
749
+
750
+
751
+ 826,388
752
+
753
+
754
+
755
+ 1,094,970
756
+
757
+
758
+
759
+
760
+
761
+
762
+
763
+
764
+
765
+
766
+
767
+
768
+
769
+
770
+ TOTAL LIABILITIES
771
+
772
+
773
+ 3,552,528
774
+
775
+
776
+
777
+ 3,488,442
778
+
779
+
780
+
781
+
782
+
783
+
784
+
785
+
786
+
787
+
788
+
789
+
790
+
791
+
792
+ STOCKHOLDERS DEFICIT
793
+
794
+
795
+
796
+
797
+
798
+
799
+
800
+
801
+
802
+
803
+ Preferred stock, $0.001 par value, 5,000,000 shares authorized, none issued and outstanding, respectively
804
+
805
+
806
+
807
+
808
+
809
+
810
+
811
+
812
+
813
+
814
+ Common stock, $0.001 par value, 1,000,000,000 shares authorized, 224,836,785 and 200,735,730 shares issued and outstanding, respectively
815
+
816
+
817
+ 224,838
818
+
819
+
820
+
821
+ 200,736
822
+
823
+
824
+
825
+ Additional paid-in capital
826
+
827
+
828
+ 28,714,488
829
+
830
+
831
+
832
+ 24,216,042
833
+
834
+
835
+
836
+ Accumulated deficit
837
+
838
+
839
+ (29,643,387
840
+ )
841
+
842
+
843
+ (25,444,056
844
+ )
845
+
846
+
847
+ TOTAL STOCKHOLDERS' DEFICIT
848
+
849
+
850
+ (704,061
851
+ )
852
+
853
+
854
+ (1,027,278
855
+ )
856
+
857
+
858
+
859
+
860
+
861
+
862
+
863
+
864
+
865
+
866
+
867
+
868
+
869
+ TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
870
+
871
+ $
872
+ 2,848,467
873
+
874
+
875
+ $
876
+ 2,461,164
877
+
878
+
879
+
880
+
881
+
882
+ The accompanying notes are an integral part of
883
+ the consolidated financial statements.
884
+
885
+
886
+
887
+ F-4
888
+
889
+
890
+
891
+
892
+
893
+ BASANITE, INC. AND
894
+ SUBSIDIARIES
895
+
896
+ CONSOLIDATED STATEMENTS OF OPERATIONS
897
+
898
+
899
+
900
+
901
+
902
+
903
+
904
+
905
+
906
+
907
+
908
+
909
+
910
+
911
+
912
+
913
+ For the year ended
914
+
915
+
916
+
917
+
918
+
919
+ December 31,
920
+
921
+
922
+
923
+
924
+
925
+ 2020
926
+
927
+
928
+ 2019
929
+
930
+
931
+
932
+ Revenue
933
+
934
+
935
+
936
+
937
+
938
+
939
+
940
+
941
+ Products sales - rebar
942
+
943
+ $
944
+ 7,161
945
+
946
+
947
+ $
948
+ 3,892
949
+
950
+
951
+
952
+
953
+
954
+
955
+
956
+
957
+
958
+
959
+
960
+
961
+
962
+
963
+ Total cost of goods sold
964
+
965
+
966
+ 4,487
967
+
968
+
969
+
970
+ 105,010
971
+
972
+
973
+
974
+
975
+
976
+
977
+
978
+
979
+
980
+
981
+
982
+
983
+
984
+
985
+ Gross profit (loss)
986
+
987
+
988
+ 2,674
989
+
990
+
991
+
992
+ (101,118
993
+ )
994
+
995
+
996
+
997
+
998
+
999
+
1000
+
1001
+
1002
+
1003
+
1004
+
1005
+
1006
+
1007
+ OPERATING EXPENSES
1008
+
1009
+
1010
+
1011
+
1012
+
1013
+
1014
+
1015
+
1016
+
1017
+
1018
+ Professional fees
1019
+
1020
+
1021
+ 438,749
1022
+
1023
+
1024
+
1025
+ 341,906
1026
+
1027
+
1028
+
1029
+ Payroll, taxes and benefits
1030
+
1031
+
1032
+ 837,348
1033
+
1034
+
1035
+
1036
+ 865,828
1037
+
1038
+
1039
+
1040
+ Consulting fees
1041
+
1042
+
1043
+ 270,525
1044
+
1045
+
1046
+
1047
+ 219,326
1048
+
1049
+
1050
+
1051
+ General and administrative
1052
+
1053
+
1054
+ 1,408,948
1055
+
1056
+
1057
+
1058
+ 2,483,226
1059
+
1060
+
1061
+
1062
+ Loss on inventory obsolescence
1063
+
1064
+
1065
+ 33,062
1066
+
1067
+
1068
+
1069
+
1070
+
1071
+
1072
+
1073
+ Total operating expenses
1074
+
1075
+
1076
+ 2,988,632
1077
+
1078
+
1079
+
1080
+ 3,910,286
1081
+
1082
+
1083
+
1084
+
1085
+
1086
+
1087
+
1088
+
1089
+
1090
+
1091
+
1092
+
1093
+
1094
+
1095
+ NET LOSS FROM OPERATIONS
1096
+
1097
+
1098
+ (2,985,958
1099
+ )
1100
+
1101
+
1102
+ (4,011,404
1103
+ )
1104
+
1105
+
1106
+
1107
+
1108
+
1109
+
1110
+
1111
+
1112
+
1113
+
1114
+
1115
+
1116
+
1117
+ OTHER (EXPENSE) INCOME
1118
+
1119
+
1120
+
1121
+
1122
+
1123
+
1124
+
1125
+
1126
+
1127
+
1128
+ Gain on sale of asset
1129
+
1130
+
1131
+ 40,838
1132
+
1133
+
1134
+
1135
+
1136
+
1137
+
1138
+
1139
+ Loss on extinguishment of debt
1140
+
1141
+
1142
+ (56,948
1143
+ )
1144
+
1145
+
1146
+
1147
+
1148
+
1149
+
1150
+ Miscellaneous income
1151
+
1152
+
1153
+ 70,817
1154
+
1155
+
1156
+
1157
+ 4,469
1158
+
1159
+
1160
+
1161
+ Gain on settlement of payables
1162
+
1163
+
1164
+ 293,678
1165
+
1166
+
1167
+
1168
+ 201,617
1169
+
1170
+
1171
+
1172
+ Impairment of fixed assets
1173
+
1174
+
1175
+
1176
+
1177
+
1178
+
1179
+ (1,478
1180
+ )
1181
+
1182
+
1183
+ Interest expense
1184
+
1185
+
1186
+ (898,257
1187
+ )
1188
+
1189
+
1190
+ (113,076
1191
+ )
1192
+
1193
+
1194
+ Total other (expense) income
1195
+
1196
+
1197
+ (549,872
1198
+ )
1199
+
1200
+
1201
+ 91,532
1202
+
1203
+
1204
+
1205
+
1206
+
1207
+
1208
+
1209
+
1210
+
1211
+
1212
+
1213
+
1214
+
1215
+
1216
+ NET LOSS FROM OPERATIONS
1217
+
1218
+
1219
+ (3,535,830
1220
+ )
1221
+
1222
+
1223
+ (3,919,872
1224
+ )
1225
+
1226
+
1227
+
1228
+
1229
+
1230
+
1231
+
1232
+
1233
+
1234
+
1235
+
1236
+
1237
+
1238
+ Deemed dividends
1239
+
1240
+
1241
+ (663,501
1242
+ )
1243
+
1244
+
1245
+ (388,932
1246
+ )
1247
+
1248
+
1249
+
1250
+
1251
+
1252
+
1253
+
1254
+
1255
+
1256
+
1257
+
1258
+
1259
+
1260
+ NET LOSS
1261
+
1262
+ $
1263
+ (4,199,331
1264
+ )
1265
+
1266
+ $
1267
+ (4,308,804
1268
+ )
1269
+
1270
+
1271
+
1272
+
1273
+
1274
+
1275
+
1276
+
1277
+
1278
+
1279
+
1280
+
1281
+
1282
+ Net loss per share - basic and diluted
1283
+
1284
+ $
1285
+ (0.017
1286
+ )
1287
+
1288
+ $
1289
+ (0.021
1290
+ )
1291
+
1292
+
1293
+
1294
+
1295
+
1296
+
1297
+
1298
+
1299
+
1300
+
1301
+
1302
+
1303
+
1304
+ Weighted average number of shares outstanding - basic and diluted
1305
+
1306
+
1307
+ 209,163,821
1308
+
1309
+
1310
+
1311
+ 186,607,492
1312
+
1313
+
1314
+
1315
+
1316
+
1317
+ The accompanying notes are an integral part of
1318
+ the consolidated financial statements.
1319
+
1320
+
1321
+
1322
+
1323
+
1324
+ F-5
1325
+
1326
+
1327
+
1328
+
1329
+
1330
+ BASANITE, INC. AND
1331
+ SUBSIDIARIES
1332
+
1333
+ CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
1334
+
1335
+
1336
+
1337
+
1338
+
1339
+
1340
+
1341
+
1342
+
1343
+
1344
+
1345
+
1346
+
1347
+
1348
+
1349
+
1350
+
1351
+
1352
+
1353
+
1354
+
1355
+
1356
+
1357
+
1358
+
1359
+
1360
+
1361
+
1362
+
1363
+
1364
+
1365
+
1366
+
1367
+
1368
+
1369
+
1370
+
1371
+
1372
+
1373
+
1374
+
1375
+
1376
+
1377
+
1378
+
1379
+
1380
+
1381
+
1382
+
1383
+
1384
+
1385
+
1386
+
1387
+
1388
+
1389
+
1390
+ Additional
1391
+
1392
+
1393
+
1394
+
1395
+
1396
+
1397
+
1398
+
1399
+ Non-
1400
+
1401
+
1402
+
1403
+ Total
1404
+
1405
+ Stockholders'
1406
+
1407
+
1408
+
1409
+
1410
+
1411
+
1412
+ Preferred Stock
1413
+
1414
+
1415
+ Common Stock
1416
+
1417
+
1418
+ Paid-in
1419
+
1420
+
1421
+ Accumulated
1422
+
1423
+
1424
+ Subscription
1425
+
1426
+
1427
+ controlling
1428
+
1429
+
1430
+ Equity
1431
+
1432
+
1433
+
1434
+
1435
+
1436
+ Shares
1437
+
1438
+
1439
+ Par Value
1440
+
1441
+
1442
+ Shares
1443
+
1444
+
1445
+ Par Value
1446
+
1447
+
1448
+ Capital
1449
+
1450
+
1451
+ Deficit
1452
+
1453
+
1454
+ Receivable
1455
+
1456
+
1457
+ Interest
1458
+
1459
+
1460
+ (Deficit)
1461
+
1462
+
1463
+
1464
+ Balance December 31, 2018
1465
+
1466
+
1467
+
1468
+
1469
+
1470
+ $
1471
+
1472
+
1473
+
1474
+
1475
+ 154,202,008
1476
+
1477
+
1478
+ $
1479
+ 154,202
1480
+
1481
+
1482
+ $
1483
+ 18,718,283
1484
+
1485
+
1486
+ $
1487
+ (21,135,252
1488
+ )
1489
+
1490
+ $
1491
+
1492
+
1493
+
1494
+ $
1495
+ 225,015
1496
+
1497
+
1498
+ $
1499
+ (2,037,752
1500
+ )
1501
+
1502
+
1503
+
1504
+
1505
+
1506
+
1507
+
1508
+
1509
+
1510
+
1511
+
1512
+
1513
+
1514
+
1515
+
1516
+
1517
+
1518
+
1519
+
1520
+
1521
+
1522
+
1523
+
1524
+
1525
+
1526
+
1527
+
1528
+
1529
+
1530
+
1531
+
1532
+
1533
+
1534
+
1535
+
1536
+
1537
+
1538
+
1539
+
1540
+
1541
+
1542
+ Stock-based compensation
1543
+
1544
+
1545
+
1546
+
1547
+
1548
+
1549
+
1550
+
1551
+
1552
+
1553
+
1554
+
1555
+
1556
+
1557
+
1558
+
1559
+
1560
+
1561
+ 1,701,316
1562
+
1563
+
1564
+
1565
+
1566
+
1567
+
1568
+
1569
+
1570
+
1571
+
1572
+
1573
+
1574
+
1575
+
1576
+
1577
+ 1,701,316
1578
+
1579
+
1580
+
1581
+ Shares issued to convert notes payable
1582
+
1583
+
1584
+
1585
+
1586
+
1587
+
1588
+
1589
+
1590
+
1591
+
1592
+ 2,139,437
1593
+
1594
+
1595
+
1596
+ 2,139
1597
+
1598
+
1599
+
1600
+ 528,961
1601
+
1602
+
1603
+
1604
+
1605
+
1606
+
1607
+
1608
+
1609
+
1610
+
1611
+
1612
+
1613
+
1614
+
1615
+
1616
+ 531,100
1617
+
1618
+
1619
+
1620
+ Stock issued for cash
1621
+
1622
+
1623
+
1624
+
1625
+
1626
+
1627
+
1628
+
1629
+
1630
+
1631
+ 21,323,570
1632
+
1633
+
1634
+
1635
+ 21,324
1636
+
1637
+
1638
+
1639
+ 1,248,756
1640
+
1641
+
1642
+
1643
+
1644
+
1645
+
1646
+
1647
+
1648
+
1649
+
1650
+
1651
+
1652
+
1653
+
1654
+
1655
+ 1,270,080
1656
+
1657
+
1658
+
1659
+ Stock issued to purchase non-controlling interest in Basalt America Territory #1
1660
+
1661
+
1662
+
1663
+
1664
+
1665
+
1666
+
1667
+
1668
+
1669
+
1670
+ 2,010,000
1671
+
1672
+
1673
+
1674
+ 2,010
1675
+
1676
+
1677
+
1678
+ 223,005
1679
+
1680
+
1681
+
1682
+
1683
+
1684
+
1685
+
1686
+
1687
+
1688
+
1689
+
1690
+ (225,015
1691
+ )
1692
+
1693
+
1694
+
1695
+
1696
+
1697
+
1698
+ Warrants exercised for cash
1699
+
1700
+
1701
+
1702
+
1703
+
1704
+
1705
+
1706
+
1707
+
1708
+
1709
+ 19,710,715
1710
+
1711
+
1712
+
1713
+ 19,711
1714
+
1715
+
1716
+
1717
+ 1,268,889
1718
+
1719
+
1720
+
1721
+
1722
+
1723
+
1724
+
1725
+
1726
+
1727
+
1728
+
1729
+
1730
+
1731
+
1732
+
1733
+ 1,288,600
1734
+
1735
+
1736
+
1737
+ Deemed dividend on common stock
1738
+
1739
+
1740
+
1741
+
1742
+
1743
+
1744
+
1745
+
1746
+
1747
+
1748
+
1749
+
1750
+
1751
+
1752
+
1753
+
1754
+
1755
+
1756
+ 388,932
1757
+
1758
+
1759
+
1760
+
1761
+
1762
+
1763
+
1764
+
1765
+
1766
+
1767
+
1768
+
1769
+
1770
+
1771
+
1772
+ 388,932
1773
+
1774
+
1775
+
1776
+ Shares issued as loan commitment fee
1777
+
1778
+
1779
+
1780
+
1781
+
1782
+
1783
+
1784
+
1785
+
1786
+
1787
+ 1,350,000
1788
+
1789
+
1790
+
1791
+ 1,350
1792
+
1793
+
1794
+
1795
+ 137,900
1796
+
1797
+
1798
+
1799
+
1800
+
1801
+
1802
+
1803
+
1804
+
1805
+
1806
+
1807
+
1808
+
1809
+
1810
+
1811
+ 139,250
1812
+
1813
+
1814
+
1815
+ Net loss
1816
+
1817
+
1818
+
1819
+
1820
+
1821
+
1822
+
1823
+
1824
+
1825
+
1826
+
1827
+
1828
+
1829
+
1830
+
1831
+
1832
+
1833
+
1834
+
1835
+
1836
+
1837
+
1838
+ (4,308,804
1839
+ )
1840
+
1841
+
1842
+
1843
+
1844
+
1845
+
1846
+
1847
+
1848
+
1849
+
1850
+ (4,308,804
1851
+ )
1852
+
1853
+
1854
+ Balance December 31, 2019
1855
+
1856
+
1857
+
1858
+
1859
+
1860
+ $
1861
+
1862
+
1863
+
1864
+
1865
+ 200,735,730
1866
+
1867
+
1868
+ $
1869
+ 200,736
1870
+
1871
+
1872
+ $
1873
+ 24,216,042
1874
+
1875
+
1876
+ $
1877
+ (25,444,056
1878
+ )
1879
+
1880
+ $
1881
+
1882
+
1883
+
1884
+ $
1885
+
1886
+
1887
+
1888
+ $
1889
+ (1,027,278
1890
+ )
1891
+
1892
+
1893
+
1894
+
1895
+
1896
+
1897
+
1898
+
1899
+
1900
+
1901
+
1902
+
1903
+
1904
+
1905
+
1906
+
1907
+
1908
+
1909
+
1910
+
1911
+
1912
+
1913
+
1914
+
1915
+
1916
+
1917
+
1918
+
1919
+
1920
+
1921
+
1922
+
1923
+
1924
+
1925
+
1926
+
1927
+
1928
+
1929
+
1930
+
1931
+
1932
+ Convertible debt and debt discount
1933
+
1934
+
1935
+
1936
+
1937
+
1938
+
1939
+
1940
+
1941
+
1942
+
1943
+ 9,305,426
1944
+
1945
+
1946
+
1947
+ 9,306
1948
+
1949
+
1950
+
1951
+ 2,008,673
1952
+
1953
+
1954
+
1955
+
1956
+
1957
+
1958
+
1959
+
1960
+
1961
+
1962
+
1963
+
1964
+
1965
+
1966
+
1967
+ 2,017,979
1968
+
1969
+
1970
+
1971
+ Stock issued for compensation
1972
+
1973
+
1974
+
1975
+
1976
+
1977
+
1978
+
1979
+
1980
+
1981
+
1982
+ 600,000
1983
+
1984
+
1985
+
1986
+ 600
1987
+
1988
+
1989
+
1990
+ 173,400
1991
+
1992
+
1993
+
1994
+
1995
+
1996
+
1997
+
1998
+
1999
+
2000
+
2001
+
2002
+
2003
+
2004
+
2005
+
2006
+ 174,000
2007
+
2008
+
2009
+
2010
+ Stock issued for cash
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+ 8,385,289
2022
+
2023
+
2024
+
2025
+ 8,386
2026
+
2027
+
2028
+
2029
+ 1,134,606
2030
+
2031
+
2032
+
2033
+
2034
+
2035
+
2036
+
2037
+
2038
+
2039
+
2040
+
2041
+
2042
+
2043
+
2044
+
2045
+ 1,142,992
2046
+
2047
+
2048
+
2049
+ Warrants exercised for cash
2050
+
2051
+
2052
+
2053
+
2054
+
2055
+
2056
+
2057
+
2058
+
2059
+
2060
+ 7,110,340
2061
+
2062
+
2063
+
2064
+ 7,110
2065
+
2066
+
2067
+
2068
+ 646,966
2069
+
2070
+
2071
+
2072
+
2073
+
2074
+
2075
+
2076
+
2077
+
2078
+
2079
+
2080
+
2081
+
2082
+
2083
+
2084
+ 654,076
2085
+
2086
+
2087
+
2088
+ Deemed dividend on common stock
2089
+
2090
+
2091
+
2092
+
2093
+
2094
+
2095
+
2096
+
2097
+
2098
+
2099
+
2100
+
2101
+
2102
+
2103
+
2104
+
2105
+
2106
+
2107
+ 663,501
2108
+
2109
+
2110
+
2111
+
2112
+
2113
+
2114
+
2115
+
2116
+
2117
+
2118
+
2119
+
2120
+
2121
+
2122
+
2123
+ 663,501
2124
+
2125
+
2126
+
2127
+ Return of shares issued with loan commitment fee
2128
+
2129
+
2130
+
2131
+
2132
+
2133
+
2134
+
2135
+
2136
+
2137
+
2138
+ (1,300,000
2139
+ )
2140
+
2141
+
2142
+ (1,300
2143
+ )
2144
+
2145
+
2146
+ (128,700
2147
+ )
2148
+
2149
+
2150
+
2151
+
2152
+
2153
+
2154
+
2155
+
2156
+
2157
+
2158
+
2159
+
2160
+
2161
+
2162
+ (130,000
2163
+ )
2164
+
2165
+
2166
+ Net loss
2167
+
2168
+
2169
+
2170
+
2171
+
2172
+
2173
+
2174
+
2175
+
2176
+
2177
+
2178
+
2179
+
2180
+
2181
+
2182
+
2183
+
2184
+
2185
+
2186
+
2187
+
2188
+
2189
+ (4,199,331
2190
+ )
2191
+
2192
+
2193
+
2194
+
2195
+
2196
+
2197
+
2198
+
2199
+
2200
+
2201
+ (4,199,331
2202
+ )
2203
+
2204
+
2205
+ Balance December 31, 2020
2206
+
2207
+
2208
+
2209
+
2210
+
2211
+ $
2212
+
2213
+
2214
+
2215
+
2216
+ 224,836,785
2217
+
2218
+
2219
+ $
2220
+ 224,838
2221
+
2222
+
2223
+ $
2224
+ 28,714,488
2225
+
2226
+
2227
+ $
2228
+ (29,643,387
2229
+ )
2230
+
2231
+ $
2232
+
2233
+
2234
+
2235
+ $
2236
+
2237
+
2238
+
2239
+ $
2240
+ (704,061
2241
+ )
2242
+
2243
+
2244
+
2245
+
2246
+ The accompanying notes are an integral part of
2247
+ the consolidated financial statements.
2248
+
2249
+
2250
+
2251
+
2252
+
2253
+ F-6
2254
+
2255
+
2256
+
2257
+
2258
+
2259
+ BASANITE, INC. AND
2260
+ SUBSIDIARIES
2261
+
2262
+ CONSOLIDATED STATEMENTS OF CASH FLOWS
2263
+
2264
+
2265
+
2266
+
2267
+
2268
+
2269
+
2270
+
2271
+
2272
+
2273
+
2274
+
2275
+
2276
+
2277
+ For the year ended
2278
+
2279
+
2280
+
2281
+
2282
+
2283
+ December 31,
2284
+
2285
+
2286
+
2287
+
2288
+
2289
+ 2020
2290
+
2291
+
2292
+ 2019
2293
+
2294
+
2295
+
2296
+ CASH FLOWS FROM OPERATING ACTIVITIES:
2297
+
2298
+
2299
+
2300
+
2301
+
2302
+
2303
+
2304
+
2305
+
2306
+
2307
+ Net loss
2308
+
2309
+ $
2310
+ (4,199,331
2311
+ )
2312
+
2313
+ $
2314
+ (4,308,804
2315
+ )
2316
+
2317
+
2318
+ Adjustments to reconcile net loss to net cash used in operating activities:
2319
+
2320
+
2321
+
2322
+
2323
+
2324
+
2325
+
2326
+
2327
+
2328
+
2329
+ Lease right-of-use asset amortization
2330
+
2331
+
2332
+ 218,686
2333
+
2334
+
2335
+
2336
+ 175,920
2337
+
2338
+
2339
+
2340
+ Depreciation
2341
+
2342
+
2343
+ 117,340
2344
+
2345
+
2346
+
2347
+ 17,143
2348
+
2349
+
2350
+
2351
+ Amortization of debt discount
2352
+
2353
+
2354
+ 707,533
2355
+
2356
+
2357
+
2358
+ (22,533
2359
+ )
2360
+
2361
+
2362
+ Gain on extinguishment of debt
2363
+
2364
+
2365
+ 56,948
2366
+
2367
+
2368
+
2369
+
2370
+
2371
+
2372
+
2373
+ Loss on sale of asset
2374
+
2375
+
2376
+ (40,838
2377
+ )
2378
+
2379
+
2380
+
2381
+
2382
+
2383
+
2384
+ Impairment of fixed assets
2385
+
2386
+
2387
+
2388
+
2389
+
2390
+
2391
+ 1,478
2392
+
2393
+
2394
+
2395
+ Loss on inventory obsolescence
2396
+
2397
+
2398
+ 33,062
2399
+
2400
+
2401
+
2402
+
2403
+
2404
+
2405
+
2406
+ Non-cash interest charges
2407
+
2408
+
2409
+
2410
+
2411
+
2412
+
2413
+ (81,806
2414
+ )
2415
+
2416
+
2417
+ Non-cash loan commitment fee
2418
+
2419
+
2420
+
2421
+
2422
+
2423
+
2424
+ 9,250
2425
+
2426
+
2427
+
2428
+ Deemed dividend
2429
+
2430
+
2431
+ 663,501
2432
+
2433
+
2434
+
2435
+ 388,932
2436
+
2437
+
2438
+
2439
+ Stock-based compensation
2440
+
2441
+
2442
+ 165,590
2443
+
2444
+
2445
+
2446
+ 1,701,316
2447
+
2448
+
2449
+
2450
+ Changes in operating assets and liabilities:
2451
+
2452
+
2453
+
2454
+
2455
+
2456
+
2457
+
2458
+
2459
+
2460
+
2461
+ Prepaid expenses
2462
+
2463
+
2464
+ (5,233
2465
+ )
2466
+
2467
+
2468
+ 56,537
2469
+
2470
+
2471
+
2472
+ Inventory
2473
+
2474
+
2475
+ (320,165
2476
+ )
2477
+
2478
+
2479
+ (102,886
2480
+ )
2481
+
2482
+
2483
+ Accounts receivable
2484
+
2485
+
2486
+ (1,907
2487
+ )
2488
+
2489
+
2490
+ 883
2491
+
2492
+
2493
+
2494
+ Subscription liability
2495
+
2496
+
2497
+ 40,000
2498
+
2499
+
2500
+
2501
+
2502
+
2503
+
2504
+
2505
+ Lease liability
2506
+
2507
+
2508
+ (223,290
2509
+ )
2510
+
2511
+
2512
+
2513
+
2514
+
2515
+
2516
+ Deposits and other current assets
2517
+
2518
+
2519
+ 49,263
2520
+
2521
+
2522
+
2523
+ (127,051
2524
+ )
2525
+
2526
+
2527
+ Accounts payable and accrued expenses
2528
+
2529
+
2530
+ (60,658
2531
+ )
2532
+
2533
+
2534
+ 32,084
2535
+
2536
+
2537
+
2538
+ Net cash used in operating activities
2539
+
2540
+
2541
+ (2,799,499
2542
+ )
2543
+
2544
+
2545
+ (2,259,537
2546
+ )
2547
+
2548
+
2549
+
2550
+
2551
+
2552
+
2553
+
2554
+
2555
+
2556
+
2557
+
2558
+
2559
+
2560
+ CASH FLOWS FROM INVESTING ACTIVITIES:
2561
+
2562
+
2563
+
2564
+
2565
+
2566
+
2567
+
2568
+
2569
+
2570
+
2571
+ Purchase of equipment
2572
+
2573
+
2574
+ (339,586
2575
+ )
2576
+
2577
+
2578
+ (766,918
2579
+ )
2580
+
2581
+
2582
+ Deposits on machinery and equipment
2583
+
2584
+
2585
+
2586
+
2587
+
2588
+
2589
+ 200,000
2590
+
2591
+
2592
+
2593
+ Net cash used in investing activities
2594
+
2595
+
2596
+ (339,586
2597
+ )
2598
+
2599
+
2600
+ (566,918
2601
+ )
2602
+
2603
+
2604
+
2605
+
2606
+
2607
+
2608
+
2609
+
2610
+
2611
+
2612
+
2613
+
2614
+
2615
+ CASH FLOWS FROM FINANCING ACTIVITIES:
2616
+
2617
+
2618
+
2619
+
2620
+
2621
+
2622
+
2623
+
2624
+
2625
+
2626
+ Proceeds from sale of common stock and exercise of warrants
2627
+
2628
+
2629
+ 1,797,068
2630
+
2631
+
2632
+
2633
+ 2,392,828
2634
+
2635
+
2636
+
2637
+ Repayment of convertible notes payable and convertible notes payable related party
2638
+
2639
+
2640
+ (348,000
2641
+ )
2642
+
2643
+
2644
+ (104,704
2645
+ )
2646
+
2647
+
2648
+ Proceeds from notes payable and notes payable related party
2649
+
2650
+
2651
+ 266,727
2652
+
2653
+
2654
+
2655
+ 234,760
2656
+
2657
+
2658
+
2659
+ Proceeds from convertible notes payable and convertible notes payable related party
2660
+
2661
+
2662
+ 1,620,000
2663
+
2664
+
2665
+
2666
+ 408,000
2667
+
2668
+
2669
+
2670
+ Repayment of notes payable and notes payable related party
2671
+
2672
+
2673
+ (66,357
2674
+ )
2675
+
2676
+
2677
+ (97,108
2678
+ )
2679
+
2680
+
2681
+ Net cash provided by financing activities
2682
+
2683
+
2684
+ 3,269,438
2685
+
2686
+
2687
+
2688
+ 2,833,776
2689
+
2690
+
2691
+
2692
+
2693
+
2694
+
2695
+
2696
+
2697
+
2698
+
2699
+
2700
+
2701
+
2702
+
2703
+ NET INCREASE IN CASH
2704
+
2705
+
2706
+ 130,353
2707
+
2708
+
2709
+
2710
+ 7,321
2711
+
2712
+
2713
+
2714
+
2715
+
2716
+
2717
+
2718
+
2719
+
2720
+
2721
+
2722
+
2723
+
2724
+
2725
+ CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
2726
+
2727
+
2728
+ 129,152
2729
+
2730
+
2731
+
2732
+ 121,831
2733
+
2734
+
2735
+
2736
+
2737
+
2738
+
2739
+
2740
+
2741
+
2742
+
2743
+
2744
+
2745
+
2746
+
2747
+ CASH AND CASH EQUIVALENTS AT END OF PERIOD
2748
+
2749
+ $
2750
+ 259,505
2751
+
2752
+
2753
+ $
2754
+ 129,152
2755
+
2756
+
2757
+
2758
+
2759
+
2760
+
2761
+
2762
+
2763
+
2764
+ The accompanying notes are an integral part of
2765
+ the consolidated financial statements.
2766
+
2767
+ F-7
2768
+
2769
+
2770
+
2771
+
2772
+
2773
+ BASANITE, INC. AND
2774
+ SUBSIDIARIES
2775
+
2776
+ CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
2777
+
2778
+
2779
+
2780
+
2781
+ For the year ended
2782
+
2783
+
2784
+
2785
+
2786
+
2787
+ December 31,
2788
+
2789
+
2790
+
2791
+
2792
+
2793
+ 2020
2794
+
2795
+
2796
+ 2019
2797
+
2798
+
2799
+
2800
+ Supplemental cash flow information:
2801
+
2802
+
2803
+
2804
+
2805
+
2806
+
2807
+
2808
+
2809
+
2810
+
2811
+ Cash paid for interest expense
2812
+
2813
+ $
2814
+ 35,723
2815
+
2816
+
2817
+ $
2818
+ 31,237
2819
+
2820
+
2821
+
2822
+
2823
+
2824
+
2825
+
2826
+
2827
+
2828
+
2829
+
2830
+
2831
+
2832
+
2833
+ Supplemental disclosure of non cash investing and financing activities:
2834
+
2835
+
2836
+
2837
+
2838
+
2839
+
2840
+
2841
+
2842
+
2843
+
2844
+ Return of loan commitment shares
2845
+
2846
+ $
2847
+ (130,000
2848
+ )
2849
+
2850
+ $
2851
+
2852
+
2853
+
2854
+
2855
+ Common shares issued for loan commitment fees
2856
+
2857
+ $
2858
+
2859
+
2860
+
2861
+ $
2862
+ 137,900
2863
+
2864
+
2865
+
2866
+ Conversion of notes payable into common stock
2867
+
2868
+ $
2869
+ 150,000
2870
+
2871
+
2872
+ $
2873
+ 531,101
2874
+
2875
+
2876
+
2877
+ Recording of debt discount on convertible notes
2878
+
2879
+ $
2880
+ 685,000
2881
+
2882
+
2883
+ $
2884
+
2885
+
2886
+
2887
+
2888
+ Conversion of convertible notes payable into common stock
2889
+
2890
+ $
2891
+ 1,182,979
2892
+
2893
+
2894
+ $
2895
+
2896
+
2897
+
2898
+
2899
+ Common shares issued to acquire interest in joint venture
2900
+
2901
+ $
2902
+
2903
+
2904
+
2905
+ $
2906
+ 502,500
2907
+
2908
+
2909
+
2910
+ Exchange of notes payable and related interest for common stock
2911
+
2912
+ $
2913
+
2914
+
2915
+
2916
+ $
2917
+ 165,852
2918
+
2919
+
2920
+
2921
+
2922
+
2923
+
2924
+
2925
+
2926
+
2927
+
2928
+
2929
+
2930
+
2931
+ The accompanying notes are an integral part of
2932
+ the consolidated financial statements.
2933
+
2934
+
2935
+
2936
+
2937
+
2938
+
2939
+
2940
+
2941
+
2942
+
2943
+
2944
+ F-8
2945
+
2946
+
2947
+
2948
+
2949
+
2950
+ BASANITE, INC. AND
2951
+ SUBSIDIARIES
2952
+
2953
+ NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2954
+
2955
+ FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019
2956
+
2957
+
2958
+
2959
+ NOTE 1 ORGANIZATION, NATURE OF
parsed_sections/legal_matters/2021/BCAB_bioatla_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ Table of Contents (3) Consists of: (i) 1,309,026 shares of common stock held by A. M. Pappas Life Science Ventures V, LP; and (ii) 106,115 shares of common stock held by PV V CEO Fund, LP. A. M. Pappas Life Science Ventures V, LP and PV V CEO Fund, LP are managed by AMP&A Management V, LLC, the general partner of A. M. Pappas Life Science Ventures V, LP and PV V CEO Fund, LP. Arthur M. Pappas has voting or investment control over the shares held by A. M. Pappas Life Science Ventures V, LP and PV V CEO Fund, LP. The address of the foregoing entities is c/o Pappas Capital, LLC, 2520 Meridian Parkway, Suite 400, Durham, NC 27519. (4) The board of directors of HBM Healthcare Investments (Cayman) Ltd. is comprised of Jean-Marc Lesieur, Richard Coles, Sophia Harris, Dr. Andreas Wicki, Paul Woodhouse and Mark Kronenfeld, none of whom has individual voting or investment power with respect to such shares, and each disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein. The address of the foregoing entity is Governors Square, Suite #4-212-2, 23 Lime Tree Bay Avenue, West Bay, Grand Cayman, Cayman Islands. (5) Consists of: (i) 513,998 shares of common stock held by Biomedical Value Fund, LP.; and (ii) 330,004 shares of common stock held by Biomedical Offshore Value Fund, Ltd. Biomedical Value Fund, LP and Biomedical Offshore Value Fund, Ltd. are each managed by Great Point Partners, LLC. Jeffrey R. Jay and Tavi Yehudai have voting or investment control over the shares held by Biomedical Value Fund, LP and Biomedical Offshore Value Fund, Ltd. The address of the foregoing entities is c/o Great Point Partners, LLC, 165 Mason Street, 3rd Floor, Greenwich, CT 06830. (6) Consists of: (i) 174,731 shares of common stock held by Ikarian Healthcare Master Fund, LP; (ii) 15,361 shares of common stock held by Boothbay Absolute Return Strategies, LP; and (iii) 10,052 shares of common stock held by Boothbay Diversified Alpha Master Fund LP. Ikarian Healthcare Master Fund, LP is managed by Ikarian Capital LLC. Boothbay Absolute Return Strategies, LP and Boothbay Diversified Alpha Master Fund LP are managed by Boothbay Fund Management LLC. Vikram Khanna has voting or investment control over the shares held by Ikarian Healthcare Master Fund, LP, Boothbay Absolute Return Strategies, LP and Boothbay Diversified Alpha Master Fund LP. The address of the foregoing entities is 100 Crescent Court, Suite 1620, Dallas, TX 75201. (7) Consists of 464,300 shares of common stock held by Deerfield Partners, L.P. Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P. Mr. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt L.P. and Deerfield Management Company L.P. Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and Mr. James E. Flynn may be deemed to beneficially own the securities held by Deerfield Partners, L.P. The address of Deerfield Partners, L.P. is c/o Deerfield Management Company, L.P., 345 Park Avenue South, 12th Floor, New York, NY 10010. (8) Consists of: (i) 92,149 shares of common stock held by Sphera Biotech Master Fund LP; and (ii) 122,151 shares of common stock held by Sphera Global Healthcare Master Fund. Sphera Biotech Master Fund LP and Sphera Global Healthcare Master Fund are managed by Sphera Healthcare US Inc. Michelle Ross, as portfolio manager, has voting or investment control over the shares held by Sphera Biotech Master Fund LP and Sphera Global Healthcare Master Fund. The address of the foregoing entities is PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands. (9) Consists of: (i) 43,255 shares of common stock held by BEMAP Master Fund Ltd; (ii) 38,181 shares of common stock held by Monashee Solitario Fund LP; (iii) 24,888 shares of common stock held by Monashee Pure Alpha SPV I LP; (iv) 7,193 shares of common stock held by SFL SPV I LLC; (v) 5,618 shares of common stock held by Bespoke Alpha MAC MIM LP; (vi) 8,651 shares of common stock held by Monashee Managed Account SP; (vii) 5,541 shares of common stock held by Mission Pure Alpha LP; and (viii) 45,273 shares of common stock held by DS Liquid Div RVA MON LLC. The above entities are managed by Monashee Investment Management LLC. Jeff Muller has voting or investment control over the shares held by the above entities. The address for the foregoing entities is c/o Monashee Investment Management LLC, 75 Park Plaza, 2nd Floor, Boston, MA 02116. (10) Hudson Bay Master Fund Ltd. is managed by Hudson Bay Capital Management LP, its investment manager. Hudson Bay Capital Management LP has voting and investment power over the shares held by Hudson Bay Master Fund Ltd. Sander Gerber is the managing member of Hudson Bay Capital GP LLC, which is the - 18 - Table of Contents general partner of Hudson Bay Capital Management LP. Each of Hudson Bay Master Fund Ltd. and Sander Gerber disclaims beneficial ownership over the shares held by Hudson Bay Master Fund Ltd. The address of the foregoing entity is c/o Hudson Bay Capital Management LP, 28 Havemeyer Place, 2nd Floor, Greenwich, CT 06830. - 19 - Table of Contents PLAN OF DISTRIBUTION The selling stockholders, which as used herein includes donees, pledgees, transferees or other successors-in-interest selling shares of our common stock or interests in shares of our common stock received after the date of this prospectus from a selling stockholder as a gift, pledge, partnership distribution or other transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of their shares of our common stock or interests in shares of our common stock on any stock exchange, market or trading facility on which the shares are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices. The selling stockholders may use any one or more of the following methods when disposing of shares or interests therein: ordinary brokerage transactions and transactions in which the broker-dealer solicit purchasers; block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block as principal to facilitate the transaction; purchases by a broker-dealer as principal and resale by the broker-dealer for its account; an exchange distribution in accordance with the rules of the applicable exchange; privately negotiated transactions; short sales effected after the date the registration statement of which this prospectus is a part is declared effective by the SEC; through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise; broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated price per share; a combination of any such methods of sale; and any other method permitted by applicable law. The selling stockholders may, from time to time, pledge or grant a security interest in some or all of the shares of our common stock owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of our common stock, from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer the shares of our common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus. In connection with the sale of our common stock or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of our common stock in the course of hedging the positions they assume. The selling stockholders may also sell shares of our common stock short and deliver these securities to close out their short positions, or loan or pledge the common stock to broker dealers that in turn may sell these securities. The selling stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). - 20 - Table of Contents The aggregate proceeds to the selling stockholders from the sale of our common stock offered by them will be the purchase price of our common stock less discounts or commissions, if any. Each of the selling stockholders reserves the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of our common stock to be made directly or through agents. We will not receive any of the proceeds from this offering. The selling stockholders also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities Act, provided that they meet the criteria and conform to the requirements of that rule. The selling stockholders and any underwriters, broker-dealers or agents that participate in the sale of our common stock or interests therein may be underwriters within the meaning of Section 2(11) of the Securities Act. Any discounts, commissions, concessions or profit they earn on any resale of the shares may be underwriting discounts and commissions under the Securities Act. Selling stockholders who are underwriters within the meaning of Section 2(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities Act. To the extent required, the shares of our common stock to be sold, the names of the selling stockholders, the respective purchase prices and public offering prices, the names of any agent, dealer or underwriter, and any applicable commissions or discounts with respect to a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus. Selling stockholders may sell the shares of common stock in compliance with the provisions of Rule 144 under the Securities Act, if available, or pursuant to other available exemptions from the registration requirements of the Securities Act. In order to comply with the securities laws of some states, if applicable, our common stock may be sold in these jurisdictions only through registered or licensed brokers or dealers. In addition, in some states our common stock may not be sold unless it has been registered or qualified for sale or an exemption from registration or qualification requirements is available and is complied with. We have advised the selling stockholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares in the market and to the activities of the selling stockholders and their affiliates. The foregoing may affect the marketability of the common stock. In addition, to the extent applicable, we will make copies of this prospectus (as it may be supplemented or amended from time to time) available to the selling stockholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling stockholders may indemnify any broker-dealer that participates in transactions involving the sale of the shares against certain liabilities, including liabilities arising under the Securities Act. We shall use reasonable efforts to keep the registration statement of which this prospectus constitutes a part effective at all times until (1) the shares may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 under the Securities Act, or (2) September 30, 2024, whichever is the earliest to occur. LEGAL MATTERS The validity of the shares of our common stock offered hereby is being passed upon for us by Orrick, Herrington & Sutcliffe LLP, San Francisco, California.
parsed_sections/legal_matters/2021/BCRD_blueone_legal_matters.txt ADDED
@@ -0,0 +1,210 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ LEGAL
2
+ MATTERS
3
+
4
+
5
+
6
+ The
7
+ validity of the shares of common stock offered under this prospectus is being passed upon for us by Brian Higley, Esq. of Business Legal
8
+ Advisors, LLC, Draper, Utah.
9
+
10
+
11
+
12
+ EXPERTS
13
+
14
+
15
+
16
+ Our
17
+ financial statements for the years ended March 31, 2021 and 2020 were audited by Hayne & Company, and are included in reliance upon
18
+ such reports given upon the authority of Hayne & Company, as experts in accounting and auditing.
19
+
20
+
21
+
22
+ ADDITIONAL
23
+ INFORMATION
24
+
25
+
26
+
27
+ We
28
+ have filed a registration statement on Form S-1 under the Securities Act (SEC File No. 333-_________) relating to the shares of common
29
+ stock being offered by this prospectus, and reference is made to such registration statement. This prospectus constitutes the prospectus
30
+ of Monetiva Inc., filed as part of the registration statement, and it does not contain all information in the registration statement,
31
+ as certain portions have been omitted in accordance with the rules and regulations of the SEC.
32
+
33
+
34
+
35
+ Upon
36
+ the effective date of the registration statement of which this prospectus is a part, we will be required to file reports and other documents
37
+ with the SEC. We do not presently intend to voluntarily furnish you with a copy of our annual report. You may read and copy any materials
38
+ we file with the SEC at the public reference room of the SEC at 100 F Street, NE., Washington, DC 20549, between the hours of 10:00 a.m.
39
+ and 3:00 p.m., except federal holidays and official closings, at the Public Reference Room. You may obtain information on the operation
40
+ of the Public Reference Room by calling the SEC at 1-800-SEC-0330. Our SEC filings are also available to you on the Internet website
41
+ for the SEC at http://www.sec.gov.
42
+
43
+
44
+
45
+ 41
46
+
47
+
48
+
49
+
50
+
51
+
52
+
53
+ INDEX
54
+ TO FINANCIAL STATEMENTS
55
+
56
+
57
+
58
+
59
+ Page
60
+
61
+
62
+
63
+ Report of Independent Registered Public Accounting Firm
64
+ F-2
65
+
66
+
67
+
68
+
69
+
70
+
71
+ Balance
72
+ Sheets at March 31, 2021 and 2020
73
+ F-3
74
+
75
+
76
+
77
+
78
+
79
+
80
+ Statements
81
+ of Operations for the years ended March 31, 2021 and 2020
82
+ F-4
83
+
84
+
85
+
86
+
87
+
88
+
89
+ Statements
90
+ of Changes in Stockholders Equity for the years ended March 31, 2021 and 2020
91
+ F-5
92
+
93
+
94
+
95
+
96
+
97
+
98
+ Statements
99
+ of Cash Flows for the years ended March 31, 2021 and 2020
100
+ F-6
101
+
102
+
103
+
104
+
105
+
106
+
107
+ Notes
108
+ to Financial Statements
109
+ F-7
110
+
111
+
112
+
113
+
114
+
115
+
116
+ Page
117
+
118
+
119
+
120
+
121
+
122
+
123
+
124
+
125
+ Unaudited
126
+ Condensed Balance Sheets at June 30, 2021 and March 31, 2021
127
+ F-17
128
+
129
+
130
+
131
+
132
+
133
+
134
+ Unaudited
135
+ Condensed Statements of Operations for the three months ended June 30, 2021 and 2020
136
+ F-18
137
+
138
+
139
+
140
+
141
+
142
+
143
+ Unaudited
144
+ Condensed Statements of Changes in Stockholders Equity for the three months ended June 30, 2021 and 2020
145
+ F-19
146
+
147
+
148
+
149
+
150
+
151
+
152
+ Unaudited
153
+ Condensed Statements of Cash Flows for the three months ended June 30, 2021 and 2020
154
+ F-20
155
+
156
+
157
+
158
+
159
+
160
+
161
+ Notes
162
+ to Condensed Financial Statements (Unaudited)
163
+ F-21
164
+
165
+
166
+
167
+
168
+ F-1
169
+
170
+
171
+
172
+
173
+
174
+
175
+
176
+ REPORT
177
+ OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
178
+
179
+
180
+
181
+ To
182
+ the Board of Directors and Stockholders of BlueOne Card, Inc.
183
+
184
+
185
+
186
+ Opinion
187
+ on the Financial Statements
188
+
189
+
190
+
191
+ We
192
+ have audited the accompanying balance sheets of BlueOne Card, Inc. (the Company) as of March 31, 2021 and 2020, and the related statements
193
+ of operations, stockholders equity, and cash flows for each of the two years in the period ended March 31, 2021, and the related
194
+ notes and schedules (collectively referred to as the financial statements). In our opinion, the financial statements present fairly,
195
+ in all material respects, the financial position of the Company as of March 31, 2021 and 2020, and the results of its operations and
196
+ its cash flows for each of the two years in the period ended March 31, 2021, in conformity with accounting principles generally accepted
197
+ in the United States of America.
198
+
199
+
200
+
201
+ Going
202
+ Concern
203
+
204
+
205
+
206
+ The
207
+ Company s financial statements are prepared using the generally accepted accounting principles applicable to a going concern. As
208
+ described in Note 1 to the financial statements, the Company has suffered recurring losses from operations, negative cash flows from
209
+ operating activities, and not generated any revenues since inception that raise substantial doubt about its ability to continue as a
210
+ going concern.
parsed_sections/legal_matters/2021/BEEP_mobile_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS Debevoise & Plimpton LLP, New York, New York will pass upon the validity of the securities offered in this prospectus with respect to Class A ordinary shares. Maples and Calder (Cayman) LLP will pass upon the validity of the securities offered in this prospectus with respect to the ordinary shares and matters of Cayman Islands law. In connection with this offering, Skadden, Arps, Slate, Meagher & Flom LLP advised the underwriters in connection with the offering of the securities.
parsed_sections/legal_matters/2021/BEPJ_brookfield_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the BEPC exchangeable shares offered by this prospectus will be passed upon by McMillan LLP, British Columbia counsel to BEPC. The validity of the BEP units issuable upon exchange, redemption or acquisition of the BEPC exchangeable shares offered pursuant to this prospectus and other matters of Bermuda law will be passed upon for BEP by Appleby (Bermuda) Limited. Certain legal matters relating to Canadian and U.S. federal income tax considerations will be passed upon on behalf BEPC and BEP by Torys LLP. Certain legal matters relating to U.S. federal and New York law will be passed upon on behalf of the underwriters by Milbank LLP. As at the date of this prospectus, the partners and associates of each of Torys LLP, McMillan LLP and Appleby (Bermuda) Limited beneficially own, directly and indirectly, less than 1.0% of the outstanding securities or other property of BEP and BEPC, their associates or their affiliates.
parsed_sections/legal_matters/2021/BFLY-WT_butterfly_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ legal matters which have arisen in the normal course of business, including but not limited to medical malpractice matters. Although the ultimate results of these matters are not currently determinable, management does not expect that they will have a material effect on the Company s consolidated balance sheet, statements of operations and comprehensive loss, or cash flows. On December 14, 2020, a stockholder of Longview filed a lawsuit in the Supreme Court of the State of New York, County of New York against Longview and the members of the Longview Board, styled Nair v. Longview Acquisition Corp. et al. (the Nair Complaint ). On December 16, 2020, a second stockholder of Longview filed a lawsuit in the Supreme Court of the State of New York, County of New York against Longview, the members of its board of directors, and Butterfly, styled Lau v. Longview Acquisition Corp., et al. (the Lau Complaint ). Both the Nair Complaint and the Lau Complaint alleged, among other things, that (i) defendants engaged in an unfair sales process and agreed to inadequate consideration in connection with the proposed transaction, and (ii) that the Registration Statement filed with the SEC on November 27, 2020 in connection with the proposed transaction is materially misleading, and sought, among other things, to enjoin the proposed transaction, rescind the transaction or award rescissory damages to the extent it is consummated, and an award of attorneys fees and expenses. The Nair Complaint was voluntarily dismissed on February 21, 2021, and the Lau Complaint was voluntarily dismissed on March 2, 2021. The parties currently are in negotiation regarding a potential attorney fee award. The Company enters into indemnification provisions under some agreements with other parties in the ordinary course of business, including business partners, investors, contractors, customers, and the Company s officers, directors and certain employees. The Company has agreed to indemnify and defend the indemnified party claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party claim because of the Company s activities or non-compliance with certain representations and warranties made by the Company. It is not possible to determine the maximum potential loss under these indemnification provisions due to the Company s limited history of prior indemnification claims and the unique facts and circumstances involved in each particular provision. To date, losses recorded in the TABLE OF CONTENTS
parsed_sections/legal_matters/2021/BKKT-WT_bakkt_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS Wilson Sonsini Goodrich & Rosati, P.C., Austin, Texas, which has acted as our counsel in connection with this offering, will pass upon the validity of our securities being offered by this prospectus.
parsed_sections/legal_matters/2021/BKSY-WT_blacksky_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the Securities offered hereby has been passed upon for us by Wilson Sonsini Goodrich & Rosati, Professional Corporation, Seattle, Washington. Certain members of, and investment partnerships comprised of members of, and persons associated with, Wilson Sonsini Goodrich & Rosati, Professional Corporation, directly or indirectly own less than 0.01% of the outstanding shares of our common stock. Table of Contents
parsed_sections/legal_matters/2021/BLBX_blackboxst_legal_matters.txt ADDED
The diff for this file is too large to render. See raw diff
 
parsed_sections/legal_matters/2021/BLZE_backblaze_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the issuance of our Class A common stock offered in this prospectus will be passed upon for us by Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, Redwood City, California. Certain legal matters in connection with this offering will be passed upon for the underwriters by White & Case LLP, New York, New York.
parsed_sections/legal_matters/2021/BMBL_bumble-inc_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the shares of Class A common stock will be passed upon for us by Simpson Thacher & Bartlett LLP, Washington, D.C. Certain legal matters in connection with this offering will be passed upon for the underwriters by Davis Polk & Wardwell LLP, New York, New York. An investment vehicle comprised of selected partners of Simpson Thacher & Bartlett LLP, members of their families, related persons and others owns interests representing less than 1% of the capital commitments of funds affiliated with Blackstone Inc.
parsed_sections/legal_matters/2021/BMEA_biomea_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ Legal matters The validity of the issuance of our common stock offered in this prospectus will be passed upon for us by Latham & Watkins LLP. Certain legal matters in connection with this offering will be passed upon for the underwriters by Cooley LLP.
parsed_sections/legal_matters/2021/BOLT_bolt_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the shares of common stock being offered by this prospectus will be passed upon for us by Cooley LLP, Seattle, Washington. Davis Polk & Wardwell LLP, Menlo Park, California is representing the underwriters.
parsed_sections/legal_matters/2021/BRCFF_brookfield_legal_matters.txt ADDED
@@ -0,0 +1 @@
 
 
1
+ LEGAL MATTERS The validity of the class A exchangeable shares offered pursuant to this prospectus and other matters of Bermuda law will be passed upon for our company by Appleby (Bermuda) Limited. The validity of the Brookfield Class A Shares offered by this prospectus will be passed upon by Torys LLP. Certain legal matters relating to Canadian and U.S. federal income tax considerations will be passed upon on behalf of Brookfield Asset Management and our company by Torys LLP. As at the date of this prospectus, the partners and associates of each of Torys LLP and Appleby (Bermuda) Limited beneficially own, directly and indirectly, less than 1.0% of the outstanding securities or other property of Brookfield Asset Management and our company, its associates or its affiliates.
parsed_sections/legal_matters/2021/BRLSW_borealis_legal_matters.txt ADDED
@@ -0,0 +1,3022 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ LEGAL MATTERS
2
+
3
+ Greenberg Traurig, P.A., Miami, Florida, is acting as our counsel in connection with the registration of our securities under the Securities Act, and as such, will pass upon the validity of the securities offered in this offering. Graubard Miller, New York, New York, is acting as counsel to the underwriters.
4
+
5
+ EXPERTS
6
+
7
+ The financial statements of Oxus Acquisition Corp. at March 22, 2021 and for the period from February 3, 2021 (inception) through March 22, 2021 included in this prospectus have been audited by Marcum LLP, independent registered public accounting firm, as set forth in their report, thereon (which contains an explanatory paragraph relating to substantial doubt about the ability of Oxus Acquisition Corp. to continue as a going concern as described in Note 1 to the financial statements), appearing elsewhere in this prospectus, and are included in reliance on such report given upon such firm as experts in auditing and accounting.
8
+
9
+ WHERE YOU CAN FIND ADDITIONAL INFORMATION
10
+
11
+ We have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the securities we are offering by this prospectus. This prospectus does not contain all of the information included in the registration statement. For further information about us and our securities, you should refer to the registration statement and the exhibits and schedules filed with the registration statement. Whenever we make reference in this prospectus to any of our contracts, agreements or other documents, the references are materially complete but may not include a description of all aspects of such contracts, agreements or other documents, and you should refer to the exhibits attached to the registration statement for copies of the actual contract, agreement or other document.
12
+
13
+ Upon completion of this offering, we will be subject to the information requirements of the Exchange Act and will file annual, quarterly and current event reports, proxy statements and other information with the SEC. You can read our SEC filings, including the registration statement, over the Internet at the SEC s website at www.sec.gov
14
+
15
+
16
+
17
+ 128
18
+
19
+ Table of Contents
20
+
21
+
22
+ OXUS ACQUISITION CORP.
23
+ FINANCIAL STATEMENTS
24
+
25
+ TABLE OF CONTENTS
26
+
27
+
28
+
29
+
30
+
31
+
32
+
33
+
34
+
35
+ Page
36
+
37
+
38
+
39
+
40
+
41
+
42
+ Report of Independent Registered Public Accounting Firm
43
+
44
+
45
+
46
+
47
+ F-2
48
+
49
+
50
+
51
+
52
+
53
+
54
+ Balance Sheets
55
+
56
+
57
+
58
+
59
+ F-3
60
+
61
+
62
+
63
+
64
+
65
+
66
+ Statements of Operations
67
+
68
+
69
+
70
+
71
+ F-4
72
+
73
+
74
+
75
+
76
+
77
+
78
+ Statements of Changes in Shareholders Equity
79
+
80
+
81
+
82
+
83
+ F-5
84
+
85
+
86
+
87
+
88
+
89
+
90
+ Statements of Cash Flows
91
+
92
+
93
+
94
+
95
+ F-6
96
+
97
+
98
+
99
+
100
+
101
+
102
+ Notes to Financial Statements
103
+
104
+
105
+
106
+
107
+ F-7 F-16
108
+
109
+
110
+
111
+
112
+
113
+
114
+
115
+ F-1
116
+
117
+ Table of Contents
118
+
119
+
120
+ REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
121
+
122
+ To the Shareholder and Board of Directors of
123
+
124
+ Oxus Acquisition Corp.
125
+
126
+ Opinion on the Financial Statements
127
+
128
+ We have audited the accompanying balance sheet of Oxus Acquisition Corp. (the Company ) as of March 22, 2021, the related statements of operations, changes in shareholders equity and cash flows for the period from February 3, 2021 (inception) through March 22, 2021, and the related notes (collectively referred to as the financial statements ). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of March 22, 2021, and the results of its operations and its cash flows for the period from February 3, 2021 (inception) through March 22, 2021, in conformity with accounting principles generally accepted in the United States of America.
129
+
130
+ Explanatory Paragraph Going Concern
131
+
132
+ The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 1 to the financial statements, the Company s business plan is dependent upon its completion of the proposed initial public offering described in Note 3 to the financial statements. The Company has a working capital deficiency as of March 22, 2021 and lacks the financial resources it needs to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. These conditions raise substantial doubt about the Company s ability to continue as a going concern. Management s plans with regard to these matters are also described in Notes 1 and 3. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
133
+
134
+ Basis for Opinion
135
+
136
+ These financial statements are the responsibility of the Company s management. Our responsibility is to express an opinion on the Company s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ( PCAOB ) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
137
+
138
+ We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company s internal control over financial reporting. Accordingly, we express no such opinion.
139
+
140
+ Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
141
+
142
+ /s/ Marcum LLP
143
+
144
+ Marcum LLP
145
+
146
+ We have served as the Company s auditor since 2021.
147
+
148
+ New York, NY
149
+
150
+ April 1, 2021, except for Note 8 as to which the date is August 19, 2021.
151
+
152
+
153
+
154
+ F-2
155
+
156
+ Table of Contents
157
+
158
+
159
+ OXUS ACQUISITION CORP.
160
+ BALANCE SHEETS
161
+
162
+
163
+
164
+
165
+
166
+
167
+
168
+
169
+
170
+ June 30,
171
+ 2021
172
+
173
+
174
+
175
+
176
+ March 22,
177
+ 2021
178
+
179
+
180
+
181
+
182
+
183
+
184
+
185
+
186
+ (Unaudited)
187
+
188
+
189
+
190
+
191
+ (Audited)
192
+
193
+
194
+
195
+
196
+
197
+
198
+ ASSETS
199
+
200
+
201
+
202
+
203
+
204
+
205
+
206
+
207
+
208
+
209
+
210
+
211
+
212
+
213
+
214
+
215
+
216
+
217
+
218
+
219
+
220
+
221
+
222
+
223
+
224
+
225
+ Current Assets
226
+
227
+
228
+
229
+
230
+
231
+
232
+
233
+
234
+
235
+
236
+
237
+
238
+
239
+
240
+
241
+
242
+
243
+
244
+
245
+
246
+
247
+
248
+
249
+
250
+
251
+
252
+ Cash
253
+
254
+
255
+
256
+
257
+ $
258
+
259
+
260
+
261
+ 87,734
262
+
263
+
264
+
265
+
266
+
267
+
268
+
269
+
270
+ $
271
+
272
+
273
+
274
+
275
+
276
+
277
+
278
+
279
+
280
+
281
+
282
+
283
+
284
+
285
+ Subscription receivable
286
+
287
+
288
+
289
+
290
+
291
+
292
+
293
+
294
+ 40
295
+
296
+
297
+
298
+
299
+
300
+
301
+
302
+
303
+
304
+
305
+
306
+
307
+
308
+
309
+
310
+
311
+
312
+
313
+
314
+
315
+
316
+
317
+
318
+ Total Current Assets
319
+
320
+
321
+
322
+
323
+
324
+
325
+
326
+
327
+ 87,774
328
+
329
+
330
+
331
+
332
+
333
+
334
+
335
+
336
+
337
+
338
+
339
+
340
+
341
+
342
+
343
+
344
+
345
+
346
+
347
+
348
+
349
+
350
+
351
+
352
+
353
+
354
+
355
+
356
+
357
+
358
+
359
+
360
+
361
+
362
+
363
+
364
+
365
+
366
+
367
+
368
+
369
+
370
+
371
+
372
+
373
+
374
+
375
+ Deferred offering costs associated with initial public offering
376
+
377
+
378
+
379
+
380
+
381
+
382
+
383
+
384
+ 230,544
385
+
386
+
387
+
388
+
389
+
390
+
391
+
392
+
393
+
394
+
395
+
396
+
397
+ 31,211
398
+
399
+
400
+
401
+
402
+
403
+
404
+
405
+
406
+
407
+
408
+ TOTAL ASSETS
409
+
410
+
411
+
412
+
413
+ $
414
+
415
+
416
+
417
+ 318,318
418
+
419
+
420
+
421
+
422
+
423
+
424
+
425
+
426
+ $
427
+
428
+
429
+
430
+ 31,211
431
+
432
+
433
+
434
+
435
+
436
+
437
+
438
+
439
+
440
+
441
+
442
+
443
+
444
+
445
+
446
+
447
+
448
+
449
+
450
+
451
+
452
+
453
+
454
+
455
+
456
+
457
+
458
+
459
+
460
+
461
+
462
+
463
+
464
+
465
+ LIABILITIES AND SHAREHOLDERS EQUITY
466
+
467
+
468
+
469
+
470
+
471
+
472
+
473
+
474
+
475
+
476
+
477
+
478
+
479
+
480
+
481
+
482
+
483
+
484
+
485
+
486
+
487
+
488
+
489
+
490
+
491
+
492
+ Current Liabilities
493
+
494
+
495
+
496
+
497
+
498
+
499
+
500
+
501
+
502
+
503
+
504
+
505
+
506
+
507
+
508
+
509
+
510
+
511
+
512
+
513
+
514
+
515
+
516
+
517
+
518
+
519
+ Accrued offering costs and expenses
520
+
521
+
522
+
523
+
524
+ $
525
+
526
+
527
+
528
+ 32,051
529
+
530
+
531
+
532
+
533
+
534
+
535
+
536
+
537
+ $
538
+
539
+
540
+
541
+ 24,129
542
+
543
+
544
+
545
+
546
+
547
+
548
+
549
+
550
+
551
+
552
+ Promissory note related party
553
+
554
+
555
+
556
+
557
+
558
+
559
+
560
+
561
+ 279,935
562
+
563
+
564
+
565
+
566
+
567
+
568
+
569
+
570
+
571
+
572
+
573
+
574
+
575
+
576
+
577
+
578
+
579
+
580
+
581
+
582
+
583
+
584
+
585
+ Total Current Liabilities
586
+
587
+
588
+
589
+
590
+
591
+
592
+
593
+
594
+ 311,986
595
+
596
+
597
+
598
+
599
+
600
+
601
+
602
+
603
+
604
+
605
+
606
+
607
+ 24,129
608
+
609
+
610
+
611
+
612
+
613
+
614
+
615
+
616
+
617
+
618
+
619
+
620
+
621
+
622
+
623
+
624
+
625
+
626
+
627
+
628
+
629
+
630
+
631
+
632
+
633
+
634
+
635
+
636
+
637
+
638
+
639
+
640
+
641
+
642
+ Commitments and Contingencies (Note 6)
643
+
644
+
645
+
646
+
647
+
648
+
649
+
650
+
651
+
652
+
653
+
654
+
655
+
656
+
657
+
658
+
659
+
660
+
661
+
662
+
663
+
664
+
665
+
666
+
667
+
668
+
669
+
670
+
671
+
672
+
673
+
674
+
675
+
676
+
677
+
678
+
679
+
680
+
681
+
682
+
683
+
684
+
685
+
686
+
687
+
688
+
689
+
690
+
691
+
692
+
693
+ Shareholders Equity
694
+
695
+
696
+
697
+
698
+
699
+
700
+
701
+
702
+
703
+
704
+
705
+
706
+
707
+
708
+
709
+
710
+
711
+
712
+
713
+
714
+
715
+
716
+
717
+
718
+
719
+
720
+ Preferred shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding
721
+
722
+
723
+
724
+
725
+
726
+
727
+
728
+
729
+
730
+
731
+
732
+
733
+
734
+
735
+
736
+
737
+
738
+
739
+
740
+
741
+
742
+
743
+
744
+
745
+
746
+
747
+
748
+
749
+
750
+
751
+
752
+
753
+ Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized;
754
+ 300,000 issued or outstanding at June 30, 2021 and 0 issued or outstanding at March 22, 2021(1)(2)
755
+
756
+
757
+
758
+
759
+
760
+
761
+
762
+
763
+ 30
764
+
765
+
766
+
767
+
768
+
769
+
770
+
771
+
772
+
773
+
774
+
775
+
776
+
777
+
778
+
779
+
780
+
781
+
782
+
783
+
784
+
785
+
786
+
787
+ Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized;
788
+ 4,312,500 shares issued and outstanding at June 30, 2021 and 4,312,500 shares issued and outstanding at March 22, 2021(3)(4)
789
+
790
+
791
+
792
+
793
+
794
+
795
+
796
+
797
+ 431
798
+
799
+
800
+
801
+
802
+
803
+
804
+
805
+
806
+
807
+
808
+
809
+
810
+ 431
811
+
812
+
813
+
814
+
815
+
816
+
817
+
818
+
819
+
820
+
821
+ Additional paid-in capital
822
+
823
+
824
+
825
+
826
+
827
+
828
+
829
+
830
+ 24,579
831
+
832
+
833
+
834
+
835
+
836
+
837
+
838
+
839
+
840
+
841
+
842
+
843
+ 24,569
844
+
845
+
846
+
847
+
848
+
849
+
850
+
851
+
852
+
853
+
854
+ Accumulated deficit
855
+
856
+
857
+
858
+
859
+
860
+
861
+
862
+
863
+ (18,708
864
+
865
+
866
+
867
+ )
868
+
869
+
870
+
871
+
872
+
873
+
874
+
875
+
876
+ (17,918
877
+
878
+
879
+
880
+ )
881
+
882
+
883
+
884
+
885
+
886
+
887
+ Total Shareholders Equity
888
+
889
+
890
+
891
+
892
+
893
+
894
+
895
+
896
+ 6,332
897
+
898
+
899
+
900
+
901
+
902
+
903
+
904
+
905
+
906
+
907
+
908
+
909
+ 7,082
910
+
911
+
912
+
913
+
914
+
915
+
916
+
917
+
918
+
919
+
920
+ TOTAL LIABILITIES AND SHAREHOLDERS EQUITY
921
+
922
+
923
+
924
+
925
+ $
926
+
927
+
928
+
929
+ 318,318
930
+
931
+
932
+
933
+
934
+
935
+
936
+
937
+
938
+ $
939
+
940
+
941
+
942
+ 31,211
943
+
944
+
945
+
946
+
947
+
948
+
949
+
950
+
951
+
952
+ ____________
953
+ (1) Consists of Underwriter Founder Shares issued to the underwriters and/or its designees (see Note 5).
954
+
955
+ (2) Through June 30, 2021, the underwriters and/or its designees effected a surrender of 60,000 Class A ordinary shares to the Company for no consideration. Subsequent to balance sheet date, the underwriters and/or its designees effected surrendered additional 40,000 Class A ordinary shares to the Company for no consideration, resulting in a decrease in the total number of Class A ordinary shares outstanding from 400,000 to 300,000. All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 5 and Note 8).
956
+
957
+ (3) Through June 30, 2021, the Sponsor effected a surrender of 1,437,500 Class B ordinary shares to the Company for no consideration. Subsequent to balance sheet date, the Sponsor surrendered additional 2,875,000 Class B ordinary shares to the Company for no consideration, resulting in a decrease in the total number of Class B ordinary shares outstanding from 8,625,000 to 4,312,500. All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 5 and Note 8).
958
+
959
+ (4) Includes up to 562,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 7).
960
+
961
+ The accompanying notes are an integral part of these financial statements.
962
+
963
+
964
+
965
+ F-3
966
+
967
+ Table of Contents
968
+
969
+
970
+ OXUS ACQUISITION CORP.
971
+ STATEMENTS OF OPERATIONS
972
+
973
+
974
+
975
+
976
+
977
+
978
+
979
+
980
+
981
+ For the
982
+ Period from
983
+ February 3,
984
+ 2021
985
+ (inception)
986
+ through
987
+ June 30,
988
+ 2021
989
+
990
+
991
+
992
+
993
+ For the
994
+ Period from
995
+ February 3,
996
+ 2021
997
+ (inception) through
998
+ March 22,
999
+ 2021
1000
+
1001
+
1002
+
1003
+
1004
+
1005
+
1006
+
1007
+
1008
+ (Unaudited)
1009
+
1010
+
1011
+
1012
+
1013
+ (Audited)
1014
+
1015
+
1016
+
1017
+
1018
+
1019
+
1020
+ Formation costs
1021
+
1022
+
1023
+
1024
+
1025
+ $
1026
+
1027
+
1028
+
1029
+ 18,708
1030
+
1031
+
1032
+
1033
+
1034
+
1035
+
1036
+
1037
+
1038
+ $
1039
+
1040
+
1041
+
1042
+ 17,918
1043
+
1044
+
1045
+
1046
+
1047
+
1048
+
1049
+
1050
+
1051
+
1052
+
1053
+ Net loss
1054
+
1055
+
1056
+
1057
+
1058
+ $
1059
+
1060
+
1061
+
1062
+ (18,708
1063
+
1064
+
1065
+
1066
+ )
1067
+
1068
+
1069
+
1070
+
1071
+ $
1072
+
1073
+
1074
+
1075
+ (17,918
1076
+
1077
+
1078
+
1079
+ )
1080
+
1081
+
1082
+
1083
+
1084
+
1085
+
1086
+
1087
+
1088
+
1089
+
1090
+
1091
+
1092
+
1093
+
1094
+
1095
+
1096
+
1097
+
1098
+
1099
+
1100
+
1101
+
1102
+
1103
+
1104
+
1105
+
1106
+
1107
+
1108
+
1109
+
1110
+ Weighted average Class A ordinary shares outstanding, basic and diluted(1)(2)
1111
+
1112
+
1113
+
1114
+
1115
+
1116
+
1117
+
1118
+
1119
+ 300,000
1120
+
1121
+
1122
+
1123
+
1124
+
1125
+
1126
+
1127
+
1128
+
1129
+
1130
+
1131
+
1132
+
1133
+
1134
+
1135
+
1136
+
1137
+
1138
+
1139
+
1140
+
1141
+
1142
+
1143
+ Basic and diluted net loss per Class A ordinary shares
1144
+
1145
+
1146
+
1147
+
1148
+ $
1149
+
1150
+
1151
+
1152
+ (0.00
1153
+
1154
+
1155
+
1156
+ )
1157
+
1158
+
1159
+
1160
+
1161
+ $
1162
+
1163
+
1164
+
1165
+ (0.00
1166
+
1167
+
1168
+
1169
+ )
1170
+
1171
+
1172
+
1173
+
1174
+
1175
+
1176
+
1177
+
1178
+
1179
+
1180
+
1181
+
1182
+
1183
+
1184
+
1185
+
1186
+
1187
+
1188
+
1189
+
1190
+
1191
+
1192
+
1193
+
1194
+
1195
+
1196
+
1197
+
1198
+
1199
+
1200
+ Weighted average Class B ordinary shares outstanding, basic and diluted(3)(4)
1201
+
1202
+
1203
+
1204
+
1205
+
1206
+
1207
+
1208
+
1209
+ 3,750,000
1210
+
1211
+
1212
+
1213
+
1214
+
1215
+
1216
+
1217
+
1218
+
1219
+
1220
+
1221
+
1222
+ 3,750,000
1223
+
1224
+
1225
+
1226
+
1227
+
1228
+
1229
+
1230
+
1231
+
1232
+
1233
+ Basic and diluted net loss per Class B ordinary shares
1234
+
1235
+
1236
+
1237
+
1238
+ $
1239
+
1240
+
1241
+
1242
+ (0.00
1243
+
1244
+
1245
+
1246
+ )
1247
+
1248
+
1249
+
1250
+
1251
+ $
1252
+
1253
+
1254
+
1255
+ (0.00
1256
+
1257
+
1258
+
1259
+ )
1260
+
1261
+
1262
+
1263
+
1264
+
1265
+ ____________
1266
+ (1) Consists of Underwriter Founder Shares issued to the underwriters and/or its designees (see Note 5).
1267
+
1268
+ (2) Through June 30, 2021, the underwriters and/or its designees effected a surrender of 60,000 Class A ordinary shares to the Company for no consideration. Subsequent to balance sheet date, the underwriters and/or its designees effected surrendered additional 40,000 Class A ordinary shares to the Company for no consideration, resulting in a decrease in the total number of Class A ordinary shares outstanding from 400,000 to 300,000. All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 5 and Note 8).
1269
+
1270
+ (3) Through June 30, 2021, the Sponsor effected a surrender of 1,437,500 Class B ordinary shares to the Company for no consideration. Subsequent to balance sheet date, the Sponsor surrendered additional 2,875,000 Class B ordinary shares to the Company for no consideration, resulting in a decrease in the total number of Class B ordinary shares outstanding from 8,625,000 to 4,312,500. All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 5 and Note 8).
1271
+
1272
+ (4) Excludes up to 562,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 7).
1273
+
1274
+ The accompanying notes are an integral part of these financial statements.
1275
+
1276
+
1277
+
1278
+ F-4
1279
+
1280
+ Table of Contents
1281
+
1282
+
1283
+ OXUS ACQUISITION CORP.
1284
+ STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY
1285
+
1286
+
1287
+
1288
+
1289
+
1290
+
1291
+
1292
+
1293
+
1294
+ Class A
1295
+ Ordinary Shares
1296
+
1297
+
1298
+
1299
+
1300
+ Class B
1301
+ Ordinary Shares
1302
+
1303
+
1304
+
1305
+
1306
+ Additional Paid-in Capital
1307
+
1308
+
1309
+
1310
+
1311
+ Accumulated Deficit
1312
+
1313
+
1314
+
1315
+
1316
+ Total Shareholders Equity
1317
+
1318
+
1319
+
1320
+
1321
+
1322
+
1323
+
1324
+
1325
+ Shares
1326
+
1327
+
1328
+
1329
+
1330
+ Amount
1331
+
1332
+
1333
+
1334
+
1335
+ Shares
1336
+
1337
+
1338
+
1339
+
1340
+ Amount
1341
+
1342
+
1343
+
1344
+
1345
+
1346
+
1347
+
1348
+ Balance February 3, 2021 (inception)
1349
+
1350
+
1351
+
1352
+
1353
+
1354
+
1355
+
1356
+
1357
+
1358
+
1359
+
1360
+
1361
+
1362
+ $
1363
+
1364
+
1365
+
1366
+
1367
+
1368
+
1369
+
1370
+
1371
+
1372
+
1373
+
1374
+
1375
+
1376
+
1377
+
1378
+
1379
+
1380
+
1381
+
1382
+
1383
+
1384
+ $
1385
+
1386
+
1387
+
1388
+
1389
+
1390
+
1391
+
1392
+
1393
+
1394
+
1395
+
1396
+
1397
+ $
1398
+
1399
+
1400
+
1401
+
1402
+
1403
+
1404
+
1405
+
1406
+ $
1407
+
1408
+
1409
+
1410
+
1411
+
1412
+
1413
+
1414
+
1415
+
1416
+
1417
+
1418
+
1419
+ $
1420
+
1421
+
1422
+
1423
+
1424
+
1425
+
1426
+
1427
+
1428
+
1429
+
1430
+
1431
+
1432
+
1433
+
1434
+ Issuance of Class B ordinary shares to Sponsor(1)
1435
+
1436
+
1437
+
1438
+
1439
+
1440
+
1441
+
1442
+
1443
+
1444
+
1445
+
1446
+
1447
+
1448
+
1449
+
1450
+
1451
+
1452
+
1453
+
1454
+
1455
+
1456
+
1457
+
1458
+
1459
+
1460
+
1461
+ 8,625,000
1462
+
1463
+
1464
+
1465
+
1466
+
1467
+
1468
+
1469
+
1470
+
1471
+
1472
+
1473
+
1474
+ 863
1475
+
1476
+
1477
+
1478
+
1479
+
1480
+
1481
+
1482
+
1483
+
1484
+
1485
+
1486
+
1487
+ 24,137
1488
+
1489
+
1490
+
1491
+
1492
+
1493
+
1494
+
1495
+
1496
+
1497
+
1498
+
1499
+
1500
+
1501
+
1502
+
1503
+
1504
+
1505
+
1506
+
1507
+
1508
+
1509
+ 25,000
1510
+
1511
+
1512
+
1513
+
1514
+
1515
+
1516
+
1517
+
1518
+
1519
+
1520
+ Surrender of Class B ordinary shares by Sponsor(2)(3)
1521
+
1522
+
1523
+
1524
+
1525
+
1526
+
1527
+
1528
+
1529
+
1530
+
1531
+
1532
+
1533
+
1534
+
1535
+
1536
+
1537
+
1538
+
1539
+
1540
+
1541
+
1542
+
1543
+
1544
+
1545
+
1546
+
1547
+ (4,312,500
1548
+
1549
+
1550
+
1551
+ )
1552
+
1553
+
1554
+
1555
+
1556
+
1557
+
1558
+
1559
+
1560
+ (432
1561
+
1562
+
1563
+
1564
+ )
1565
+
1566
+
1567
+
1568
+
1569
+
1570
+
1571
+
1572
+
1573
+ 432
1574
+
1575
+
1576
+
1577
+
1578
+
1579
+
1580
+
1581
+
1582
+
1583
+
1584
+
1585
+
1586
+
1587
+
1588
+
1589
+
1590
+
1591
+
1592
+
1593
+
1594
+
1595
+
1596
+
1597
+
1598
+
1599
+
1600
+
1601
+
1602
+
1603
+
1604
+
1605
+
1606
+ Net loss
1607
+
1608
+
1609
+
1610
+
1611
+
1612
+
1613
+
1614
+
1615
+
1616
+
1617
+
1618
+
1619
+
1620
+
1621
+
1622
+
1623
+
1624
+
1625
+
1626
+
1627
+
1628
+
1629
+
1630
+
1631
+
1632
+
1633
+
1634
+
1635
+
1636
+
1637
+
1638
+
1639
+
1640
+
1641
+
1642
+
1643
+
1644
+
1645
+
1646
+
1647
+
1648
+
1649
+
1650
+
1651
+
1652
+
1653
+
1654
+
1655
+
1656
+
1657
+
1658
+
1659
+
1660
+
1661
+
1662
+
1663
+
1664
+
1665
+
1666
+
1667
+
1668
+ (17,918
1669
+
1670
+
1671
+
1672
+ )
1673
+
1674
+
1675
+
1676
+
1677
+
1678
+
1679
+
1680
+
1681
+ (17,918
1682
+
1683
+
1684
+
1685
+ )
1686
+
1687
+
1688
+
1689
+
1690
+
1691
+
1692
+ Balance March 22, 2021 (Audited)
1693
+
1694
+
1695
+
1696
+
1697
+
1698
+
1699
+
1700
+
1701
+
1702
+
1703
+
1704
+
1705
+
1706
+
1707
+
1708
+
1709
+
1710
+
1711
+
1712
+
1713
+
1714
+
1715
+
1716
+
1717
+
1718
+
1719
+ 4,312,500
1720
+
1721
+
1722
+
1723
+
1724
+
1725
+
1726
+
1727
+
1728
+ $
1729
+
1730
+
1731
+
1732
+ 431
1733
+
1734
+
1735
+
1736
+
1737
+
1738
+
1739
+
1740
+
1741
+ $
1742
+
1743
+
1744
+
1745
+ 24,569
1746
+
1747
+
1748
+
1749
+
1750
+ $
1751
+
1752
+
1753
+
1754
+ (17,918
1755
+
1756
+
1757
+
1758
+ )
1759
+
1760
+
1761
+
1762
+
1763
+ $
1764
+
1765
+
1766
+
1767
+ 7,082
1768
+
1769
+
1770
+
1771
+
1772
+
1773
+
1774
+
1775
+
1776
+
1777
+
1778
+ Issuance of Underwriter Founder
1779
+ Shares
1780
+
1781
+
1782
+
1783
+
1784
+ 400,000
1785
+
1786
+
1787
+
1788
+
1789
+
1790
+
1791
+
1792
+
1793
+
1794
+
1795
+
1796
+
1797
+ 40
1798
+
1799
+
1800
+
1801
+
1802
+
1803
+
1804
+
1805
+
1806
+
1807
+
1808
+
1809
+
1810
+
1811
+
1812
+
1813
+
1814
+
1815
+
1816
+
1817
+
1818
+
1819
+
1820
+
1821
+
1822
+
1823
+
1824
+
1825
+
1826
+
1827
+
1828
+
1829
+
1830
+
1831
+
1832
+
1833
+
1834
+
1835
+
1836
+
1837
+
1838
+
1839
+
1840
+
1841
+
1842
+
1843
+
1844
+
1845
+
1846
+
1847
+
1848
+
1849
+
1850
+
1851
+
1852
+
1853
+
1854
+ 40
1855
+
1856
+
1857
+
1858
+
1859
+
1860
+
1861
+
1862
+
1863
+
1864
+
1865
+ Surrender of Underwriter Founder Shares(4)
1866
+
1867
+
1868
+
1869
+
1870
+ (100,000
1871
+
1872
+
1873
+
1874
+ )
1875
+
1876
+
1877
+
1878
+
1879
+
1880
+
1881
+
1882
+
1883
+ (10
1884
+
1885
+
1886
+
1887
+ )
1888
+
1889
+
1890
+
1891
+
1892
+
1893
+
1894
+
1895
+
1896
+
1897
+
1898
+
1899
+
1900
+
1901
+
1902
+
1903
+
1904
+
1905
+
1906
+
1907
+
1908
+
1909
+
1910
+
1911
+
1912
+
1913
+
1914
+
1915
+
1916
+
1917
+
1918
+ 10
1919
+
1920
+
1921
+
1922
+
1923
+
1924
+
1925
+
1926
+
1927
+
1928
+
1929
+
1930
+
1931
+
1932
+
1933
+
1934
+
1935
+
1936
+
1937
+
1938
+
1939
+
1940
+
1941
+
1942
+
1943
+
1944
+
1945
+
1946
+
1947
+
1948
+
1949
+
1950
+
1951
+ Net loss
1952
+
1953
+
1954
+
1955
+
1956
+
1957
+
1958
+
1959
+
1960
+
1961
+
1962
+
1963
+
1964
+
1965
+
1966
+
1967
+
1968
+
1969
+
1970
+
1971
+
1972
+
1973
+
1974
+
1975
+
1976
+
1977
+
1978
+
1979
+
1980
+
1981
+
1982
+
1983
+
1984
+
1985
+
1986
+
1987
+
1988
+
1989
+
1990
+
1991
+
1992
+
1993
+
1994
+
1995
+
1996
+
1997
+
1998
+
1999
+
2000
+
2001
+
2002
+
2003
+
2004
+
2005
+
2006
+
2007
+
2008
+
2009
+
2010
+
2011
+
2012
+
2013
+ (790
2014
+
2015
+
2016
+
2017
+ )
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
+
2026
+ (790
2027
+
2028
+
2029
+
2030
+ )
2031
+
2032
+
2033
+
2034
+
2035
+
2036
+
2037
+ Balance June 30, 2021 (Unaudited)
2038
+
2039
+
2040
+
2041
+
2042
+ 300,000
2043
+
2044
+
2045
+
2046
+
2047
+
2048
+
2049
+
2050
+
2051
+ $
2052
+
2053
+
2054
+
2055
+ 30
2056
+
2057
+
2058
+
2059
+
2060
+
2061
+
2062
+
2063
+
2064
+ 4,312,500
2065
+
2066
+
2067
+
2068
+
2069
+
2070
+
2071
+
2072
+
2073
+ $
2074
+
2075
+
2076
+
2077
+ 431
2078
+
2079
+
2080
+
2081
+
2082
+
2083
+
2084
+
2085
+
2086
+ $
2087
+
2088
+
2089
+
2090
+ 24,579
2091
+
2092
+
2093
+
2094
+
2095
+ $
2096
+
2097
+
2098
+
2099
+ (18,708
2100
+
2101
+
2102
+
2103
+ )
2104
+
2105
+
2106
+
2107
+
2108
+ $
2109
+
2110
+
2111
+
2112
+ 6,332
2113
+
2114
+
2115
+
2116
+
2117
+
2118
+
2119
+
2120
+
2121
+
2122
+ ____________
2123
+ (1) Includes up to 1,125,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 7).
2124
+
2125
+ (2) Through June 30, 2021, the Sponsor effected a surrender of 1,437,500 Class B ordinary shares to the Company for no consideration. Subsequent to balance sheet date, the Sponsor surrendered additional 2,875,000 Class B ordinary shares to the Company for no consideration, resulting in a decrease in the total number of Class B ordinary shares outstanding from 8,625,000 to 4,312,500. All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 5 and Note 8).
2126
+
2127
+ (3) Includes up to 562,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 7).
2128
+
2129
+ (4) Through June 30, 2021, the underwriters and/or its designees effected a surrender of 60,000 Class A ordinary shares to the Company for no consideration. Subsequent to balance sheet date, the underwriters and/or its designees effected surrendered additional 40,000 Class A ordinary shares to the Company for no consideration, resulting in a decrease in the total number of Class A ordinary shares outstanding from 400,000 to 300,000. All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 5 and Note 8).
2130
+
2131
+ The accompanying notes are an integral part of these financial statements.
2132
+
2133
+
2134
+
2135
+ F-5
2136
+
2137
+ Table of Contents
2138
+
2139
+
2140
+ OXUS ACQUISITION CORP.
2141
+ STATEMENTS OF CASH FLOWS
2142
+
2143
+
2144
+
2145
+
2146
+
2147
+
2148
+
2149
+
2150
+
2151
+ For the
2152
+ Period from
2153
+ February 3,
2154
+ 2021
2155
+ (inception)
2156
+ through
2157
+ June 30,
2158
+ 2021
2159
+
2160
+
2161
+
2162
+
2163
+ For the
2164
+ Period from
2165
+ February 3,
2166
+ 2021
2167
+ (inception)
2168
+ through
2169
+ March 22,
2170
+ 2021
2171
+
2172
+
2173
+
2174
+
2175
+
2176
+
2177
+
2178
+
2179
+ (Unaudited)
2180
+
2181
+
2182
+
2183
+
2184
+ (Audited)
2185
+
2186
+
2187
+
2188
+
2189
+
2190
+
2191
+ Cash Flows from Operating Activities:
2192
+
2193
+
2194
+
2195
+
2196
+
2197
+
2198
+
2199
+
2200
+
2201
+
2202
+
2203
+
2204
+
2205
+
2206
+
2207
+
2208
+
2209
+
2210
+
2211
+
2212
+
2213
+
2214
+
2215
+
2216
+
2217
+
2218
+ Net loss
2219
+
2220
+
2221
+
2222
+
2223
+ $
2224
+
2225
+
2226
+
2227
+ (18,708
2228
+
2229
+
2230
+
2231
+ )
2232
+
2233
+
2234
+
2235
+
2236
+ $
2237
+
2238
+
2239
+
2240
+ (17,918
2241
+
2242
+
2243
+
2244
+ )
2245
+
2246
+
2247
+
2248
+
2249
+
2250
+
2251
+ Adjustments to reconcile net loss to net cash used in operating activities:
2252
+
2253
+
2254
+
2255
+
2256
+
2257
+
2258
+
2259
+
2260
+
2261
+
2262
+
2263
+
2264
+
2265
+
2266
+
2267
+
2268
+
2269
+
2270
+
2271
+
2272
+
2273
+
2274
+
2275
+
2276
+
2277
+
2278
+ Changes in operating assets and liabilities:
2279
+
2280
+
2281
+
2282
+
2283
+
2284
+
2285
+
2286
+
2287
+
2288
+
2289
+
2290
+
2291
+
2292
+
2293
+
2294
+
2295
+
2296
+
2297
+
2298
+
2299
+
2300
+
2301
+
2302
+
2303
+
2304
+
2305
+ Accrued offering costs and expenses
2306
+
2307
+
2308
+
2309
+
2310
+
2311
+
2312
+
2313
+
2314
+ 790
2315
+
2316
+
2317
+
2318
+
2319
+
2320
+
2321
+
2322
+
2323
+
2324
+
2325
+
2326
+
2327
+
2328
+
2329
+
2330
+
2331
+
2332
+
2333
+
2334
+
2335
+
2336
+
2337
+
2338
+ Net cash used in operating activities
2339
+
2340
+
2341
+
2342
+
2343
+
2344
+
2345
+
2346
+
2347
+ (17,918
2348
+
2349
+
2350
+
2351
+ )
2352
+
2353
+
2354
+
2355
+
2356
+
2357
+
2358
+
2359
+
2360
+ (17,918
2361
+
2362
+
2363
+
2364
+ )
2365
+
2366
+
2367
+
2368
+
2369
+
2370
+
2371
+
2372
+
2373
+
2374
+
2375
+
2376
+
2377
+
2378
+
2379
+
2380
+
2381
+
2382
+
2383
+
2384
+
2385
+
2386
+
2387
+
2388
+
2389
+
2390
+
2391
+
2392
+
2393
+
2394
+
2395
+ Cash flows from financing activities:
2396
+
2397
+
2398
+
2399
+
2400
+
2401
+
2402
+
2403
+
2404
+
2405
+
2406
+
2407
+
2408
+
2409
+
2410
+
2411
+
2412
+
2413
+
2414
+
2415
+
2416
+
2417
+
2418
+
2419
+
2420
+
2421
+
2422
+ Proceeds from issuance of Class B ordinary shares to Sponsor
2423
+
2424
+
2425
+
2426
+
2427
+
2428
+
2429
+
2430
+
2431
+ 25,000
2432
+
2433
+
2434
+
2435
+
2436
+
2437
+
2438
+
2439
+
2440
+
2441
+
2442
+
2443
+
2444
+ 25,000
2445
+
2446
+
2447
+
2448
+
2449
+
2450
+
2451
+
2452
+
2453
+
2454
+
2455
+ Proceeds from promissory note related party
2456
+
2457
+
2458
+
2459
+
2460
+
2461
+
2462
+
2463
+
2464
+ 279,935
2465
+
2466
+
2467
+
2468
+
2469
+
2470
+
2471
+
2472
+
2473
+
2474
+
2475
+
2476
+
2477
+
2478
+
2479
+
2480
+
2481
+
2482
+
2483
+
2484
+
2485
+
2486
+
2487
+
2488
+ Payment of offering costs
2489
+
2490
+
2491
+
2492
+
2493
+
2494
+
2495
+
2496
+
2497
+ (199,283
2498
+
2499
+
2500
+
2501
+ )
2502
+
2503
+
2504
+
2505
+
2506
+
2507
+
2508
+
2509
+
2510
+ (7,082
2511
+
2512
+
2513
+
2514
+ )
2515
+
2516
+
2517
+
2518
+
2519
+
2520
+
2521
+ Net cash provided by financing activities
2522
+
2523
+
2524
+
2525
+
2526
+
2527
+
2528
+
2529
+
2530
+ 105,652
2531
+
2532
+
2533
+
2534
+
2535
+
2536
+
2537
+
2538
+
2539
+
2540
+
2541
+
2542
+
2543
+ 17,918
2544
+
2545
+
2546
+
2547
+
2548
+
2549
+
2550
+
2551
+
2552
+
2553
+
2554
+
2555
+
2556
+
2557
+
2558
+
2559
+
2560
+
2561
+
2562
+
2563
+
2564
+
2565
+
2566
+
2567
+
2568
+
2569
+
2570
+
2571
+
2572
+
2573
+
2574
+
2575
+
2576
+
2577
+
2578
+ Net Change in Cash:
2579
+
2580
+
2581
+
2582
+
2583
+
2584
+
2585
+
2586
+
2587
+ 87,734
2588
+
2589
+
2590
+
2591
+
2592
+
2593
+
2594
+
2595
+
2596
+
2597
+
2598
+
2599
+
2600
+
2601
+
2602
+
2603
+
2604
+
2605
+
2606
+
2607
+
2608
+
2609
+
2610
+
2611
+ Cash Beginning
2612
+
2613
+
2614
+
2615
+
2616
+
2617
+
2618
+
2619
+
2620
+
2621
+
2622
+
2623
+
2624
+
2625
+
2626
+
2627
+
2628
+
2629
+
2630
+
2631
+
2632
+
2633
+
2634
+
2635
+
2636
+
2637
+
2638
+
2639
+
2640
+
2641
+
2642
+
2643
+
2644
+ Cash Ending
2645
+
2646
+
2647
+
2648
+
2649
+ $
2650
+
2651
+
2652
+
2653
+ 87,734
2654
+
2655
+
2656
+
2657
+
2658
+
2659
+
2660
+
2661
+
2662
+ $
2663
+
2664
+
2665
+
2666
+
2667
+
2668
+
2669
+
2670
+
2671
+
2672
+
2673
+
2674
+
2675
+
2676
+
2677
+
2678
+
2679
+
2680
+
2681
+
2682
+
2683
+
2684
+
2685
+
2686
+
2687
+
2688
+
2689
+
2690
+
2691
+
2692
+
2693
+
2694
+
2695
+
2696
+
2697
+
2698
+
2699
+
2700
+
2701
+ Supplemental disclosure of non-cash investing and financing activities:
2702
+
2703
+
2704
+
2705
+
2706
+
2707
+
2708
+
2709
+
2710
+
2711
+
2712
+
2713
+
2714
+
2715
+
2716
+
2717
+
2718
+
2719
+
2720
+
2721
+
2722
+
2723
+
2724
+
2725
+
2726
+
2727
+
2728
+
2729
+
2730
+
2731
+
2732
+
2733
+
2734
+ Deferred offering costs in accrued offering costs and expenses
2735
+
2736
+
2737
+
2738
+
2739
+ $
2740
+
2741
+
2742
+
2743
+ 32,051
2744
+
2745
+
2746
+
2747
+
2748
+
2749
+
2750
+
2751
+
2752
+ $
2753
+
2754
+
2755
+
2756
+ 24,129
2757
+
2758
+
2759
+
2760
+
2761
+
2762
+
2763
+
2764
+
2765
+
2766
+
2767
+ Issuance of Underwriter Founder Shares
2768
+
2769
+
2770
+
2771
+
2772
+ $
2773
+
2774
+
2775
+
2776
+ 40
2777
+
2778
+
2779
+
2780
+
2781
+
2782
+
2783
+
2784
+
2785
+ $
2786
+
2787
+
2788
+
2789
+
2790
+
2791
+
2792
+
2793
+
2794
+
2795
+
2796
+
2797
+
2798
+
2799
+
2800
+ Surrender of Underwriter Founder Shares
2801
+
2802
+
2803
+
2804
+
2805
+ $
2806
+
2807
+
2808
+
2809
+ (10
2810
+
2811
+
2812
+
2813
+ )
2814
+
2815
+
2816
+
2817
+
2818
+ $
2819
+
2820
+
2821
+
2822
+
2823
+
2824
+
2825
+
2826
+
2827
+
2828
+
2829
+
2830
+
2831
+
2832
+ The accompanying notes are an integral part of these financial statements.
2833
+
2834
+
2835
+
2836
+ F-6
2837
+
2838
+ Table of Contents
2839
+
2840
+
2841
+ OXUS ACQUISITION CORP.
2842
+ NOTES TO FINANCIAL STATEMENTS
2843
+
2844
+ NOTE 1 ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS
2845
+
2846
+ Oxus Acquisition Corp. (the Company ) is a blank check company incorporated in the Cayman Islands on February 3, 2021. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a Business Combination ). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.
2847
+
2848
+ Although the Company is not limited to a particular industry or geographic region for purposes of completing a Business Combination, the Company intends to focus its search on targets in energy transition technologies, such as battery materials, energy storage, electric vehicle ( EV ) infrastructure and advanced recycling in emerging/frontier countries including the Commonwealth of Independent States ( CIS ), South and South-East Asia and Middle East and North Africa ( MENA ) regions. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
2849
+
2850
+ As of June 30, 2021, the Company had not commenced any operations. All activity for the period from February 3, 2021 (inception) through June 30, 2021 relates to the Company s formation and the proposed initial public offering ( Proposed Public Offering ), which is described below. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Proposed Public Offering. The Company has selected December 31 as its fiscal year end.
2851
+
2852
+ The Company s ability to commence operations is contingent upon obtaining adequate financial resources through a Proposed Public Offering of 15,000,000 units (the Units and, with respect to the ordinary shares included in the Units being offered, the Public Shares ) at $10.00 per Unit (or 17,250,000 Units if the underwriters over-allotment option is exercised in full), which is discussed in Note 3, and the sale of warrants (the Private Warrants ) in a private placement to Oxus Capital Pte. Ltd. (the Sponsor ) that will close simultaneously with the Proposed Public Offering.
2853
+
2854
+ The Company s management has broad discretion with respect to the specific application of the net proceeds of the Proposed Public Offering and the sale of the Private Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more operating businesses or assets that together have an aggregate fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions) at the time of the Company s signing a definitive agreement in connection with its initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires an interest in the target business or assets sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the Investment Company Act ). Upon the closing of the Proposed Public Offering, management has agreed that an amount equal to at least $10.20 per Unit sold in the Proposed Public Offering, including the proceeds from the sale of the Private Warrants, will be held in a trust account ( Trust Account ), located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.
2855
+
2856
+ The Company will provide its holders of the outstanding Public Shares (the public shareholders ) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.20 per Public Share, plus any pro rata interest
2857
+
2858
+
2859
+
2860
+ F-7
2861
+
2862
+ Table of Contents
2863
+
2864
+
2865
+ OXUS ACQUISITION CORP.
2866
+ NOTES TO FINANCIAL STATEMENTS
2867
+
2868
+ NOTE 1 ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS (cont.)
2869
+
2870
+ earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company s warrants. The Public Shares subject to redemption will be recorded at redemption value and classified as temporary equity upon the completion of the Proposed Public Offering in accordance with the Financial Accounting Standards Board s ( FASB ) Accounting Standards Codification ( ASC ) Topic 480 Distinguishing Liabilities from Equity.
2871
+
2872
+ The Company will only proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by applicable law or stock exchange rules and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the Amended and Restated Certificate of Incorporation ), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission ( SEC ) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by applicable law or stock exchange rules, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5), and any Public Shares purchased during or after the Proposed Public Offering in favor of approving a Business Combination. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all.
2873
+
2874
+ Notwithstanding the above, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Certificate of Incorporation provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a group (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the Exchange Act )), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.
2875
+
2876
+ The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares (as defined at Note 5) and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Company s obligation to allow redemption in connection with the Company s initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to shareholders rights or pre-initial business combination activity, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
2877
+
2878
+ The Company will have until 18 months from the closing of the Proposed Public Offering to complete a Business Combination (the Combination Period ). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company s remaining shareholders and the Company s board of directors, dissolve and liquidate, subject in each case to the Company s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.
2879
+
2880
+ The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares (as defined at Note 5) if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Proposed Public Offering, such Public Shares will be entitled to liquidating distributions
2881
+
2882
+
2883
+
2884
+ F-8
2885
+
2886
+ Table of Contents
2887
+
2888
+
2889
+ OXUS ACQUISITION CORP.
2890
+ NOTES TO FINANCIAL STATEMENTS
2891
+
2892
+ NOTE 1 ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS (cont.)
2893
+
2894
+ from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Proposed Public Offering price per Unit ($10.00).
2895
+
2896
+ In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.20 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company s indemnity of the underwriters of the Proposed Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the Securities Act ). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
2897
+
2898
+ Going Concern Consideration
2899
+
2900
+ At June 30, 2021, the Company had $87,734 in cash and a working capital deficiency of $224,212. The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. These conditions raise substantial doubt about the Company s ability to continue as a going concern within one year after the date that the financial statements are issued. Management plans to address this uncertainty through the Proposed Public Offering as discussed in Note 3. There is no assurance that the Company s plans to raise capital or to consummate a Business Combination will be successful or successful within the Combination Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
2901
+
2902
+ Risks and Uncertainties
2903
+
2904
+ Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
2905
+
2906
+ NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
2907
+
2908
+ Basis of Presentation
2909
+
2910
+ The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America ( GAAP ) and pursuant to the rules and regulations of the SEC.
2911
+
2912
+ Emerging Growth Company
2913
+
2914
+ The Company is an emerging growth company, as defined in Section 2(a) of the Securities Act, as amended by the Jumpstart Our Business Startups Act of 2012, (the JOBS Act ), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of
2915
+
2916
+
2917
+
2918
+ F-9
2919
+
2920
+ Table of Contents
2921
+
2922
+
2923
+ OXUS ACQUISITION CORP.
2924
+ NOTES TO FINANCIAL STATEMENTS
2925
+
2926
+ NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)
2927
+
2928
+ Emerging Growth Company (cont.)
2929
+
2930
+ Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
2931
+
2932
+ Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
2933
+
2934
+ Use of Estimates
2935
+
2936
+ The preparation of financial statements in conformity with GAAP requires the Company s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
2937
+
2938
+ Cash and Cash Equivalents
2939
+
2940
+ The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021.
2941
+
2942
+ Deferred Offering Costs Associated with the Proposed Public Offering
2943
+
2944
+ Deferred offering costs consist of legal, accounting, and other expenses incurred through the balance sheet date that are directly related to the Proposed Public Offering and that will be charged to shareholders equity upon the completion of the Proposed Public Offering. Should the Proposed Public Offering prove to be unsuccessful, these deferred costs, as well as additional expenses to be incurred, will be charged to operations.
2945
+
2946
+ Net Loss Per Ordinary Share
2947
+
2948
+ The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, Earnings Per Share. Net loss per ordinary shares is computed by dividing net loss attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average ordinary shares at June 30, 2021 were reduced for the effect of an aggregate of 562,500 ordinary shares that are subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 6). As of June 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per ordinary share is the same as basic loss per ordinary share for the period presented.
2949
+
2950
+ Concentration of Credit Risk
2951
+
2952
+ Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the federal depository insurance coverage corporation limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
2953
+
2954
+
2955
+
2956
+ F-10
2957
+
2958
+ Table of Contents
2959
+
2960
+
2961
+ OXUS ACQUISITION CORP.
2962
+ NOTES TO FINANCIAL STATEMENTS
2963
+
2964
+ NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)
2965
+
2966
+ Financial Instruments
2967
+
2968
+ The fair value of the Company s assets and liabilities, which qualify as financial instruments under FASB ASC 820, Fair Value Measurements and Disclosures, approximates the carrying amounts represented in the balance sheets.
2969
+
2970
+ Income Taxes
2971
+
2972
+ The Company complies with the accounting and reporting requirements of FASB ASC, 740, Income Taxes, . Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. There were no unrecognized tax benefits as of June 30, 2021.
2973
+
2974
+ FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at June 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
2975
+
2976
+ The provision for income taxes was deemed to be de minimis for the period from February 3, 2021 (inception) through June 30, 2021.
2977
+
2978
+ Warrant Liabilities
2979
+
2980
+ ASC 480 requires a reporting entity to classify certain freestanding financial instruments as liabilities (or in some cases as assets). ASC 480-10-S99 addresses concerns raised by the SEC regarding the financial statement classification and measurement of securities subject to mandatory redemption requirements or whose redemption is outside the control of the issuer. If the stock subject to mandatory redemption provisions represents the only shares in the reporting entity, it must report instruments in the liabilities section of its statement of financial position. The stock subject must then describe them as shares subject to mandatory redemption, so as to distinguish the instruments from other financial statement liabilities. The Company concludes that the Public Unit Warrants do not exhibit any of the above characteristics and, therefore, are outside the scope of ASC 480.
2981
+
2982
+ The Company will account for the 23,400,000 warrants to be issued in connection with this offering (representing 15,000,000 public warrants included in the units and 8,400,000 private placement warrants, assuming the underwriters over-allotment option is not exercised) in accordance with the guidance contained in ASC 815-40, Derivatives and Hedging Contracts in Entity s Own Equity. Such guidance provides that because the warrants meet the criteria for equity treatment.
2983
+
2984
+ Recent Accounting Pronouncements
2985
+
2986
+ Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company s financial statements.
2987
+
2988
+ NOTE 3 PROPOSED PUBLIC OFFERING
2989
+
2990
+ Pursuant to the Proposed Public Offering, the Company will offer for sale up to 15,000,000 Units (or 17,250,000 Units if the underwriters over-allotment option is exercised in full) at a purchase price of $10.00 per Unit. Each Unit will consist of one ordinary share and one warrant ( Public Warrant ). Each Public Warrant will entitle the holder to purchase one ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 7).
2991
+
2992
+
2993
+
2994
+ F-11
2995
+
2996
+ Table of Contents
2997
+
2998
+
2999
+ OXUS ACQUISITION CORP.
3000
+ NOTES TO FINANCIAL STATEMENTS
3001
+
3002
+ NOTE 4 PRIVATE WARRANTS
3003
+
3004
+ The Sponsor and the underwriters have committed to purchase an aggregate of 8,400,000 Private Warrants (or 9,300,000 Private Warrants if the underwriters over-allotment is exercised in full) at a price of $1.00 per Private Warrant from the Company in a private placement that will occur simultaneously with the closing of the Proposed Public Offering. Each Private Warrant is exercisable for one ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7). The proceeds from the sale of the Private Warrants will be added to the net proceeds from the Proposed Public Offering held in the Trust Account.
3005
+
3006
+ If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Warrants will expire worthless.
3007
+
3008
+ NOTE 5 RELATED PARTY TRANSACTIONS
3009
+
3010
+ Founder Shares
3011
+
3012
+ During the period from February 3, 2021 (inception) through March 22, 2021, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration for 8,625,000 Class B ordinary shares (the Founder Shares ).
3013
+
3014
+ The Founder Shares include an aggregate of up to 1,125,000 Class B ordinary shares subject to forfeiture by the Sponsor to the extent that the underwriters over-allotment is not exercised in full or in part, so that the number of Founder Shares will collectively represent 20% of the Company s issued and outstanding shares upon the completion of the Proposed Public Offering.
3015
+
3016
+ Through June 30, 2021, the Sponsor returned to the Company for no consideration, an aggregate of 1,437,500 Founder Shares, which have been cancelled.
3017
+
3018
+ Subsequent to balance sheet date, the Sponsor transferred an aggregate of 150,000 Founder Shares to the Company s independent director nominees.
3019
+
3020
+ Subsequent to balance sheet date, the Sponsor surrendered additional 2,875,000 Founder Shares to the Company for no consideration, resulting in a decrease in the total number of Class B ordinary shares outstanding from 8,625,000 to 4,312,500 (up to 562,500 of which are subject to forfeiture by the Sponsor if the underwriters over-allotment option is not exercised in full). All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 8).
3021
+
3022
+ Founder Shares are subject to lock-up until (i) with respect to 50% of the Founder Shares, the earlier of one year after the date of the consummation of the initial business combination and the date on which the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations and re